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Abstract 
 
Nathan E. Hudson: The Structural Hierarchy and Mechanical Properties of Fibrin 
Described with a Multi-scale Model 
(Under the Direction of Professors Richard Superfine and Michael R. Falvo) 
 
 Fibrin networks form the structural scaffold of blood clots during hemostasis.  To 
survive in the dynamic environment of the vasculature, these networks have a diverse set 
of mechanical and dynamical properties.  In this work, a series of experiments and 
molecular dynamics simulations bridge the gap between the mechanical properties of 
fibrin networks and the origins of those properties at the fiber and molecular scales.  
Mechanical measurements on individual fibrin fibers indicated that fibrin fibers are soft 
in stretching, strain stiffen, and exhibit an increased stiffness when ligated by 
transglutaminase FXIIIa.  We hypothesized that these properties derived from one 
particular part of the fibrin molecule, the αC region and developed a mechanical model 
for the fiber based on the extension of the αC region.  Measurements on the recoil 
dynamics of fibrin fibers indicated that they recoil on μs timescales and regain their full 
tension within a few ms of relaxation in agreement with the αC model.  In spite of the 
success of the αC extension model, the fibrin molecule is complex and several other 
regions including the coiled coil region and the γ-nodule have previously been implicated 
as potential sources of extension.  To test these hypotheses we ran constant force Steered 
Discrete Molecular Dynamics Simulations on each region of the fibrin molecule.  The 
simulations confirmed that the αC region is the most likely to extend at forces as low as 
10pN, but implicated other regions of the molecule as well.  This led a more complete 
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model for the mechanical properties of individual fibrin fibers dubbed the SLαCK model.  
Finally, to probe how the mechanical properties of individual fibrin fibers affect network 
strength, 2-D fibrin networks suspended between channels were stretched to failure using 
and Atomic Force Microscope.  The strain of individual fibers in the network was 
tracked, and it was shown that fibrin network strength is enhanced by the strain stiffening 
of individual fibrin fibers.  This work provides a framework for a predictive model in 
which the affects from alterations at the molecular level could be observed in the 
mechanical properties of the higher levels of the hierarchy. 
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Chapter 1. Introduction 
1.1 Fibrinogen and Fibrin: Structure and Polymerization 
 The cardiovascular system consists of a network of arteries, capillaries and veins 
(the vasculature) designed to distribute oxygen and nutrients throughout the body.  The 
vasculature can be a very dynamic environment with the heart pumping blood at 1Hz, 
and shear rates ranging from close to 0s
-1
 in near static conditions up to 100,000s
-1
 in 
areas of stenosis.(1)  In spite of the wide range of environmental conditions, the body 
must have a functioning wound healing system that can withstand the high shear rates, 
without plugging the vasculature at low shear rates.  The physiological ability to 
accommodate this dynamic range of behaviors is achieved in large part through the 
properties of the blood protein fibrinogen and its activated counterpart fibrin.   
 Fibrin and fibrinogen play a complex and important role in the process of 
hemostasis, the stopping of blood flow near a wound.  The soluble fibrinogen molecule is 
the third most prevalent protein in the blood plasma, and acts as a molecular link to 
mediate platelet aggregation at the sight of a wound.(2)  Subsequently, fibrinogen is 
converted into insoluble fibrin, which polymerizes sequentially, through specific 
interactions into larger linear fibers and eventually networks which form the structural 
backbone of blood clots. (3-7)  Formation of these networks, which comprise only 0.25% 
of the volume of a physiological clot, is the last step of the blood coagulation cascade, the 
chemical process of blood clot formation.(8)  After the wound healing process completes, 
an additional protein called plasmin can cleave the fibrin molecule at specific sites in a 
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process called fibrinolysis and dissolve the fibrin network, allowing blood to circulate 
freely again.(9, 10)  Proper wound healing requires that the clot polymerize properly, 
withstand any shear stresses without failing, and dissolve rapidly after the healing is 
complete.   
 Clinically, patients with severe bleeding disorders can often have the roots of the 
diatheses traced back to an abnormality in fibrinogen (dysfibrinogenemias).  Fibrinogen 
Gaurenas for example truncates 143 amino acids short in the C-terminus of its α-chain.  
Clots formed from this fibrinogen variant were three times stiffer than those of normal 
fibrinogen, while at the same time consisted of thinner and more highly branched 
fibers.(11)  Thus, an abnormality at the molecular level led to morphology changes on 
both the fiber and network levels resulting in stiffer clots and sever bleeding.  This 
example highlights the importance of having a model for fibrin polymerization, fiber and 
network structure, and the mechanical properties arising from these organizations.  The 
goal of this dissertation is to generate a multi-scale model of the mechanical and 
dynamical properties of fibrin based on the structural hierarchy of the material.  This 
model highlights the unique material properties of fibrin that allow it to function as a 
sealant within the vasculature while suggesting regions of the molecule that could be 
altered through protein design to tune the properties at higher levels in the hierarchy. 
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Figure 1.1 The Fibrin Hierarchy:  Fibrin, as a protein based biopolymer, has a 
structural hierarchy spanning many orders of spatial magnitude.  The lowest level is a 
chain of amino acids; these fold into secondary structures such as helical turns.  These 
secondary structures form tertiary structures containing α-helices and β-sheets.  Finally 
these structures combine to form the whole molecule.  These molecules then polymerize 
into protofibrils, fibers and eventually networks.  A complete model of the fibrin 
hierarchy, will be able to predict how a mutation in a particular amino acid will affect the 
mechanics of fibrin networks. 
1.1.1  Fibrin(ogen) Molecular Structure 
 Human fibrinogen is a soluble 340 kDa glycoprotein found in the blood stream.  
The structure of the molecule can be observed in Figure 1.2.  It is assembled as a dimer of 
two subunits of three amino acid chains (called A, B, and ) each.(6)  The chains 
consist of 610, 461 and 411 amino acid residues respectively.  Amino acid chains, or 
polypeptides, are structurally polar, with an amino end (N-terminus) and a carboxyl end 
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(C-terminus).  Within the fibrinogen molecule, all six chains are oriented so that their N-
termini are located in the central region (historically called the E region) of the molecule, 
and their C-termini are located in the periphery (See Figure 1.2).  From both sides of the 
central nodule, three chains extend into coiled-coils that terminate in the two distal 
nodules. The C-terminal segments of the B and  chains fold independently to form the 
compact, globular - and -nodules, respectively (the last part of the coiled-coil 
combined with the β-nodule and γ-nodule are referred to as the D region).  The C-
terminal segment of the A chain goes through the D region, and folds back to form a 
brief fourth α-helix, but beyond this fourth coil the structure of the C-terminus of the A 
chain (the αC region) is not visible in the X-ray structure indicating an inhering flexibility 
in this region.(12)  The αC region is often grouped into two sub regions, the αC connector 
(221-391) and the αC domain (392-610).  The αC connector region is thought to be 
unstructured while there exists some debate about the structure of the αC domain.(13, 14)   
 The molecule is stabilized by 29 di-sulfide bonds, pictured in yellow in Figure 
1.2.  Five of the di-sulfides link the two subunits of the molecule together near the N-
termini of the A, B, and  chains (Aα1Cys28- Aα2Cys28, γ1Cys8-γ2Cys9, γ1Cys9-
γ2Cys8, Aα1Cys36- Bβ2Cys65, and Aα2Cys36- Bβ1Cys65). (15-17)  The coiled coil 
region of the molecule is book-ended by a ring of interchain disulfides: αCys45-γCys23, 
αCys49-βCys76, and βCys80-γCys19 on the N-terminal side of the coiled coil and 
αCys161-γCys135, αCys165-βCys193, and γCys139-βCys197 in the C-terminal 
region.(18, 19)  The rest of the disulfides are intrachain in the C-terminal portions of the 
molecule: the αC region is connected via AαCys442-AαCys472; the βC region via 
BβCys201- BβCys286, BβCys211-BβCys240, and BβCys394- BβCys407; and the γ-C 
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region via γCys153-γCys182 and γCys326-γCys339.(12, 19)  Taken as a whole, the di-
sulfide bonds make portions of the molecule much more mechanically stable to resist 
forced unfolding as will be discussed more in chapter 3.  From one γ-nodule to the other, 
the structured part of the molecule measures 45nm, which gives it a half-distance of 
22.5nm; and the coiled coil regions of the molecule measure 17nm each.   
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Figure 1.2  The Fibrinogen molecule: The fibrinogen molecule above was created using 
crystal structure 3GHG(12), combined with Discrete Molecular Dynamics Methods 
(DMD, see Appendix A) to fill in amino acids Aα1-26, Aα201-610 and Bβ1-57.  This 
image is intended to highlight various parts of the fibrinogen molecule, however it should 
not be treated as an exact representation of the structure of the molecule in solution or 
even within a fiber as it has inherent flexibility not represented in this view.  Aα201-610 
were modeled from homology modeling as described in section 3.3.  The αC connector 
region is largely unstructured and links to the bulk of the model, while the αC domain is 
seen as a β-helix.  The Aα chain is colored in green, the Bβ chain is colored in red, and 
the γ chain is colored in blue.  The 29 cysteins participating in di-sulfide bonds are 
represented as spheres and colored in yellow.  FpA is colored in purple and FpB is 
colored in cyan, both are removed upon the conversion from fibrinogen to fibrin.  It 
should be noted that the location of the αC regions is not known.  Some data indicates 
that it is packed against the bulk of the molecule or attached to FpB.  Here we have left it 
separate from the molecule as it would likely be in fibrin.  The image was generated in 
PYMOL (The PyMOL Molecular Graphics System, Version 1.4, Schrödinger, LLC.). 
 8 
 
 
  Fibrinogen is converted into the insoluble fibrin when the enzyme thrombin 
cleaves fibrinogen at 4 sites: after residue 16 in each A chain releasing fibrinopeptide A 
(FpA), and after residue 14 in the B chain releasing fibrinopeptide B (FpB).(6)  After 
FpA and FpB release, the fibrin chains are known simply as α, β, and γ, and exposed 
binding sites known respectively as knob A and knob B are active.  Knob A consists of 
the α17-19 Gly-Pro-Arg residues, while knob B consists of β15-17 Gly-His-Arg 
residues.(20)  The A and B knobs bind to complimentary “holes” (hole a and hole b 
respectively) in the peripheral D domains of nearby fibrin molecules; forming A:a and 
B:b interactions mediated primarily through electrostatic salt bridges and hydrogen bond 
interactions.(19, 21)  These knob-hole interactions, allow for the formation of a half-
staggered fibrin molecule arrangement in which the knobs in the E region of one 
molecule, bind to holes in two nearby molecules. (See Figure 1.3a)  The half-staggered 
polymerization allows additional molecules to continuously bind to the unbound knobs at 
the end of the overlapping molecule.  As this occurs, the chain extends longitudinally into 
a double-stranded fibrin polymer that has been termed a protofibril (Figure 1.3b).(22)  
Finally, the protofibrils bundle together laterally to form fibers.  This process may be 
mediated by the B:b interactions, which are believed to form after the A:a interactions, or 
by the fibrin αC region.(23-26)   
 Simultaneously with FpA and FpB cleavage, thrombin also catalyzes the 
activation of FXIII to FXIIIa, which is bound to fibrinogen and fibrin.  FXIIIa, also called 
fibrin stabilizing factor is a transglutaminase that catalyzes the formation of isopeptide 
bonds (intermittently known as ligation or cross-linking) between γ1Lys406-γ2Gln398 or 
γ2Gln399 at the C-terminal γ-nodules, forming longitudinal γ–γ dimers (See Figure 1.3a, 
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and note the nomenclature, the interface between two adjacent γ-nodules will be referred 
to as the γ-γ interface).(27)  These interactions, serve to strengthen the protofibrils.  It has 
been proposed that rather than γ-γ dimers, FXIIIa serves to cross-link latitudinally, (See 
Figure 1.6) but that is the minority view and seems to conflict with mechanical data.(28)  
Additionally, FXIIIa, can form bonds and between αC regions of several fibrin 
molecules, forming networks termed α polymers. (29, 30) 
  While this is the standard model of polymerization, it should be noted that there 
has been controversy even recently as to the exact molecular packing of protofibrils and 
the type of interactions and locations of those interactions within protofibrils.(7, 31-33)  
In developing our mechanical model, we have assumed the standard model of 
polymerization, but it is possible that future insights will require an update to the model 
including the alternative packing arrangements within the fiber. 
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Figure 1.3 Fibrin knob:hole interactions and Protofibril Formation:  Fibrin 
polymerization proceeds through a series of knob-hole interactions.  Knob A is exposed 
by the thrombin cleavage of FpA and knob B is exposed by thrombin cleavage of FpB 
(See Figure 1.2 and text).  Both A-knobs bind to corresponding “hole a’s” located in the 
C-terminal region of the γ chain of adjacent molecules.  In the figure, the molecule with 
the exposed knobs (green chains) is labeled as molecule 1, and the molecules with the 
holes are molecules 2 and 3.  Similarly, the B-knobs (red chains) bind to “hole b’s” in the 
C-terminal region of the β chain.   The abutment of the D region of molecule with the D 
region of molecule 3 will be referred to in this document as the γ-γ interface. Image (A) 
was generated in PYMOL (The PyMOL Molecular Graphics System, Version 1.4, 
Schrödinger, LLC.).  The original structure was taken from the D-D crystal structure 
published as 1FZC in the protein data base.(34)  The FXIIIa ligation site located in amino 
acids γ398-411 was not present in the crystal structure, and was built into the model using 
DMD. The Aα chain is colored in green, the Bβ chain is colored in red, the γ chain is 
colored in blue, and the di-sulfide bonds are represented as yellow spheres.  The 
knob:hole interactions allow the formation of a double-stranded protofibril as seen in 
image (B).  The αC regions were omitted from the protofibril image for simplicity. 
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1.1.2 The Fibrin Fiber Structure 
 In order to understand the mechanical properties of fibrin fibers, one first must 
understand how the fibrin molecules are packed within the fibers.  This is crucial because 
a fiber where protofibrils span the entire length of the fiber and are packed tightly in 
parallel across the width of the fiber has the potential to behave much differently than a 
fiber consisting of short protofibrils packed loosely within the fiber and held together by 
tethers such as the αC region. 
 Fibrin fibers were first imaged using electron microscopy by Hawn and Porter 
in 1947(35).  They reported seeing fiber bundles, and a banding pattern of 25nm.  They 
also reported that the banding pattern seemed to vary with fibers presumably under 
tension.  C.E. Hall continued this work in 1949, where he measured a banding pattern on 
average of 22.7nm (although the actual banding ranged from 19-27nm) down the length 
of the fiber.(36, 37)  This work was followed up by C. Cohen in 1966, who showed that 
fibrinogen, under certain ionic conditions, can also form structures with 22.6nm 
banding(38).  The banding patterns indicate that there is a lateral registry between 
protofibrils in the fiber (See Figure 1.4).  Based on these measurements, J Hermans in 
1979 proposed that fibrin fibers have a crystalline structure, and proposed four possible 
packing orientations(39).  In 1980, R Hantgan and J Hermans did a comparison of EM 
structures of fibrin at different stages of polymerization and compared those images to 
light scattering data(40).  They saw that at many stages in polymerization, the fibers 
appear like loose bundles.  In 1981, Weisel and Cohen used recent x-ray data to suggest 
that the fibrin monomer was more complicated than a simple dumb-bell shape, and had 
additional outer units, corresponding to the sub-banding pattern of 7-9nm often observed 
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between the 22.5nm bands in EM images(41).  Voter and Erickson then used 
Transmission Electron Microscopy (TEM) sectioning and Small Angle X-ray Scattering 
(SASX) to look for crystallinity within the lateral cross-section of a fiber(42).  They 
concluded that there did not seem to be any repeating pattern within the fiber cross-
sections. In the same year, using refractive index matching, Voter and Erickson reported 
that fibers consist of 78% water(43).  Also in 1986, Weisel attempted a variety of staining 
techniques with TEM imaging to look for lateral order.  He noted that the banding in the 
fibers exhibited a saw-toothed pattern at the edges of the fibers. He reported seeing 
“diffuse equatorial reflections” in the lateral diffraction pattern across the edges of the 
fibers with a 4nm spacing using most stains, and in 6/300 fibers he reported a strong 
equatorial reflections with 19.5nm spacing(44).  A year later using a “cryo-drying” 
technique with negative staining, Weisel reported seeing a twisting of the fibers with a 
pitch of 1.9µm, presumably coming from protofibrils wrapping around the fiber, limiting 
radial growth.(45)  In 1990, negatively stained images from the early stages of fibrin 
polymerization by Medved and Weisel showed that protofibrils themselves are 
twisted.(46)  These observations of twisting prompted the hypothesis that fibrin fibers 
form under tension because protofibrils must stretch to stay in registry while wrapping 
around the fiber.(45)  In 2000, Yang and Doolittle, based on the first fibrinogen molecule 
crystal structure, proposed a packing arrangement within a fiber.  The structure consisted 
of a way to arrange protofibrils within a 19x19x46nm unit cell within the fibers allowing 
lateral interactions between the β and γ domains of individual molecules within the 
protofibrils(47).  In 2003, Caracciolo and Arcovito performed Energy Dispersive X-Ray 
Diffraction (EDXD) studies on hydrated fibrin fibers.   These studies indicated two 
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diffraction peaks, one at 22.7nm and one at 18.4nm which they claimed agrees with the 
unit cell model of Yang(48).  The Yang model is currently the generally accepted model 
for the packing of the fibrin fiber, however, it should be noted that the model does not 
account for the inherent flexibility of the fibrin molecule due to its crystalline basis. 
 In spite of this progress, there are still many unresolved questions about the 
fibrin structure including: 1) What is the length of the protofibrils in fibers?  2) Where 
does the water fit into the structure? 3)  How structurally do larger molecules like FXIIIa 
fit into to fiber, while still allowing for lateral registry?  4)  Where do the αC domains 
reside within the structure?  5)  What is the native persistence length of a protofibril 
within the fiber 6) Where are the locations of the native contacts between protofibrils? 7) 
Some fibers do not readily exhibit banding in EM images, are these fibers structurally 
different? 8) If the fibers are crystalline, how is this broken at branch points?  
 Within this discussion of fibrin polymerization and structure, it may be important 
to note that in addition to fibers, fibrin has recently been reported to form molecularly 
thin 2-D sheets, and even bubbles (unpublished data from our lab).(49, 50)  Sheets 
polymerize under static conditions on surfaces, and under flow conditions within a 
certain phase space of shear rate, and thrombin concentration.(50)   Sheets appear 
continuous at magnifications of 300,000, act as a reversibly elastic membranes, and form 
under tension.(49)  These results are difficult to reconcile with the standard model of 
fibrin polymerization and fiber packing as described above.  It is possible that the sheets 
are composed of protofibrils laid flat in 2-D registry, but an alternative mechanism of 
fibrin polymerization could play a role in sheet formation as well.  Other models of 
polymerization have included single stranded “protofibrils” arising from an interlacing 
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molecule assembly and “profibrils” by end to end oligomerization.(33, 51)  In this work, 
we have assumed the “standard” polymerization model with double stranded protofibrils, 
but given fibrin’s ability to form sheets, future models may need to include additional 
molecular interactions or polymerization morphologies not present in the standard model. 
 
Figure 1.4 Fibrin Fiber Banding:  Many EM images, including the Cryo-EM image 
above, indicate a longitudinal banding pattern within fibrin fibers.  The banding pattern 
indicates a lateral registry between protofibrils.  The primary banding distance is 
approximately 22.5nm, or half the length of the fibrin molecule.  Minor bands exist 
between the major bands with a spacing of approximately 7.5nm.  The above diagram 
gives the current view of how lateral registry between protofibrils gives rise to the 
observed banding.   The mechanism of lateral registry between protofibrils is not well 
understood.  The αC regions are not included in the figure.   
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1.2 The Mechanical Properties of Fibrin 
 Because fibrin networks provide the structural support for blood clots that must 
withstand the shear rates of up to 100,000s
-1
in the vasculature, they perform an inherently 
mechanical and dynamical function.(1)  The emergent mechanical properties of a fibrin 
network are a function of the mechanical properties of the components of each 
hierarchical level – protein monomer, protofibril, fiber, and network – and the 
architectural transitions between one level and the next – monomer-monomer 
interactions, lateral aggregation, and branching.   In order to have an understanding of the 
emergent properties of the network, the mechanical properties and architecture of the 
lower levels of the heirarchy must be fully characterized.  
 The macroscopic mechanical properties of the highest rung in this structural 
hierarchy, fibrin gels, have been studied for decades going back to the pioneering work of 
John Ferry (52-54) and others (55-57). These studies showed that fibrin networks exhibit 
highly non-linear elasticity manifested in strain stiffening behavior (58-60) and negative 
normal stress (61).  Macroscopic studies have also long established the importance of 
FXIIIa-induced ligation in stabilizing clots  (5).   Ligated clots show a much higher 
storage modulus, lower loss modulus and are more resistant to lysis by plasmin (5, 62).  
Additional rheological studies of whole clots and networks have focused on the 
correlation between clot structure (i.e., thickness of fibers, branch point density, and 
porosity) and viscoelastic dynamics and mechanics.(53, 54, 63) 
 While the mechanical properties of fibrin gels have been studied since the 1940’s, 
the mechanical properties of individual fibers have only received attention in the last ten 
years.  Collet et al. used laser tweezers to measure the bending modulus of individual 
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fibrin fibers within a clot.(64)  They reported that unligated fibrin fibers have an elastic 
modulus of 1-3MPa, while FXIIIa ligated fibers had an elastic modulus of 10-20MPa.  
AFM measurements on fibrin fibers suspended between microchannels indicated that 
fibrin fibers are among the most extensible in nature, with uncross-linked fibers being 
able to extend up to 3.3x their original length before failing, ligated fibers extending to 
4.3x their original length before failure, and in both cases much of the extension was 
reversible.(65, 66)  A recent paper by Liu et al. indicated that fully ligated (γ-γ and αC-
αC) fibers are in fact less extensible and less elastic than unligated fibers, while partially 
ligated (only γ-γ cross-links) fibers are more extensible than unligated fibers.(67)  
 To understand the underlying mechanism behind these single fiber behaviors, 
several experiments have measured the mechanical properties of various parts of the 
fibrin molecule.  Two groups have claimed to measure the stretching of the fibrinogen 
coiled-coil region.  Brown et al. linked fibrinogen molecules end to end with FXIIIa to 
form fibrinogen oligomers.  They reported a saw-tooth like unfolding pattern with an 
average force of 94pN and an average extension of 23nm.  Lim et al. pulled on individual 
fibrinogen molecules, and measured a plateau in the force extension trace of 15nm at a 
force of 60pN and inferred that this indicated coiled coil unfolding.  Additionally they 
pulled on fibrin protofibrils, showing a stepwise unfolding at forces around 1000pN, and 
a partial refolding of the protofibrils on the timescales of a few seconds.(68) 
 The strength of the knob:hole interactions has been probed by both optical 
tweezers spectroscopy and atomic force microscopy.  In two seminal papers, Litvinov et 
al showed that the A:a interaction is critical for fibrin polymerization and can withstand 
forces of up to 120pN, (69) while the B:b interaction can withstand forces of 15-20pN 
 17 
 
before failing.(70)  This work was followed up in a beautiful study by Averett et al. 
showing that the A:a unbinding is actually a multi-step process, with a characteristic 
profile of four force peaks with two distinct populations of specific forces: 110 ± 34pN 
and 224 ± 31pN.  The four force peaks, seem to correspond to three unfolding events, 
corresponding to extension of the fibrin γ-C domain by extensions of 11nm, 9nm, and 
18nm, before the final unbinding of the A-knob at the fourth peak.(71, 72)  
 Finally, the non-ligation-mediated interactions between the αC regions were 
studied using laser tweezers.(73)  The authors used three α-chain fragments in the study: 
the “αC region” corresponding to Aα221-610, the “αC connector” corresponding to 
Aα221-391, and the “αC domain” corresponding to Aα392-610.  The authors found that 
αC region and αC region interact with each other with a higher frequency than other αC 
interaction and exhibit three distinct force thresholds of 19±3pN, 36± 2pN, and 48±2pN.  
The αC region and αC-domain interact with three distinct force thresholds of 17±5pN, 
36± 2pN, and 49±2pN.  The αC region and αC connector interact with each other less 
regularly and exhibit one force thresholds of 31±6pN.  And finally the αC domain and αC 
connector exhibit one force threshold at 25± 3pN.  Combining the results indicates that 
the αC domain part of the αC region can bind to other αC domains to withstand forces of 
up to 50pN, while the αC domain can interact with the αC connector with much lower 
specificity and at lower forces ~25pN.(73)  
1.3 Mechanical Models for the Extension of Fibrin Fibers within a Network 
 Given everything that is now known about the fibrin molecule and its interactions, 
three models have been proposed for the fibrin fiber mechanical properties, one based 
upon the unfolding of the coiled coil domains (See Figure 1.5), one based on an 
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alternative mechanism of cross-linking, and another which we proposed and is developed 
in more detail in Chapter 2, based upon the extension of the αC regions between sliding 
protofibrils.  In this section, I will briefly describe each model, followed by a discussion 
of a few pros and cons of each.  
 
Figure 1.5  Coiled-coil (CC) extension model: In the coiled-coil extension model, the 
fibrin monomer can be thought of as two springs fixed between rigid beads (See panel 
“C” for the schematic version).  The coiled coil in the fibrin molecule act as two state 
springs that can either be unstretched (folded) or stretched (unfolded).  The fiber is 
composed of many springs in series and parallel down and across the fiber.  When force 
is applied to the fiber, the coils unfold in a zipper-like manner.  Protofibrils are assumed 
to span the entire length of the fiber, and little shear between protofibrils is assumed. 
 The coiled-coil unfolding (CC for short) model was proposed by Brown et. al 
after their fibrinogen oligomers experiment and was developed more fully in a recent 
paper showing that fibrin networks can stretch to strains of 250% before failing.(74, 75)  
The model views the fiber mechanically as a network of coiled-coil springs in series 
down the length of the fiber and in parallel across the diameter of the fiber (See Figure 
1.5).  The protofibrils within the fiber are assumed to be laterally attached in such a way 
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that they cannot slide.  In the model, the fibrin extension comes from a zipper-like 
unfolding of the coils as the fiber is stretched.   
 This model is discussed in some detail in Chapter 2, briefly, the CC model is 
attractive in that it can account for fiber strains of 100%, and it explains the lack loss of 
23nm signal in SAXS measurements of fibrin networks unfolding.  The 23nm signal is 
attributed to the coiled coil structure of the molecules in the fiber.(74)  However, there 
are several concerns with the coiled-coil unfolding model.  The expected forces required 
to unfold the coiled-coil seem too high to explain the stretching of the fibrin fiber (this is 
discussed in great detail in section 2.3.6).  In addition, while extensions of 100% strain 
are impressive, it is well established now that fibrin fibers can reversibly recover from 
strains of over 180%, and the coiled coil cannot account for all of this extension.(66) 
 
Figure 1.6:  The Transverse Cross-linking (TCL) Extension Model:  The model 
assumes that γ-γ cross-links in fibrin fibers occur transversely (red lines) between to γ 
domains attached to half-staggered A-knobs, rather than longitudinally at the γ-γ interface 
as represented in Figure 1.3.  Extension could come from breaking the A:a interactions 
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and intraprotofibril sliding of the fibrin molecules.  Elastic recovery could occur for 
cross-linked fibers, but it is not clear how this model would account for un-cross-linked 
fibers. (Reprinted from Mosesson, M.W. “Cross-linked γ-Chains in fibrin fibrils bridge 
transversely between strands: yes” Journal of Thrombosis and Haemostasis, 2, 388-393.  
Used with Permission from John Wiley and Sons © 2004) 
 A second model for fibrin fiber extension was proposed by Mosesson in a 
discussion on the orientation of the γ cross-links between fibrin molecules within the 
fibrin.(32)  In this proposal, the cross-links actually act transversely as seen in Figure 1.6.  
If the fiber was then stretched, and the A:a and B:b interactions were broken, the fiber 
would then be able to stretch up to 1.8 times its original length according to the 
authors.(32)   
 While this model would account for fiber strains of 180%, it presents other 
contradictions with existing data.  First, the model is based on the assumption of 
transverse cross-linking, but evidence for transverse cross-linking has been disputed. (76)  
In addition, the model does not explain how un-ligated fibers can reversibly stretch to 
1.8x their original length, which they are known to do.(67)  Finally, it assumes that the 
A:a and B:b interactions will fail, but the fiber will retain its elasticity.  While simulation 
results presented in Chapter 4 and AFM measurements indicate that A:a disruption can 
occur this only happens after unfolding the γ-C region which likely would cause plastic 
deformations in the fiber.(68, 70, 71, 75)  Because of these issues, further discussion of it 
is not included in this document.  However, if in the future it is shown conclusively that 
the main mode of cross-linking within fibers is transverse, then this model may need re-
visiting. 
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Figure 1.7: The αC extension model:  This model is laid out in detail in Chapter 2.  
Briefly, the model considers the fibrin fiber as a series of stiff and soft springs in parallel 
and series down the fiber.  The stiff springs represent the protofibrils consisting mainly of 
the coiled-coil, and the soft springs represent the αC regions linking the protofibrils.  
Stretching comes from sliding of the protofibrils. 
 We have recently proposed a third model (the αC model), based on evidence 
accumulated from single fiber stretching measurements, that the stretching of the fibrin 
fiber comes primarily from stretching of the αC region.(77, 78)  The evidence and details 
for the model are laid on in Chapter 2.  Briefly, the model treats the fiber as a series of 
soft springs in series with stiff strings (See Figure 1.7).  The soft springs represent a 
natively unfolded region such as the αC region, while the stiff springs represent the 
structured protofibrils.  While we believe that this model is a good starting point for fibrin 
mechanics, it needs to be developed to include all parts of the fibrin molecule and the 
higher order fibrin hierarchy.  
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 To be complete, a hybrid model involving an α-helical to β-strand conversion of 
the coiled-coil region followed by an extension of the aC-region, followed by a partial 
unfolding of the γ-C domain was proposed by Guthold and Liu.(65, 67)  While this 
model is more comprehensive than any of the other models as far as regions of the fibrin 
molecule involved, it is more abstract in nature, and not specific in details. 
 Thus, there are several models proposed to explain the mechanics of the fibrin 
fiber.  Each model focuses on one part of the molecule (coiled-coil or αC region) or on a 
particular aspect of polymerization (transverse ligation mode) without accounting for 
other regions of the fibrin molecule.  This, in part, is due to the fact that the structure of 
the αC domain, and the stability of the γ-C domains, and even the structure and topology 
of interactions within the fibrin fiber itself all have some level of uncertainty associated 
with them.  In order to construct a full scale model of the fibrin fiber, these issues must be 
addressed.  In chapter 4 of this paper we extend our original αC model into the fuller 
SLαCK model based on the results of our molecular dynamics simulations.  We believe 
that the SLαCK model contains enough molecular detail to account for the full range of 
single fiber properties. 
 Ultimately, the properties of the single fibers will manifest themselves at the 
network level, so it is important to tie in the single fiber model with a network model.  
The attempts to do this thus far which can be broken down into two categories: shear 
models and stretching models.  The shear models attempt to predict network behavior 
observed in cone and plate rheological studies originally pioneered by Ferry.(53, 54, 79)  
The original models considered the fiber as either a rigid, or semi-flexible rod and 
attempted to explain the network strain stiffening from that premise.(80, 81)  A recent 
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model treated the fiber as a loosely bundled network of semi-flexible protofibrils linked 
by flexible cross-links (corresponding the the αC domains).(82)  All of these models 
treated the fiber as either a rigid or semi-flexible polymer between network branch points, 
but were not able to originate the network behavior on the molecular level. 
 A molecular level model was employed by Brown et al. in their paper on fibrin 
networks under tensile stress.(83)  The model implemented the CC stretching model 
within a model for biomacromolecular networks containing domains that unfold under 
force.(84)  The model is elegant and generates fits that account for fibrin network 
behavior; however as discussed in 2.3.6 Analysis of the Coiled-Coil (CC) unfolding 
model, the molecular parameters needed to fit the network level behavior are non-
physical.  In chapter 5, we present a model for fibrin network stretching based our αC 
stretching model for the single fiber.  While the model is simple in form, it was able to 
predict the network response to the strain stiffening of individual fibers.  At the network 
level, the CC model predicts the same strain stiffening behavior as the αC model; 
however the origins of the behavior are different, and the expected force levels differ by 
at least an order of magnitude.(85) 
1.4 Significance and Goals of this project 
 There is increasing appreciation of the hierarchical design found in biomaterials 
like fibrin that give rise to their remarkable properties (86-88).   At the same time, in 
order to build a mechanical model for these materials, not only the mechanical properties 
of the individual components, but also the connectivity of each component must be 
characterized.  Fibrin has been studied for over seventy years, and the structure of the 
molecule, the interactions involved in protofibril assembly, and the overall role of 
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fibrin(ogen) in the blood coagulation cascade are now generally understood and 
accepted.(6)  In addition, a series of measurements on the network, fiber, and molecular 
level have begun characterizing the mechanical properties of fibrin.(71, 83, 89)  In spite 
of these advances, the complexity of the polymerization process and the hierarchical 
design of fibrin have proved to be difficult hurdles in the development of a complete 
multi-scale mechanical model of the fibrin network.   
 
Table 1.1 A comparison of the potential models for fibrin mechanical properties: A 
green circle represents a molecular, fiber level, or network level property that is 
explained by the model, a red filled circle represents a property that is not explained by 
the model, a red open circle represents a property that may be explained by the model but 
needs more investigation and a black open circle represents a property not addressed by 
the model.   
 In this work, I will present a series of experiments and discrete molecular 
dynamics (DMD) simulations designed to bridge the gap between the molecular 
mechanics and dynamics of fibrin, the manifestations of those molecular underpinnings 
in the mechanics and dynamics of individual fibrin fibers, and the higher order network 
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implications stemming from the mechanical properties of the molecule.  The results of 
these projects will serve as a template to construct a model of fibrin mechanics and 
dynamics that bridges all levels of the fibrin hierarchy.  In so doing, we will be able to 
provide a complete view of the mechanical role of fibrin in the process of Hemostasis. 
 This document is organized into measurements on three different length scales: 
the molecular length scale, the fiber length scale and the network length scale.  The 
document begins by looking at the mechanical and dynamical properties at the 
intermediate length scale of the fibrin fiber, because the properties observed at the fiber 
level necessitate an investigation of their origins at the molecular level.  The document 
then moves to the molecular length scale to investigate the origins of the fiber level 
properties and concludes at the network scale in an attempt to model the behavior of 
fibrin networks with a molecular model.  The goal of Chapter 1 was to provide a brief 
overview of the fibrin(ogen) structure, function, polmerization and mechanics, while 
laying out the relevant questions remaining in understanding fibrin as a mechanical 
material.  Chapter 2 details a series of AFM experiments indicating that fibrin fibers are 
elastomeric, meaning they have a low modulus, high extensibility, and strain stiffen.  
Evidence for these properties originating in the unstructured αC region of the molecule is 
presented, and a simple model for fibrin extension based on the Worm-like chain is 
presented.  In chapter 3, fibrin recoil dynamics were probed using the atomic force 
microscope and high speed photography.  This data was combined with DMD of the 
recoiling coiled-coil structure to understand the origins of fibrin’s dynamic properties.  
Chapter 4 describes a series of steered discrete molecular dynamics simulations carried 
out to test the mechanical stability of various parts of the fibrinogen molecule.    First a 
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structural model for the αC region was developed using homology modeling.  Then 
simulations were run applying constant force to the αC region, the coiled-coil region, the 
γ-γ region, and the A:a interface to measure the relative stabilities of each part of the 
fibrinogen molecule.  We conclude the chapter by presenting the SLαCK model for fibrin 
extension which extends our αC model to include stretching of the γ-γ interface and γ-C 
domains of the fibrin molecule.  Chapter 5 focuses on the role of the individual fibrin 
fiber in fibrin network mechanics.  We show using a simple model for network topology, 
that fibrin network strength is enhanced by the strain stiffening of individual fibrin fibers.   
Finally, a discussion of the conclusions and future directions of this work is presented in 
Chapter 6. 
  
 
Chapter 2. Evidence that the αC Region is the Origin of the Low Modulus, High 
Extensibility, and Strain Stiffening in Fibrin fibers 
2.1 An Introduction to Fibrin Fiber Mechanics 
 We recently reported that individual fibrin fibers exhibit extraordinary 
extensibility with an elastic regime in excess of a strain of 1.0, and strains at breaking of 
up to 3.0 (strain is defined here as fiber extension divided by original fiber length. A 
strain of 1.0 is a doubling of the fiber length) (65, 66).  Several important and related 
questions emerge from that work: What are the full force extension characteristics of the 
fibrin fiber? Is fibrin an elastomeric fiber? What are the molecular origins of 
extensibility?   How does FXIIIa ligation affect stiffness and extensibility?  Along with 
very high extensibility, fibrin has a relatively low modulus (1-10 MPa range) and exhibits 
strain stiffening behavior above strains of 100% as we have recently reported (90) and as 
Liu et al. showed in their recent evaluation of the viscoelastic properties of fibrin fibers 
(91).  These properties place fibrin squarely in the category of biomaterials such as 
elastin, resilin and spider silk (92, 93).  This result is somewhat surprising given fibrin is 
predominantly a structured globular protein which polymerizes into ordered semi-
crystalline arrangements in fibers (44). In contrast, elastomeric protein structures consist 
primarily of disordered networks of natively unfolded polypeptides with randomly 
distributed covalent crosslinks (94).  
 We present force vs. extension data on fibrin fibers with and without FXIIIa 
ligation, and show fibrin fibers have relatively low elastic moduli and exhibit pronounced 
strain stiffening.  In situ measurements of fibrin fibers pre and post FXIIIa ligation 
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indicate a doubling in stiffness in the fiber after ligation.  Based on the elastomeric nature 
of the fibrin fiber, along with previous measurements indicating that fibrin elasticity is 
tied to the length of the αC connector region, we present a mechanical model (henceforth 
called the αC model) of the fibrin fiber consisting of an ordered network of worm-like 
chain segments.(95)  The success of this model in fitting our force vs. extension data 
suggests that fibrin’s elasticity is entropic in origin, and that the observed stiffness and 
extensibility have their origins in unstructured regions of the protein.   
2.2 Methods 
 For our measurements, we used an Explorer atomic force microscope (Explorer, 
Veeco Instruments, Woodbury, NY) resting on the manipulation stage of the optical 
epifluorescence (described in the next section) microscope enabling simultaneous AFM 
manipulation and optical data acquisition.  For brief introductions to fluorescence 
microscopy and atomic force microscopy, the reader is referred to Appendices B and C 
respectively.    
2.2.1 Structured Surface Preparation 
 Using PDMS (Sylgard 184; Dow Corning Co. Midland, MI) poured over an SU-8 
master we created a stamp for the structured surfaces (SS). We then used the stamp to 
make channels on 24 x 50 mm 1.5 cover-glass (Corning) in Norland Optical #81 which 
we cured under UV light for 70 seconds.  Channels were either 10 or 20 microns wide 
and ~10 microns deep. (See Figure 2.1)   
 29 
 
 
Figure 2.1  Set up for single fiber and network stretching experiments. Suspended fibrin 
fibers are labeled with fluorescent beads and then stretched with the AFM tip Movies of 
the stretching are taken from below with epifluorescence imaging. 
2.2.2 Fibrinogen Preparation 
 In all experiments we used recombinant human fibrinogen produced in Chinese 
Hamster Ovary (CHO) cells (96, 97).  Recombinant human fibrinogen was grown in 
CHO cells without other blood coagulation factors and has been shown to be identical to 
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plasma fibrinogen in nearly all aspects.  We assessed purity and homogeneity of this 
material through polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot 
analyses. Fibrinogen function was assessed through thrombin-catalyzed fibrinopeptide 
release monitored by High Performance Liquid Chromatography (HPLC), polymerization 
monitored by turbidity, and FXIII-catalyzed ligation monitored by SDS-PAGE, and blot 
analysis as described. 
To form unligated fibrin fibers, fibrinogen was diluted in HBS (20 mM HEPES, 
150 mM NaCl, pH 7.4) to 0.04 mg/ml and deposited onto the SS. Human thrombin 
(Enzyme Research Laboratories; final concentration 1 NIH U/ml in HBS with 10 mM 
CaCl2) was added to the surface at the same volume as the fibrinogen (usually 8-10μL) 
and pipetted up and down to mix.  The sample was incubated at 37
o
C for two hours in a 
water-saturated atmosphere, rinsed and stored in HBS.  Fibers were fluorescently labeled 
by adding a 1/10,000 suspension of 24 nm volume-labeled red fluorescent carboxyl-
coated microspheres (Invitrogen- Molecular Probes) in Ca-free HBS to the SS, incubated 
5minutes and washed with buffer.  To form fibers that were ligated during 
polymerization, we mixed FXIII (Enzyme Research Laboratories; final concentration: 0.5 
mg/ml) with thrombin at 1 NIH U/mL in HBS with 10mM CaCl2 to activate it into its 
active FXIIIa form and immediately added it to the SS containing 0.04 mg/mL 
fibrinogen.  The samples were incubated for two hours at 37
o
C and then gently rinsed via 
buffer substitution.  . 
2.2.3 Optical Microscopy 
   For observation and manipulation of fibers, the coverslips were placed face up on 
an inverted Nikon Diophot microscope with epifluorescence illumination (Nikon Diaphot 
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200, Southern Micro Instruments, Atlanta, GA), and imaged using a rhodamine HQ filter 
set (Chroma Technology, Rockingham, VT) and a 1.3 or 1.4 na 100X oil objective.  
Images were recorded using a high speed Cooke PCO 1600 camera with C-link and 
recorded with CamWare (Cooke Corp., Romulus, MI).  All single fiber and network data 
was acquired as described previously (65, 66).  For a full discussion of illumination 
techniques, see appendix B. 
2.2.4 AFM 
  The atomic force microscope (Explorer, Veeco Instruments, Woodbury, NY) rests 
on the manipulation stage of the optical epifluorescence microscope enabling 
simultaneous AFM manipulation and optical data acquisition.  Both OMCL-AC240TS-
W2 (Olympus, Micro Cantilever) and RC150VB Biolever (Olympus, Asylum Research) 
AFM cantilevers (SiN) were used for manipulation.  Force data was determined through 
calibration of the lateral deflection signal. The angular optical sensitivity of the twisting 
mode is the same as for the bending mode given we have a geometrically symmetric 
quadrant photodiode and similar gain settings for each quadrant.  The twisting mode 
optical sensitivity and in deflection units and lateral spring constant are then determined 
using the specific geometry (length, tip length) of the cantilever using equations 2.1, 2.2 
and C.6.  The AFM tip was controlled using the Nanomanipulater software (3rdTech, Inc. 
Durham, NC).   The tip was positioned within the channel next to a fiber and moved in 
one direction at 1µm/sec in 75nm increment steps to stretch the fiber.  We note that this 
corresponds to a strain rate of roughly 0.1 s
-1
 (max/t ~ (20m/10m)/30 s ~2.0/30s ~ 0.1 
s
-1
) which is comparable to other force spectroscopy studies including those on myosin 
coiled coils (98).   Care was taken to insure the fiber was contacted at the very end of the 
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AFM tip (< 1 micron from end)). For the stress vs. strain data depicted in Figure C.2 and 
Figure 2.2, force data was converted to stress by taking the calibrated force data and 
dividing by cross sectional area of the fibrin fiber as determined by AFM imaging (AFM 
measured fiber diameter which was converted to area assuming circular cross section).  
This was accomplished by imaging the fibrin fiber on the ridge immediately adjacent to 
the portion of the fiber suspended over the channel.   Strain was determined by taking the 
extension (change in length, L) of the fiber segments and dividing by the original 
length, L0 (Strain : = L/ L0).  .  The twisting mode optical sensitivity in deflection units 
can be determined using the specific geometry (length, tip length) of the cantilever: 
t
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The lateral cantilever spring constant (kL)was calculated from cantilever/geometry and 
SiN materials constants, as described in Equation C.7.  Figure 2.1 depicts a diagram of 
the setup.   
2.2.5 In-situ measurement of fiber Stiffening 
To measure the change in stiffness due to ligation, of an individual fibrin fiber 
(In-situ), we prepared the fibrin on the SS without FXIII, and pulled the fiber to strains of 
up to 1.0 strain.  Human fibrin fibers have been shown to be capable of strains up to 
180% before sustaining plastic damage (66).  To ligate the fibers we lifted the AFM from 
the sample, removed the buffer, and added HBS with Ca
2+
 (10 mM HEPES, 150 mM 
NaCl, 5mM CaCl2, pH 7.4) with 5 mg/mL FXIII (which is activated to FXIIIa by 
thrombin) and 1 U/mL thrombin, and incubated for an hour at 37
o
C and then gently 
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rinsed via buffer substitution.  After this, we replaced the AFM and pulled on the same 
fiber as we pulled on before ligation.  As a control, we ran the whole experiment 
described above except doing a buffer transfer without adding FXIII and thrombin.  All 
such controls showed no change in stiffness of the fibers. To confirm that ligation took 
place when we added FXIIIa to fibrin already deposited on the structured surfaces, we 
prepared additional fibrin samples on the structured surfaces without FXIIIa. We added 
FXIII and thrombin at 5mg/ML and 1 NIH U/mL respectively, incubated at 37
o
C for an 
hour, and then prepared the samples for Western blot analysis by replacing the fibrin 
buffer with 6X SDS, scraping the fibrin off the structured surfaces using a pipette tip (this 
was repeated three times) and combining all the samples in one tube, boiling the samples 
for 5 min, and then freezing them. A polyclonal antibody to fibrinogen (DAKO, 
Carpinteria, CA) was used for western blot analysis.  Figure 2.4 shows that ligation of 
fibrin can be achieved after polymerization on the structured surface.  
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 2.3 Results & Discussion 
2.3.1 Single Fiber Stress vs. Strain 
 We prepared fibrin samples on micropatterned substrates with individual fibers 
suspended across channels (experimental geometry depicted in Figure 2.1). The sequence 
in Figure 2.2A-D depicts an AFM measurement of a single fibrin fiber stretched to the 
point of failure.  The raw AFM force and position data were converted into fiber tensile 
strain and stress (see Methods).  Typical stress vs. strain data for both FXIIIa ligated (red) 
and un-ligated fibers (blue) are depicted in Figure 2.2E, while Figure 2.2F shows their 
strain dependent tangent moduli (the slopes of the stress vs. strain curves in Figure 2.2E). 
At strain below 1.0, both fibers had a low and constant modulus.   Above strain of 1.0 the 
fibers showed strain stiffening behavior.  Both fibers exhibited roughly a ten-fold 
increase in stiffness between low and high strain. The bar plot in Figure 2.3 depicts the 
average differential modulus at discrete strains for fibers with and without FXIIIa 
ligation.  The FXIIIa ligated fibers had an average elastic modulus of 2.1 ± 0.3 MPa at 
0.25 strain rising to an average of 9.8 ± 1.2 MPa at failure.  The un-ligated fibers showed 
1.1 ± 0.2 MPa at 0.25 strain rising to 6.9 ± 1.3 MPa at failure. As a way of quantifying 
strain stiffening, we calculated the average ratio of maximum modulus to the modulus at 
0.25 strain; the ligated fibers stiffened by a factor 6.2 ± 0.8 and un-ligated fibers stiffened 
by a factor 7.7 ± 1.5.   
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Figure 2.2 Stress vs. Strain plots  of individual fibrin fibers. (A-D) AFM manipulation of 
a fibrin fiber suspended over micro patterned channel.  The AFM tip (not visible) was 
brought in contact with a suspended fiber and stretched (B-C) to the point of failure (D). 
Scale bar = 10 µm. (E)   Representative stress vs. strain data of individual fibers with and 
without FXIII ligation.  Both fibers show relatively linear behavior up to strain just above 
1.0 followed by significant stiffening. (F) Tangent modulus illustrating the strain 
dependent stiffness. These traces were found by numerically differentiating the traces in 
(E).   
 
Figure 2.3 Average tangent modulus at discrete strains for ligated (N=14) and un-ligated 
(N=14) fibers.  At 0.25 strain, the ligated fibers have an elastic modulus of 2.1 ± 0.3 MPa 
while the un-ligated have a modulus of 1.1 ± 0.2 MPa (P < 0.003).   The average modulus 
rises to 9.8 ± 1.2 MPa for ligated and 6.9 ± 1.3 MPa for un-ligated fibers (P < 0.05).     
2.3.2 In situ measurements 
 Determination of the stress vs. strain behavior of fibers yields intensive materials 
parameters, such as elastic modulus, by normalizing the raw force vs. elongation data by 
the length and diameter of the fibers.   This allowed comparison of the stiffness of 
different fibers over many experiments.   We estimated the fiber cross sectional area by 
using the AFM to measure the diameter of the fiber on the ridge.  In calculating stress, we 
assumed that the fiber cross section is circular, that the fiber diameter on the ridge surface 
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is equivalent to the suspended fiber diameter, and that the diameter is constant over the 
suspended length. A comparison of the full stress vs. strain behavior from one experiment 
to another also requires comparing data from different AFM tips and force calibrations 
which adds additional uncertainties.   
 In order to address these uncertainties in comparing ligated to unligated fibers, 
and to corroborate the stress vs. strain data, we measured the relative change in stiffness 
of individual fibrin fibers before and after FXIIIa ligation in-situ (Figure 2.4). Results of 
a western blot indicating successful ligation is shown in Figure 2.4 (see Methods).  These 
measurements provided direct comparisons of fiber stiffness with and without ligation in 
the same fibers, thus obviating the need for geometrical normalizations or force 
calibration.  Fibrin was prepared on structured surfaces without ligation then stretched 
with the AFM.  These initial stretches corresponded to strains of 0.40 or less in order to 
maintain mechanical reversibility.   FXIIIa was then added to the sample and the same 
fiber was stretched again.  Figure 2.4 shows representative data revealing increased 
stiffness with addition of FXIIIa.  We observed an increase in stiffness after ligation by 
FXIIIa in all eight fibers we measured; the average increase was 80%, in agreement with 
an increase of 90 ± 44% obtained from the stress vs. strain measurements at strain of 0.25 
(Figure 2.3).   These results show that FXIIIa acts directly on the mechanical properties 
of the fiber itself; ligation more than doubles fiber stiffness.   Our results are also 
consistent with low strain thermal noise spectrum measurements taken on fibers in clots 
(64).    
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Figure 2.4 Left:  Western blot of fibrin showing  ,  and  bands without FXIIIa (A) 
and , and    dimer following ligation with FXIIIa (B).  Right: In-situ fiber stiffness 
measurements. Fiber stiffness before (blue) and after (red) FXIII ligation.   
2.3.3 The αC Stretching Model 
 To interpret the force vs extension data, we developed a model of the mechanics 
of fibrin fiber extension (the αC extension model).  Figure 2.5 shows the structure of the 
fibrin monomer (Figure 2.5A&B), and our mechanical model of a fibrin fiber consisting 
of an ordered array of fundamental mechanical units (Figure 2.5D&E).  Each 
fundamental unit has an “unstructured portion” modeled mechanically as a worm-like 
chain (WLC) and a structured portion modeled as a Hookean spring.  Previous reports 
agree that the extreme extensibility of the fibrin fiber reflects properties of the fibrin 
monomer. These reports suggest that an unfolded segment in the molecule is critical: 
either a natively unfolded region such as the C domain (95) or a force-unfolded region 
such as the coiled-coil (74, 75) or the gamma domain in the D region (71).  In any case, a 
large portion of the monomer’s structured architecture will remain folded and is 
represented by the stiff spring.  As this spring represents the structured globular regions 
of the protein, its stiffness is expected to be several orders of magnitude higher than the 
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unstructured region, and will not contribute significantly to the extension of the fiber [See 
section 2.3.4]. This force-extension model assumes that fiber extension is accommodated 
only by the unstructured region, which we model as a WLC.  We have not explicitly 
included unfolding as a mechanism of the αC extension model. Unfolding may very well 
be happening, but our analysis shows it is unlikely until higher strain. Our force vs. 
extension data also shows no signatures or features indicative of abrupt structural changes 
within the fiber, and is suggestive of a single extension mechanism especially up to 
strains of 1.0.  Our model is intended to present the simplest explanation of fibrin fiber 
extensibility that is consistent with what is known about fibrin fiber structure, the 
magnitudes of protein unfolding force thresholds, and the form of our force vs. extension 
data.  
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Figure 2.5 Fibrin structure and corresponding mechanical model. (A) Crystal structure of 
fibrinogen. A, B and  polypeptides in blue, green and red respectively, with a cartoon 
of the C terminus region of the alpha chain (in dashed blue).(B) Cartoon depiction of the 
fibrinogen. (C)  Upper model: Simplified Fibrin fiber structure.  Intra-Protofibril FXIII 
induced covalent interactions are indicated by red dashes.  Protofibrils are connected 
through C region interactions (C regions in blue).  We note that this picture is 
simplified for clarity.  In a real fiber, each monomer has two C regions extending. Blue 
lines spanning protofibrisl represent C/C interactions.  Though the figure suggests 
only pairwise C interactions, it is known that C regions typically form interactions 
with multiple other C regions. Lower Model: Stretching of the fiber under stress. This 
cartoon depicts a model of one potential mechanism of extensibility. In this case the C 
domains, though linking protofibrils laterally, accommodate the tensile strain induced by 
applied force (green arrows). The stiff protofibrils, within this model, are represented by 
the stiff springs and accommodate little of the strain. (D) Simple mechanical model of the 
fibrin monomer.  The linear spring (black) represents the stiff structured portion of the 
monomer (spring constant k). The random coil (green) represents the unstructured 
portions of the protein. These could be either those regions natively unfolded (C 
domain) or any mechanically unfolded region of the protein such as the coiled coil or 
portion of the D region. The WLC force vs. extension relation is parameterized with 
persistence length, Lp, and contour length, Lc . (E) Simplified mechanical model of the 
fibrin fiber.  There are M monomers in series and N single monomer chains in parallel. 
The model includes no lateral interactions as they have no relevance to uniform tensile 
stretching.   
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 Figure 2.5C depicts fibrin fiber structure in cartoon form, and a candidate model 
for fibrin extension.  The model depicts protofibrils laterally aggregated through C 
interactions.    The C domains (blue) accommodate the majority of the fiber strain and 
are represented in the mechanical model (Figure 2.5D&E) by the WLC.  As the cartoon 
of the strain fiber indicates, the aC regions can accommodate tensile strain and act as 
spring in series within this proposed model despite acting as lateral tethers between 
protofibrils. As the fiber is strained, these tethers align along the fiber axis and act as 
series connections between the stiffer protofibrils.    The distribution of protofibril lengths 
depicted within this cartoon is consistent with published studies of protofibril lengths.(40, 
99)    
 A WLC model has successfully described the force-extension behavior of DNA, 
intrinsically unstructured polypeptides, and force-unfolded proteins (98, 100-104).   The 
WLC is an idealized non-self-interacting flexible chain undergoing thermal fluctuations 
along its contour. The force of extension of the WLC is mediated entirely by entropic 
elasticity. Though this model has primarily been used to describe single molecule force 
spectroscopy data, we apply it here, in scaled form, to a full fibrin fiber.   The form of the 
force vs. extension for a WLC in the Marko-Siggia form (104) is as follows.    
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Where, l is extension (L- L0), kB is the Boltzmann constant, T is temperature, lp 
is persistence length, and lc is the contour length. We note our use of l in Eqn. 2.3, 
rather than end-to-end length as is appropriate for a single random coil polymer chain.  In 
our case we assume the relaxed length of the fiber segment, L0, is due entirely to the 
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structured portions of the monomer; the unstructured portion only contributes appreciable 
length to the fiber as it extends.  In reality, the unstructured domains may contribute a 
small percentage to the unstretched fiber length, but we assume this contribution is 
negligible. 
 We model the force-extension behavior of the fundamental mechanical unit (Fig 
D) as a WLC (Eqn (1)).  The whole fibrin fiber is modeled by M identical fundamental 
units in series and N of these chains in parallel (Figure 2.5E). A chain with M, identical, 
WLCs linked in series behaves as a WLC with a contour length equal to M times the 
contour length of the primitive unit: 
Lc = M  lc  (2.4) 
 Substituting Eqn. 2.4 into Eqn. 2.3, yields the force extension relation for a series 
of MWLC’s   
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where L is the extension of the entire fiber. The force of N WLC’s in parallel is N times 
the force of the individual WLCs.  
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where here we normalize the extension, L, and contour length, M*lc , to the original 
fiber segment length, Lo, to produced force as a function of strain (= L/L0). Because of 
the ordered arrangement of monomers within our fibrin fiber model, the force extension 
relation for the full fiber (Eqn. 2.6) is a scaled version of the single WLC relation with 
the persistence length lp and contour length lc replaced with  lp/N and Mlc respectively.  
 As Fig. 4.8 shows, the scaled WLC equation (Eqn. 4) does a very good job of 
fitting force vs. strain data for both the FXIIIa ligated and unligated fibers.   The fitting 
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parameters obtained are the scaled persistence length (lp/N) and the scaled contour length 
(Mlc/ L0).    Both parameters provide insight into the molecular origins of fibrin’s strain 
accommodation.  To tease out the molecular parameters lp and lc, an estimate is made for 
M and N based on the geometry of the fiber determined by AFM of fibers on the ridges 
for diameter and fluorescence microscopy for the length.   The number N, is found by 
taking the ratio of the cross sectional area of the fibrin fiber to the estimated cross 
sectional area of a monomer (or the ratio of the squares of the diameters).   Using 3-7 nm 
as a rough estimated range for the effective individual monomer diameter –corresponding 
to 200 - 1100 monomers in parallel for a 100 nm fiber (see supplemental material)- we 
obtain an average persistence length value of 0.1 - 0.6 nm.  This number is intended to be 
taken as an order of magnitude bench mark to compare with results from other single 
molecule force spectroscopy studies.  Experimental persistence lengths for polypeptides 
fall in the range of 0.4-1.5nm (75, 101, 105, 106).   
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Figure 2.6 Force vs. Strain data (black circles) for un-ligated fiber (above) and ligated 
fiber below (5% of data points shown for clarity). The red curve is the fit of Eqn 2.6.  
 The second fitting parameter (Mlc/ L0) describes the effective contour length of 
the fiber as a strain.  L0 is simply M times the original length of the monomer (L0=Mlo) -  
for our fibers, Lo is typically 10 microns - and lo is 45 nm,  yielding M= 220 monomers 
in series. Substituting, the fitting parameter simplifies to (lc/lo).   This is a scaled contour 
length that expresses the contour length of the unstructured portion of the monomer as a 
fraction of the original monomer length, lo.  We obtained a scaled contour length of 2.5 
+/- 0.4;  at full extension of the unstructured portion of the monomer, the additional 
extension is 2.5  times the original length  (and therefore the end to end length is 3.5  
times the original end to end distance).   For a monomer of 46 nm, this yields an 
additional length of ~115 nm.    This length corresponds to 320 residues responsible for 
the WLC like extension of the monomer, which when split between the two identical 
sides of the fibrin monomer yields 160 residues.   The tethered C region contains nearly 
400 amino acids, at least 200 of which are known to be part of an unstructured region and 
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could easily account for this additional length.  An unfolded portion of the D region of 
the protein could also account for this additional length. Unfolding and completely 
extending both coiled coil regions leads to 46 nm extra length (75) accounting for less 
than half of the extension.   We found no statistically significant difference between 
FXIIIa ligated and un-ligated fibers in either the persistence length (p > 0.20) or contour 
length (p > 0.05) parameters.    
2.3.4 Enthalpic backbone stiffness of the fibrin fiber 
 The WLC model fitting to the force extension data described above (Eqn. 2.6) and 
Figure 2.6) takes into account entropic elasticity only, ignoring the effects arising from 
enthalpic effects (stretching of chemical or physical bonds).   Following Wang et. al. 
(107) we can add enthalpic contributions to the extension of a WLC, which in the case of 
fibrin could result from stretching of the coiled coil or other structured regions. We 
modify the WLC by making the following substitution for Eqn 2.3:  
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 This substitution adds the contribution of the backbone strain to the overall 
extension;  F/K0 is equal to the strain under force F due to stretching of a Hookean spring 
element. The spring stiffness is represented by K0 which has units of force per unit strain. 
Alternately, we can express the stiffness in terms of a Young’s modulus E=A*K0   where 
A is the cross sectional area of the spring element(s). Substituting Eqn. 2.7 into 2.3 yields 
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 The enthalpic correction, F/K0 , is non-negligible in the case of relatively weak 
backbone stiffness  or relatively large forces, i.e. F << K0 . For typical values for the 
radius of a fibrin fiber (50-100nm,) and we assume the differential modulus of the coiled 
coil is 1GPa - the same order of magnitude as other proteins consisting of coiled coils, 
such as alpha keratin - we get K0 ~7500 – 30,000 nN. As the maximum force measured, 
before breaking, for fibrin fibers is in the 10’s of nN range, it is clear that the condition F 
<< K0 is met. If the stiffness of the enthalpic components is ~10MPa then K0 ~75 – 300 
nN and we would expect a noticeable change to the force extension curve. For extensions 
near and beyond the contour length the force curve will become linear, although, fibrin 
fibers are libel to break before reaching these extensions, even if K0 is sufficiently small.  
The fact that the un-modified WLC model fits our data so closely seems to indicate that 
we are in the F << K0 limit and the backbone stiffness can be ignored.  Figure 2.7 shows 
several additional experimentally obtained force curves, fit using the WLC, entropic 
forces only, model.  
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Figure 2.7 Several representative experimentally obtained force curves in addition to the 
two in the main text. These where fit using the WLC model. The green lines show the 
fitted values, the blue points are the experimentally observed data for un-ligated fibrin 
fibers, and the red points are the experimentally observed data for fibers ligated by FXIII.  
2.3.5 Does the αC connector region mediate fibrin’s initial extensibility?   
 In a recent study, we demonstrated that fibrin extensibility is correlated to the 
length of the C connector region in the fibrin monomer(95).  The longer the length of 
the unstructured region, the longer the fiber was able to extend.  In order for the C 
regions to play a key role in the elastic modulus and extensibility of fibrin, they must be 
arranged within the fiber such that they make series connections (longitudinal) between 
protofibrils in addition to parallel (lateral) connections. The conventional picture of fibrin 
structure is that the C regions connect in a lateral arrangement. However, work by 
Hantgan and Ferry among others has shown that protofibrils have a distribution of 
lengths varying from a few monomers up to 20 or so in standard polymerization 
conditions (40, 99, 108). Given the protofibrils are relatively short - a few hundred nm at 
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most, as compared to the whole fiber which is tens of microns long - the inter-protofibril 
connections must be crucial to supporting tensile forces. The C regions are therefore 
likely to play a role as “springs in series” with the stiffer protofibrils (See Figure 2.5E).  
This view is consistent with our WLC in series model for fibrin extension and is 
generally consistent with the observed low modulus and high extensibility. However, this 
model strongly argues that the series C connections give rise to a significant fraction of 
the total extension of the fiber.   
Another important piece of the experimental evidence that is relevant to this question 
is the stiffening of the fiber with FXIII ligation.   The fibrin monomer has known ligation 
sites within its  domains and its C region (30, 109).  Within a model in which coiled-
coil domain unfolding leads to fibrin’s extensibility, and FXIII ligation only strengthens 
already existing gamma-gamma contacts (intra-protofibril interactions), it is hard to 
construct a scenario which FXIIIa ligation would result in fiber stiffening.  An increase in 
fiber strength – a higher tensile stress before failure – would be expected, but not 
stiffening.  Instead, stiffening suggests the mechanisms of extension are becoming more 
restricted through FXIIIa ligation.  Addition of new constraints on conformational 
freedom are required to provide this, and we believe the most obvious places this could 
happen are in the inter-protofibril C connections. The C region is known to have 
multiple sites that can form dipeptide bonds through FXIIIa ligation.  Like in a polymer 
gel, where increased crosslink density results in a stiffer material, additional covalent C 
connections facilitated by FXIIIa would stiffen the inter-protofibril mechanical linkages.   
Within our model, this would effectively reduce the average contour length of the 
constituent WLC’s.  Our fits to the force extension curves did not indicate clear change in 
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the contour length fitting parameter, though we did observe stiffening of fibrin fibers with 
FXIIIa ligation.    This could be due to incomplete ligation of the C chains by FXIIIa in 
our reaction.  Recent work by Liu et. al. showed that full C ligation reduces the 
extensibility of the fiber, reducing the contour length (91).    Further refinement in the 
force vs. extension data as well as the WLC-in-series model may be required to tease out 
subtle changes in the effective contour length of the C upon FXIIIa ligation.   
2.3.6 Analysis of the Coiled-Coil (CC) unfolding model 
 A 2007 force spectroscopy study of oligomers of fibrinogen showed compelling 
evidence of coiled-coil unfolding. In these studies, the applied force was necessarily 
transferred through the D region, coiled-coil and E region, eliminating any contribution 
of the unstructured C region. Thus, although these studies provide evidence that the 
coiled-coil is unfolding, it is not clear that the data are relevant to the stretching of 
physiological fibrin fibers, which are polymers with many parallel and series connections 
between monomers.  More recently, a two-state model for fibrin extensibility has recently 
been proposed by Brown et al. (74) as part of an impressive multi-scale study of large 
fibrin networks (See Figure 1.5).   This model assumes that unfolding of the coiled-coil 
region mediates fibrin’s extensibility.  In the model, the coiled-coils can be in two states: 
(a) the folded state where their stress-strain behavior is linear, and (b) the unfolded state 
where the coil is unfolded and behaves like a worm-like chain at high extensions (110).  
The distribution of folded and unfolded monomers is governed thermodynamically by the 
unfolding energy barrier and the distance between the energy wells of the folded and 
unfolded states.  This model is appealing in that it meshes well with the conventional 
view of fibrin structure in which the tensile force is supported completely through 
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gamma-gamma contacts within the protofibrils with the coiled-coils acting as “springs in 
series”.  However, the coiled-coil mediated extensibility model has difficulty accounting 
for the full stress-strain behavior of the fibrin fiber presented here and in other 
publications (90, 91).   
 We will now apply the two -state model recently proposed by Brown et al. to our 
single fiber data.  In the model, the coiled-coils can be in two states: (a) the folded state 
where their stress-strain behavior is linear, and (b) the unfolded state where the coil is 
unfolded and behaves like a worm-like chain at high extensions (The Marko-Siggia 
worm-like chain also includes a linear region at low extensions which is not part of this 
two state model). (111)  This model for individual fiber elasticity was then used in the 8-
chain polymer physics model to represent the behavior of a fibrin network under tensile 
deformation.  (84)  The 8-chain model was fit to the network data using thermodynamic 
properties (the alpha-helix unfolding energy barrier and the alpha-helix unfolded 
extension length) as fitting parameters.  While the authors were able to use the coiled-coil 
single fiber model to fit their network data, the single fiber force extension model 
embedded within the network model was not compared to single fiber force extension 
data.   
The force curve given in the Brown paper is defined as the following (74): 
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and x is the fiber extension, F is the force exerted on the fiber, N is the number of 
monomers/fiber cross-section, Lu is the unfolded coil contour length, Lf is the folded coil 
length, Δπ is the unfolding energy barrier, Δz is the distance between the folded and 
unfolded lengths and lp is the WLC persistence length.   
For the 8-chain model fit in the paper, Lu/Lf was assumed to be 2.1 based on the 
length of the unfolded coiled-coil, N was 1200, EA=387.5nN,  lp=0.8nm, and ΔGB and 
Δz were kept as the fitting parameters.  The fit yielded parameters of ΔGB = 16.5kBT and 
Δz=19.2nm.  Equation 2.9 is plotted with these parameters in Figure 4.10.    Our physical 
interpretation of this plot is that as the fiber is stretched, it will actually shrink from its 
folded length before beginning to stretch.   Due to the large values for ΔGB and Δz, this 
shrinking is likely due to the many coiled-coils unfolding within a relatively narrow force 
range, leaving the WLC’s to entropically shrink before being stretched back out.   This 
behavior is inconsistent with our force extension data which shows smooth, linear, low 
stiffness behavior up to strains of 100% or more. The plot is also hard to reconcile with 
single molecule force extension data for coiled-coils (103, 112-114).  
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Figure 2.8 Single fiber force strain plot for coiled-coil model.  The plot represents the 
extension-force curve arising from the assumptions and fitting parameters (Δπ = 16.5kT 
and Δz=19.2nm) from the coil-coil network fit .     
In the model for single fiber elasticity presented in the Brown et al. study, a value of 
14 MPa is used as the elastic modulus of the coiled-coil. This assumption is based on a 
previous experimental results indicating a 14.5 MPa elastic modulus for a fibrin fiber 
(64).  However, the assumption that the elastic modulus of the fiber is similar to the 
modulus of the in-tact (unfolded) coiled-coil region is questionable given the known 
stiffness of coiled-coil structures.  Biomaterials whose extensibility is known to be 
mediated by coiled-coil unfolding,  including myosin, egg capsule(113), and intermediate 
filament based materials such as keratin(112), vimentin(114, 115), and others, all show a 
characteristic force vs. extension signature that includes three force regimes: an initial 
stiff regime ranging from 150 –1000 MPa corresponding the unfolding of the hydrogen 
bond mediated coiled coil, a softer regime corresponding to the extension of the uncoiled 
peptide chain, and a second stiffening regime where the uncoiled chain reaches its 
contour length. Gigapascal scale stiffness is also consistent with numerous theoretical 
treatments of the alpha helix stiffness (116-118).  In some cases such as soft keratins and 
hagfish slime thread (119, 120), intermediate filament based materials show much lower 
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low strain modulus (a few MPa), but in these cases low stiffness is attributed to the 
unstructured elastomeric protein matrix connected in series with the stiffer coiled coils. 
 Thus, experimental, theoretical, and computational studies yield elastic modulus 
values for coiled-coil that are 3-4 orders of magnitude higher than that for the overall 
fiber measured in this study and others.  The volume fraction of protein material within 
the fiber is one possible explanation for the discrepancy.  However, estimates put the 
water fraction within the fiber at 70% which would provide a factor of 3 or 4 to work 
with, well short of the factor of 1000 to 10,000 needed to reconcile fibrin fiber stiffness 
and expected coil-coil stiffness.     
We evaluated our single fiber force vs. extension data using the two state model 
assuming a three values of stiffness for the coiled-coil structure:  2 MPa, the measured 
modulus of the fiber measured using the AFM, 100 MPa (The low-end value for a 
material with stiffness known to be mediated by coiled-coil unfolding)(113), and 800 
MPa, (The modulus of a 2 GPa stiff coiled coil structure surrounded by 80% water).  
While the fits using the low elastic modulus (2MPa) for the coils do match the data, they 
produce fitting parameters that are non-physical (e.g. picometer range persistence length).   
On the other hand, using a stiff spring model for the coiled coils requires an anomalously 
low unfolding energy barrier at low strain and the fit fails significantly at high strain. 
Three fits to one fiber force vs. extension curve are shown in Figure 2.9.  The fiber had a 
radius of 45nm.  The fits were performed using 4 fitting parameters, ΔGB, Δz, lp, and 
Lu/Lf. using Origin Pro (OriginLab Corp. Northampton, MA).  The fits were dependent 
on the initial starting parameters, and most starting parameters did not lead to a 
convergent answer.  In particular, fits attempted using a starting value of ΔGB > 5kBT did 
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not converge.  Plots A and B in Figure 2.9 were performed using the starting parameters 
GB= 5kT; Δz=3nm; Lc/Lo=2.5; Lp = 0.8nm, while Plot C was formed using : ΔGB = 
0.3kT; Δz =0.3nm; Lc/Lo =2.5; Lp = 0.2nm.   
Plot A in Figure 2.9 fits the data fairly well (R2=0.99), but it assumes a coil-coiled 
modulus of 2 MPa, much lower than the measured modulus of a coiled coil.  In addition, 
some of the fitting parameters do not make physical sense:  ΔGB = 4.1kT; Δz =0.08nm; 
Lc/Lo =3.66; Lp = 0.008nm.  While the ΔGB value can be reconciled with theoretical 
coiled-coil unfolding barriers, Δz =0.08nm and Lp = 0.008nm do not make sense 
physically. (121)  The known Lp for unraveled or natively unstructured proteins is 0.2-
0.9nm, (98, 100, 101) two orders of magnitude higher than the fits to our model, while 
the same experiments and molecular dynamics simulations show that coils unfold at 3-
15% strain, (103, 112-114) the fitting parameter Δz =0.08 corresponds to 0.1% strain, 
much lower than the known values.   
On the other hand, plots B and C use a coiled-coil modulus of 0.8GPa, similar to the 
known values of the coiled-coil modulus.  Plot B clearly does not fit the data at all, but 
does resemble other coiled-coil unfolding plots which have a very sharp peak in force 
before coil-unraveling begins to occur (103, 112-114).  Plot C does fit the data at low 
extension before diverging in the strain stiffening regime, however once again some of 
the fitting parameters yielded do not make physical sense:  ΔGB = 1.99kBT; Δz =0.02nm; 
Lc/Lo =2.827; Lp = 0.2nm.  These fitting parameters indicate that the coils would have to 
unfold at relatively low unfolding energies and at Δz values corresponding to 0.04% 
strain.  In addition to the fits shown, other fits were done with a coil modulus of 100Mpa, 
yielding similar results to those done with the 0.8Gpa modulus.   
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Figure 2.9 Fitting Single Fiber force vs. extension data with the Coiled-coil model.  Plot 
A shows data assuming a coiled-coil modulus of 2MPa while plots B and C assume a coil 
modulus of 0.8GPa. 
The SAXS data presented in the Brown et al. study are compelling, and do suggest 
coiled-coil unfolding may be occurring, however the data may also be explained by 
protofibril sliding within the fiber, causing the protofibrils to lose registry and thereby 
widen the 23nm signal.  Interestingly the authors note that the fact the peak stays at 23nm 
indicates that a portion of the molecules stay folded giving rise to the 23nm signal, even 
though the width of the signal has widened.(74)  It is not obvious how FXIII ligation 
would affect this signal.  There are known ligation sites both in the C domains and -
domains of the fibrin monomer. (30, 109)  - ligation has been shown longitudinally 
within protofibrils, but to our knowledge, not laterally between protofibrils.  C-C and 
C- interactions could be within protofibrils or between adjacent protofibrils, but it is 
not obvious that ligating these interactions would prevent protofibril shearing.  Thus, with 
the known ligation sites within the fibrin fiber, it does not seem that FXIIIa crosslinking 
would necessarily prevent protofibrils from sliding and accounting for the decrease in the 
23nm signal in the SAXS data. 
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2.3.7 Force per Monomer 
   AFM force spectroscopy studies over the past decade have established the range 
of forces required to unfold secondary and tertiary protein structure. (98, 101, 122).   For 
protein unfolding to occur within strained fibrin fibers, the resolved forces (per 
monomer) would have to exceed these thresholds.  To address this issue, we present 
estimates of force per monomer at all strains of fibrin fiber.  
For our stress vs. strain curves, both the force vs. extension as well as the fiber 
diameter data were collected.  With this information we made estimates of the average 
force per molecule (FPM) during the stretching process and compared to known protein 
unfolding forces determined in AFM force spectroscopy experiments. This estimate is 
subject to an assumption of the packing density of the monomers within the fiber.   We 
calculated the FPM for three packing densities corresponding to a high “close packing”, a 
low “loose packing”, and an intermediate “intermediate packing” packing density.  FPM 
calculations were made by assuming that the fibrin fiber consists of fibrin molecules 
acting mechanically as springs in series down the length of the fiber and in parallel across 
the cross-section of the fiber. FPM is then equal to total force on the fiber divided by 
Nmol, the number of fibrin molecules in parallel.  For the first model, we assumed that 
fibrin monomers are close packed within the fibrin fiber, thus the number of monomers in 
parallel can be calculated by Nmol=(Dfib/Dmol)
2 
, where Dfib is the diameter of the fiber and 
Dmol is the diameter of the monomer from x-ray crystallography , Dmol = 4.5 nm.  It is 
widely assumed that fibrin fibers contain mostly water (70-80%), so close packing is 
likely not accurate for a full fiber (43, 123).  The second “loose-packed model” followed 
that of Brown et. al (74), which assumed fibrin fibers contain 80% water, so the number 
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of monomers in parallel were calculated as Nmol=0.2*(Dfib/Dmol)
2
 (This makes the 
effective diameter per monomer, Dmol
eff
 =10nm).  This second model assumes that the 
entire monomer as a space filling cylinder into which no water can penetrate.  In 
actuality, the fibrin molecule is dumbbell shaped with 4.5nm diameter end domains, 2nm 
diameter coiled-coils, and a 4nm central domain (12).    Based on these dimensions, we 
estimate that nearly 50% of the volume occupied by a fibrin protofibril consists of water.  
Thus, although most of the fiber is occupied by water, the majority of this water can fit 
within close-packed monomers.  One can estimate an effective monomer diameter 
required to account for the other 20-30% of water occupying the fiber structure by 
assuming the cross-sectional area of a protofibril is roughly an ellipse, and estimating the 
effective area of the ellipse required to allow for 80% water volume.  This ratio of areas 
can then be converted into an (upper end) effective monomer diameter by assuming that 
each monomer within the protofibril has the cross-sectional area of a circle.  We estimate 
that an effective fibrin monomer diameter of 6.9 nm will account for the rest of the space 
needed for water within the fiber.  Thus our third model is an “intermediate packing” 
model where the number of monomers in parallel is calculated by Nmol= (Dfib/Dmol
eff
)
2  
, 
where Dmol
eff
  = 6.9 nm.  In each model, the force per monomer can then be calculated as 
Ffib/Nmol. 
Figure 2.10 shows the FPM plots for one fiber, assuming the three different models.  
The different assumptions about packing lead to significant differences in the scale of the 
force on each monomer.  The very lowest force we would expect a coiled-coil or globular 
protein domain to unfold would be in the 30-50 pN range (98, 103).  Previous work has 
shown that the fibrin coiled-coil may unfold at even higher forces at around 100pN (74, 
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75).   (See Figure 2.11)  Note that even in the loose-packed case, these forces (the lower 
end of the range) are not reached until the fiber is strained beyond 0.50.  For the 
intermediate and close packed models, this threshold is reached at strains of 1.0 and 
beyond. For the intermediate packing case, the fiber strain at which the 100pN coiled-coil 
unfolding threshold is reached is 113±23% for ligated fibers and 108±15% for unligated 
fibers.  At 50% fiber strain, in the linear fiber regime, the average FPM value was 27 ± 8 
pN for ligated fibers and 18 ± 4 pN for unligated fibers, suggesting that coiled-coil 
unfolding is not a prominent process in the linear strain regime.  While coils have been 
seen to unfold at forces as low as 50pN, on average it seems that most fibers do not have 
much coil unfolding until after 100% strain.   
 
Figure 2.10 Force per molecule (FPM) plots for one fiber with three different packing 
assumptions.  Frame [A] corresponds to a close-packed model fiber (Dmol = 4.5 nm), 
frame [B] corresponds to the loose-packed model (Dmol
eff
  = 10nm), and frame [C] 
corresponds to the effectively close-packed model (Dmol
eff
  = 6.9nm).   
Our analysis indicates that though the FPM in our fibrin stretching experiments may 
reach the thresholds for unfolding the coiled-coil, these forces are not accessed until the 
fiber is strained beyond 0.5 for even the most conservative model of fibrin monomer 
packing (loose-packed).   Most likely, this threshold is reached well beyond 0.5 strain.  
This suggests the unfolding mechanism is not a significant contributor to extension until 
very high strains are reached.  
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One counter-argument to this analysis that could be made is for concentrated forces 
within the fiber. Concentrated forces will make the FPM much higher locally than the 
average, inducing unfolding and then propagating across the fiber in a zipper like 
manner.  While this may be occurring, there is no known structural data to support this 
model.  We do point out that even if fibrin fiber diameter shrinking is occurring as 
indicated by other studies(74) , the number of monomers connected in parallel, down the 
fiber will remain constant and thus FPM=Ffib/Nmol should remain the same at all points 
along the fiber.  Additionally, some have claimed that the strain rates of the single 
molecule work were different than that in our whole fiber measurements, leading to 
inflated unfolding forces, however, we note that in our measurements the local strain rate 
– which is known to affect measured unfolding forces - is comparable to typical single 
molecule force spectroscopy measurements. (124)   
 
Figure 2.11 Force per monomer as a function of fiber strain: Assuming the loose-
packed model, the force per monomer can be calculated over the entire fiber extension.  
The red line indicates the experimentally observed critical force for coiled-coil 
unfolding.(75) 
2.3.8 Fibrin as Elastomeric Protein 
  The persistence length and contour length parameters that emerge from our 
model fitting together with the soft (MPa range) elastic modulus, strain stiffening, and 
 59 
 
high extensibility of individual fibers presents a body of evidence that strongly suggests 
that the origin of fibrin’s mechanical properties lie in the straightening of natively 
unstructured polypeptides.   If this is the case, the tensile elasticity of the fibrin fiber itself 
is entropic in origin, mediated by straightening of a randomly coiled polypeptide, rather 
than enthalpic and mediated by straining of chemical bonds within the backbone.  The 
entropic elastic behavior comes not from thermal fluctuations of the fiber segment’s 
overall contour, but from internal degrees of freedom residing in the unstructured peptide 
sequences within the monomer.   The argument has been made in the literature that the 
architectural parameters for fibrin gels (branch point density in particular) are not 
consistent with rubber like elasticity even though fibrin’s extensibility and stiffness is 
comparable to rubber (63, 125). This is because unlike in rubbers where very stiff (GPa-
scale tensile modulus), very thin, polymer molecules or polypeptides are polymerized 
into a complex highly crosslinked random coil networks, fibrin gels are made up of thick 
structurally complex fibers with very low branch point densities. Instead, we propose that 
for fibrin, the fibers themselves are rubber-like; the fiber is itself a flexible polymer 
network.  
2.4 Conclusions 
 We have performed a full stress vs. strain evaluation of individual fibrin fibers,  
revealing elastomeric mechanical properties including low modulus (MPa), and high 
extensibility, and strain stiffening behavior.  We found that FXIIIa ligation roughly 
doubles the stiffness of fibrin both in the low and high strain limit.  This underlines a 
crucial point in fibrin mechanics: in addition to any architectural effects FXIIIa ligation 
confers to the overall fibrin network such as fiber diameter and branch point density, it 
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also directly affects individual fiber segment stiffness.  We also point out that an increase 
in stiffness must come from the αC region of the molecule, not γ-γ ligation. We have 
proposed the first mechanical model of the fibrin fiber based on the stretching of the αC 
region of the molecule. The model depicts the fibrin fiber as a set of parallel chains of 
monomers linked in series. Each monomer consists of a soft WLC element representing 
an unstructured region of the fibrin protein monomer.  Our force vs. strain data is fit well 
by the scaled WLC model and indicates that the unstructured portions of the monomer 
mediate the mechanical response of fibrin fibers.   
 
 
 
  
 
Chapter 3. Fibrin Fiber Recoil Dynamics 
3.1 Introduction 
In the previous chapter we fully characterized the mechanical properties of fibrin 
fibers and developed a mechanical model for their elasticity.  Furthermore, we compared 
our αC stretching model with the CC model, the other prominent hypothesis for the 
elastic behavior of fibrin fibers.  We now turn our attention to a property perhaps even 
more pertinent to the survival of blood clots: fibrin fiber dynamics.  The heart pumps 
blood at approximately 1Hz, so fibers must regain their full elasticity prior to the next 
pulse or risk plastic deformation and eventual failure over the course of several load 
cycles.  It is crucial, then, to have an understanding of fibrin’s dynamic response to force.  
In addition, measurements of the dynamic response of fibrin fibers can speak to the 
molecular underpinnings of the property.  The two competing models for fibrin elasticity 
come from either protein unfolding or the entropic relaxation of a natively unfolded 
protein.  In the CC model, the coiled-coil region must refold to re-gain the full elasticity 
of the fiber, while in the other model an entropic recoil without re-folding would be 
expected (See Figure 3.1). 
We report measurements of fibrin fiber recoil dynamics, showing that fibrin fibers 
behave like rubber bands, recoiling on timescales of ~500μs, and tensing back into an 
elastically taut conformation on millisecond timescales.  We probed the molecular origins 
of this behavior using discrete molecular dynamics simulations.  We find that α-helical 
coiled-coil portions of the molecule unfold into an energetically stable β-sheet 
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conformation.  If this does in fact occur upon fiber stretching, it would prevent a μs recoil 
response, however without experimental corroboration, we cannot rule out a model of 
coiled-coil unfolding without forming β-sheets, entropically relaxing and slowly re-
forming coiled-coils on μs timescales.  We conclude then, that the recoil dynamics are 
most likely governed by the unstructured αC regions of the molecule, however further 
experimental validation is required.   
The dynamic behavior of fibrin fibers is quite surprising given the distinct 23nm 
banding pattern shown in SEM and TEM images indicating lateral contacts between 
protofibrils and a crystalline packing of the fiber (See Figure 3.1).(47)  One could argue 
that this places fibers in a unique materials category…that of a crystalline rubber.
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Figure 3.1 Fibrin Fiber Recoil Models Based on the Mechanism of Extension: (A) 
The Coiled-Coil (CC) model involves stretching of the coiled-coil region of the fibrin 
molecule.  Upon the release of force, the model would predict that the coiled-coil region 
would refold.  (B) The αC model involves stretching of the αC region of the molecule.  
Upon the removal of force the αC regions would be expected to entropically relax and 
allow the lateral connections to regain their periodicity.   
 
3.2 Materials and Methods 
3.2.1 Optical microscopy 
  Experiments were performed using a combined inverted optical 
microscope/Atomic force microscope as described in Ch. 2.2. (78)  Fluorescently labeled 
fibers were suspended between ridges with a 20µm pitch and then stretched from the 
center with an AFM tip.  Fibers were allowed to slip off the tip and fiber relaxation was 
measured optically.  Because the timescales of relaxation were faster than the frame-rate 
of our current camera, an Evolve 128 camera (Photometrics, Tucson, AZ) was generously 
loaned to us by Photometrics.  We measured the frame rate of the camera to be 120-150 
frames per second (fps) in full frame mode, and up to 4,000 fps in region of interest 
(ROI) mode which only measures the photon counts in a certain region of the detector. 
3.2.2 Discrete Molecular Dynamics  
DMD simulations were carried out on the Biomedical Analysis and Simulation 
Supercomputer (BASS) at the University of North Carolina at Chapel Hill.  The basics of 
DMD are discussed in Appendix A.5.  Simulations first stretched the coiled-coil structure 
at constant force causing it to unfold into a stable β-sheet conformation which is 
described in more detail in chapter 4.4.  To test the stability of this conformation, we ran 
additional simulations on this region after the force was turned off.  The initial 
conformation used for these relaxation simulations was the final conformation of the 
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coiled-coil structure after 10ns of DMD simulation under 700pN of force (See Figure 3.4 
top image for the initial conformation). 
The coiled-coil structure was extracted from PDB structure 3GHG.(12)  
Specifically amino acids α27-200, β58-198, and γ14-130 from 3GHG were used to 
generate the initial structure for the simulation.  Each chain of the coiled-coil structure 
terminates consists of 111 amino acids surrounded on each end by one (or more) Cystein 
residues.  Di-sulfide bonds, between αCys161-γCys135, αCys165-βCys193, and 
γCys139-βCys197 on the C-terminal end and αCys45-γCys23, αCys49-βCys76, and 
βCys80-γCys19 on the N-terminal end were incorporated as described in chapter 4.4.1 
Methods.  The simulations were performed in a rectangular box of dimensions 
100Åx100Åx2000Å with periodic boundary conditions.  An Anderson thermostat (See 
Appendix A.3.2) was used to maintain room temperature (300K).(126) 
3.2.3 Fibrin Polymerization 
 Fibers were polymerized across channels at the same concentrations and in the 
same manner as described in Ch.2.  Fibers were formed with and without FXIIIa cross-
linking.  Additional experiments were performed in the presence of 
ethylenediaminetetraacetic acid (EDTA) and after glutaraldehyde cross-linking.  In this 
document only the data from non-ligated fibers is presented, but the data analysis from 
the additional experiments is ongoing. 
3.3 Experimental Results 
Fibrin fibers where non-specifically attached to an AFM tip by bringing the gold-
coated tip in contact with the fiber surface.  The tip was then moved in a direction away 
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from the fiber (See Figure 3.2) until the fiber detaches from the tip and recoils back into 
its taut conformation.   
 
Figure 3.2 Experimental Setup: (A) The AFM tip is brought towards the fiber on the 
right side.  Once in contact with the fiber, the tip is moved back to the right (B) before 
eventually slipping off and recoiling (C). 
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Figure 3.3 Fibrin Recoil Dynamics Captured with High Speed Fluorescence 
Microscopy: (A) A fiber suspended between two ridges and stretched by an AFM, slips 
off the AFM tip and recoils.  The top left image shows a fast recoil which cannot be 
captured at the full frame camera frame rate, followed a recovery of tension within 10ms. 
B) Imaging only a region of interest allowed frame rates of 4000fps, enabling the initial 
recoil event to be captured.  (C-D) The tensing time, defined as the decay constant of an 
exponential fit to the recoil data, was measured by plotting the average position of the 
center of the fiber vs. time. (C) Each fiber was pulled a minimum of three times, and the 
tensing time was measured for each recoil. Data is separated by color indicating whether 
the data point came from the first fiber pull, the second fiber pull…etc.  Based on the 
data, there is not a direct correlation between tensing time and the number of times the 
fiber is pulled, indicating that fibers are not plastically deformed over a series of stretch 
and relax cycles.  (D) Recoil was also analyzed on a per fiber basis to test whether certain 
fibers tensed on a characteristic timescale.  Each color in plot “D” represents data taken 
from one fiber.  The circled data points represent one fiber with a slower tensing time, but 
otherwise most fibers appeared to behave in a similar manner.  Additionally, both (C) and 
(D) show no direct correlation between the tensing time and the fiber strain at the point 
when the fiber began relaxing.  
 
In full frame mode, most fibers were observed to detach from the tip and regain 
their full tension within 5ms (Figure 3.3A).  The initial time of the recoil could not be 
captured in full frame mode, so additional videos were taken using only the fiber center 
in a region of interest.  ROI imaging revealed that the first part of the recoil occurs on 
timescales of approximately 500μs, which corresponds to a recoil strain rate of ≈ -4000s-
1
, while the average strain rate over the entire relaxation is 12s
-1
.  Fibers generally tensed 
back into their taut conformations within 5ms as seen in Figure 3.3. 
.  The tensing time (η) was defined as the mean decay time of the fiber and was 
calculated for each fiber by fitting an exponential function to the fiber center position (R) 
as a function of time:  R=Roexp(-t/η).  The most strained fibers observed in this set of 
experiments reached strains of 100%, and a full recovery of elasticity (based on a 
consistent tensing time) was observed upon repeated stretching cycles of the same fiber.  
There does not appear to be a correlation between η and fiber strain at the point of 
detachment up to 100% strain.  It should be noted that in previous experiments, plastic 
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deformation of fibers has been observed at strains above 120%, however due to the non-
specific interactions between the fiber and tip in these experiments, fibers did not reach 
the point of plastic deformation before detachment. (66) 
3.4 An α-helix to β-sheet transition 
To probe the molecular origins of these properties, we used discrete molecular 
dynamics simulations to stretch coiled-coil region of the fibrin molecule under constant 
force. (See 3.2.2 Discrete Molecular Dynamics)  We found that as the coiled-coils unfold, 
they form hydrogen bonds with adjacent chains, and form a stable β-sheet structure.  (See 
Figure 3.4 and Figure 4.8).  The unfolding force was then turned off, and the structure 
was allowed to relax.  Instead of entropically collapsing into a molten globule state and 
re-folding into a coiled-coil structure, as would be expected from the coiled-coil 
stretching model, the β-sheets appeared to lock the chains into an energetically stable 
position that prevented immediate re-folding.  The β-sheet rich structure was 
energetically stable for 100ns of simulation time.  As a comparison, the single gamma 
chain of the coiled coil was stretched to its full contour length and then released.  The 
chain immediately relaxed, collapsed, and began re-forming an α-helix. (See Figure 3.4)   
This is not the first α-helix to β-sheet transition observed in nature.  Astbury in his 
seminal work which actually defined the α-helix and β-sheet structures in X-ray signals, 
noticed that the keratin double helix coiled coil undergoes this transformation in wool 
and hair fibers after stretching.(127)  This transition was re-characterized by Kreplak et 
al. who showed that in keratin, first the α-helices must unravel starting at 5% strain, and 
β-sheet formation does not occur until 20% strain, but between 20% strain and 40% strain 
both forms are present in the fibers.(128, 129)  Interestingly, the same authors earlier 
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showed that keratins stretched in only 30% relative humidity did not form β-sheet 
structures after the disappearance of the α-helix signal indicating the presence of water is 
important in β-sheet formation.(129)  An impressive study on hydrated hagfish slime, a 
keratin based material, showed that threads made of this material undergo an irreversible 
α-helix to β-sheet transition above strains of 30% leading to plastic deformation. (120)  In 
conclusion, it seems that hydrated keratins undergo an irreversible α-helix to β-sheet 
transition at strains above 30%, while keratins not in the presence of water do not 
necessarily make the transition.  Recent MD studies on keratins such as vimentin also 
indicate an irreversible α-helix to β-sheet transition.(114, 130)   In one study, the authors 
predict that the α-helix to β-sheet transition is a universal feature of double helix coiled-
coil structures greater than 40 amino acids.(130)   
Single molecule protein refolding studies have offered a mixed bag of results.  
One impressive study showed that the 768 amino acid double helix of muscle motor 
protein myosin II can elastically stretch and refold when stretched on timescales of 2-7s.  
FRET and AFM studies on the coiled coil structure of the GCN4 leucine zipper show that 
it can refold on ms timescales after unzipping, however the direction of applied force in 
the AFM studies would seem to pull the coils apart preventing β-sheet formation.(131, 
132)  AFM measurements on 106 amino acid triple helix spectrin repeats indicated that in 
repeating load-unload cycles a fraction of the coiled-coil structures could re-fold on the 
order of 1s, but many did not re-fold(98).  Finally, in perhaps the most relevant work to 
this paper, fibrin protofibrils were repeatedly stretched on timescales of a few seconds.  It 
is not exactly clear what was unfolding in those measurements, but the authors 
interpreted it as coiled-coil unfolding and saw that several of the force peaks were present 
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in multiple extension-retraction curves indicating a partial refolding of some of the 
molecules.(68)  Thus, the timescales of coiled-coil refolding from single molecule 
experiments do not necessarily rule out an α-helix to β-sheet transition, but they do not 
provide evidence that the a stretched coiled-coil would recoil on the order of μs either.  
Conclusive single molecule work on fast-folding globular proteins such as the Ig domain 
have shown refolding times on the order of 40ms for repeated stretching cycles.(133)  
This likely rules out the re-folding of the fibrin γ-nodule or β-nodule as a mechanism of 
relaxation as they are rather large (~300 amino acids) globular regions and would not be 
expected to re-fold faster than the 100 amino acid Ig domain described above.  
Our MD results combined with the experimental keratin data, MD simulations of 
other coiled-coil structures, and the single molecule measurements on coiled coil 
structures indicate that if the fibrin coiled coil does undergo an α-helix to β-sheet 
transition, the transformation is likely irreversible upon the release of force.  Even in 
single molecule studies where an α-helix unfolding event did occur, the refolding was 
often only observed in a fraction of the molecules after several seconds of relaxation 
time.(68, 98)  This would indicate that stretching of the coiled-coil cannot account for 
500μs elastic response time of the fibrin fibers, and is likely not the predominant 
mechanism of extensibility within the fibrin fibers.  This analysis is not complete 
however, and further studies should be carried out to measure whether fibrin does truly 
undergo an α-helix to β-sheet transition. 
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Figure 3.4 β-sheet Relaxation: Left:  Simulations of the β-sheet form of the fibrin 
coiled-coil.  The β-sheet form is obtained by stretching the coiled-coil at constant force.  
Once obtained, the β-sheet appears stable, and prevents, an immediate recoil.  Right:  
Simulations of the γ chain of the coiled coil part of the molecule.  Contrary, to the β-sheet 
structure, just the γ chain in isolation, immediately collapses and begins re-forming an α-
helix structure.  The collapse happens faster than it would physiologically due to the use 
of an implicit solvent in both simulations, and hence no viscosity.  Nevertheless, the 
distinct difference in recoil behavior between the β-sheet structure and the γ chain in 
isolation indicate, that the β-sheet structure is not the source of the recoil dynamics 
properties of the fibrin fiber. 
3.5 Conclusions 
 The cumulative evidence from experiments and simulations suggests that the 
most likely explanation for the initial 500μs relaxation followed by tensing on the order 
of 1-10ms comes from the entropic recoil of the αC region of the fibrin fiber in 
accordance with the αC stretching model (See Figure 3.1).(78)   Mathematical modeling 
of the recoil behavior using polymer recoil dynamics (Rouse and Zimm dynamics) is the 
next step in the analysis, and preliminary work is ongoing.   We will treat the fiber as a 
series of cylinders (representing the protofibrils) connected by polymer chains.  The 
relaxation timescales will be calculated from the entropic restoring force of a stretched 
chain and the intrinsic viscosity of the polymer chain combined with the drag generated 
by the cylinder. 
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 In previous work, the stress relaxation of fibrin fibers has been measured, where 
the fibers where stretched to a certain strain and then held constant.(67)  In stress 
relaxation, the fibers also exhibited two relaxation times, however the times were on the 
order of 2s and 50s, indicating different mechanisms than those observed in our strain 
relaxation experiments.   
The relaxation dynamics of fibrin fibers continue the mounting evidence that 
fibrin fibers are elastomeric in nature.  Most other elastomeric materials are also 
comprised of networks of unstructured polymer chains. (92, 134)  The most classic 
example is rubber, which consists of cross-linked hydrocarbon chains, and can recoil at 
average strain rates of -41s
-1
 in water.(135)  Biopolymers such as elastin and resilin also 
consist of disordered networks of amino acid chains.(134, 136)  The difference between 
fibrin, and these materials is that fibrin fibers may have a crystalline packing, while other 
elastomers start as a random array of unstructured chains.  The trick with fibrin is that the 
part of the protein giving rise to the elastic properties, the αC regions, are independent 
from those forming the crystalline packing (the structured coiled-coil and D regions). 
 One type of material that also contains crystalline structure while also having 
large extensibilities is spider silk.(137-139)  Spider silk is different than fibrin however in 
that it contains β-sheet nanocrystals embedded in a soft matrix of disordered material.  
Stretching of both viscid and dragline silks indicated that spider silk thread stretching was 
not reversible on ms timescales; rather silk threads after stretching resume a taut 
conformation if left slack for about 10 minutes.(92)  Fibrin fibers are therefore unique 
elastomers.  In an unstrained state, they have a regular packing giving rise to banding 
patterns across the fiber.  At the same time, between the crystal-like structure, they 
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contain networks of disordered amino acid chains, allowing fibers to stretch to triple their 
length and resume taut conformations on ms timescales.  The timescales observed in 
these recoil dynamics experience could be explained by: 1) an entropic recoil of the 
stretched αC regions, followed by a re-formation of the lateral contacts between 
protofibrils allowing the fiber to regain its crystalline packing.  The plastic deformation 
observed in stretching fibers beyond their elastic limit may come from stretching the 
ordered parts of the fibrin molecule such as the γ-C domain as explained in Chapter 4. 
.  We conclude that fibrin fibers behave like rubber bands in their recoil behavior which 
is remarkable for a material with the internal order of a fibrin fiber.  They contain 
unstructured polymer networks that can allow rapid stretching and recoiling on 
microsecond timescales.  Unlike rubber bands however, they contain additional 
structured regions which must re-form contacts on ms timescales.   
  
 
Chapter 4.  Unfolding Energy Barriers of the Coiled coil, γ-γ and αC region of the 
Fibrin Molecule 
4.1 Beyond the αC region 
 The previous two chapters describe a variety of fiber properties that ultimately 
must be explained on the molecular level.  Fibrin fibers are highly extensible, exhibit 
strain stiffening behavior, stiffen when ligated by FXIIIa, recoil on µs timescales, and 
regain tension on ms timescales.  The evidence so far indicates that many of these 
mechanical properties arise from an unstructured part of the molecule, likely the αC 
region.  However, the exact structure of the αC region is not known, making it difficult to 
devise the mechanism by which the extension can arise from this region.  In addition, 
given that the αC regions allow extension between protofibrils (See Figure 2.5), the 
amount of fiber strain generated from this mechanism is related to the ratio of protofibril 
length to αC length.  The distribution of protofibril lengths within a fiber has never been 
measured.  Distribution of protofibril lengths during polymerization have ranged from 1 
to 20 or more monomers which (assuming a half-staggered arrangement) corresponds to 
protofibril lengths ranging from 45 to 450nm or greater.(99)  Given that the maximum 
length of the αC region is 410Amino Acids* 0.3nm/AA=123nm, it is likely, at least at 
higher strains, that additional regions of the fibrin molecule stretch in order to reach fiber 
strains of > 200%.  
 To predict potential other mechanisms of fibrin extension and to probe the relative 
stability of the various parts of the fibrin molecule, we have used Steered Discrete 
Molecular Dynamics (SDMD) simulations to assess the relative stability of the αC 
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region, the γ-C region, and the coiled-coil region.  We started by generating a homology 
model for the αC domain, and then tested the stability of that region using a temperature 
scan and forced unfolding.(140)  We proceeded to isolate the coiled coil region of the 
molecule, and the γ-nodule (sometimes referred to in this document as the γ-C domain), 
and the γ-γ interface between molecules for molecular stretching simulations using DMD.  
A series of simulations were performed stretching each region of the molecule at forces 
ranging from 5-1000pN.  The critical force for unfolding was calculated for each region 
by assessing unfolding times at various forces.  In so doing, we were able to measure the 
relative stability of each region of the fibrin molecule, and propose a complete model for 
fibrin fiber extension. 
4.2 Developing a Structural Model for the αC Region of the Fibrin Molecule 
4.2.1 Is the αC region truly unstructured? 
The structure and function of the fibrin(ogen) αC region has been subject to much 
debate over the past 40 years. (13, 14, 26, 141-145) Originally, Doolittle proposed that 
these structures were largely unstructured and acted as “free swimming appendages.”  (4, 
142)  This view was supported by earlier circular dichroism studies indicating that the α-
C plasmin degradation product was a random coil and by amino acid sequence 
comparisons revealing a similarity between the αC region and other unstructured 
proteins.  (146, 147) However, this work was contradicted by some calorimetric and EM 
studies which indicated that part of the α-C region contained compact structures.  (143, 
148-150)  In 1983, Erickson and Fowler showed EM images indicating that the 
fibrinogen α-C region has some globular structure and is connected to the central region 
of the molecule.(148)  This globular structure was dubbed the αC domain.  This work has 
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been followed up with further EM studies of fibrinogen, fibrin, and various fragments, 
which show a structured portion of the αC domain in a high percentage of the molecules 
imaged.  (150, 151)  Recent NMR studies have indicated that recombinant truncated 
variants of both bovine and human fibrinogen αC-domains form beta sheet structure.  (14, 
152, 153)  However, a debate still exists as to whether an ordered structure is present in 
the fibrin(ogen) αC region due to the lack of an electron density in crystal structures.(13) 
 EM images of fibrinogen, indicate that the αC domains interact with each other 
intramolecularly and are positioned near the central region of the molecule.(151)  It has 
now been established that αC domains of fibrin molecules also interact intermoleculary 
through non-covalent interactions.  (73, 152, 154)  These interactions are concentration 
and pH dependent, and a recent laser tweezers study indicates some interactions between 
αC-domains that could withstand forces of up to 50pN at pH 7.4.(73, 152, 154) 
 Fibrin αC domains also interact via FXIIIa cross-linking to form networks termed 
α-polymers.  FXIIIa is another blood protein that acts as a transglutaminase, catalyzing 
the formation of a covalent bond between the free amine group of a Lysine (Lys) and the 
gamma-carboxamid group of a glutamine (Gln).  Each αC domain contains 23 potential  
Lys donor sites and 6 Gln sites, however not all are equally used in cross-linking.  Sobel 
et al. showed that the primary Lys sites are Lys556 and Lys580, and Cottrell and co-
workers indicated that the primary Gln sites are α328 and α366, indicating that some sites 
are more accessible to FXIIIa than other.(30, 155)  The mechanism for this selection does 
not seem well understood. 
 To address these issues, we have undertaken a study of the αC region structure 
using discrete molecular dynamics modeling.  We began by searching for a homology 
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model of the αC region using I-TASSER.(156, 157)  I-TASSER is a web-based protein 
structure prediction tool, which is able to find homologs and even remote homologs (with 
relatively low sequence similarity). Using these identified homolog and remote homolog 
structures, a structural model of the query sequence was built. The model was then 
energy minimized and thermally unfolded to define the equilibrium structure at various 
temperatures.    The resulting structure, which was not constrained by any of the 
previous, EM, calorimetry, or NMR data, is yet remarkably consistent with the 
aforementioned data.  The model consists of an unstructured αC connector region, 
terminating in a β-helix structure which contains the di-sulfide bond.  Beyond the β-helix 
is a second unstructured region, containing the most prevalent Lys donors for cross-
linking.   This structure is consistent with the binding and cross-linking requirements of 
the αC region and also suggests a possible mechanism by which FXIIIa can select 
residues for ligation. 
4.2.2  A computationally Identified β helix structure of the fibrin αC region 
 A series of homology models were generated for amino acids 196-610 of the 
fibrin αC domain using the online modeling resource I-TASSER.(140)  One model of 
particular interest showed a β-helix structure for the αC region and within the structure 
Cys442 and Cys472 were within 1nm of each other indicating a potential for di-sulfide 
bond formation.  Following homology modeling, the structure was relaxed using 400 
steps.  The di-sulfide bond was formed by adding constraint potentials between the 
Cys442 and Cys472,(158) and the system was allowed to relax for 10ns of DMD 
simulations at 276K. The system was then allowed to evolve for an additional 10ns of 
DMD simulations at 300K after di-sulfide formation.(159)  Figure 4.1 shows the resulting 
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structure after equilibration at 300K along with the homology derived structure.  The 
equilibrium resultant structure displays several remarkable structural features.  
 In Figure 4.1, the αC region has been separated by color to show several distinct 
regions.  Amino acids 196-240 are seen folding back on each other, however in 
simulations of the whole fibrinogen molecule where α196 was attached to the 4th coil, the 
bonding was not present.  The repeat region, amino acids 264-391, displays a random coil 
arrangement, with no discernable fold, in agreement with previous studies.(145)  A novel 
structure is seen between amino acids 392 and 520, where a partial β-helix structure is 
formed.  The helix measures approximately 2nm in diameter, and appears destabilized on 
the side of the di-sulfide bond.  The αC domain then terminates in a second random coil 
region containing the most active transglutaminase sites, Lys556 and Lys580, which 
account for 50% of all FXIIIa-catalyzed cross-links. 
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Figure 4.1 Structure of the fibrin αC region: A) The homology derived structure.  B) 
The equilibriated structure at 300K.  The blue region consists of amino acids 196-220, 
which are not in the human fibrinogen crystal structure implying an inherent flexibility 
(12), but have not historically been considered part of the αC region. (13)  The orange 
region consists of amino acids 221-391, typically called the αC connector region. (160)  
Within this region, amino acids 264-391 contain the series of 10, non-identical (13 amino 
acid each), repeats.  The green region, consisting of amino acids 392-610 is traditionally 
called the αC domain.  The Cys442-Cys472 di-sulfide bond is highlighted in yellow, 
while all the potential cross-linking sights are highlighted in red (Lysines) and teal 
(Glutamine).  All amino acids noted above are represented in atomic sphere mode, while 
the structure as a whole is represented in cartoon mode to highlight the beta sheet 
structures.  Lys580 and Lys556 contribute to 50% of αC cross-linking. 
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4.2.3 Thermal unfolding of the αC region indicates the relative stability of the β 
helix 
 We performed equilibrium DMD simulations of the αC region for 10ns over a 
wide range of temperatures (276-390K). We used the weighted histogram analysis 
method (WHAM, see appendix A.6.1 The Weighted Histogram Analysis Method 
(WHAM))(161) to compute the specific heat as a function of temperature (Figure 4.2 
top). The peaks in the specific heat vs. temperature plot correspond to the unfolding 
transitions.  As can be seen, the αC region of fibrin displays three distinct unfolding 
transitions.  Comparing the unfolding transition peaks to snapshots of the final structures 
of equilibrium simulations at 290K, 310K, and 325K, indicates the likely sources of each 
peak (Figure 4.2 bottom).  The first peak comes from denaturing and α helix structure 
that forms at low temperatures near the C-terminal end of the αC domain.  The second 
peak at 320K, comes from the thermal denaturing of the β-helix structure.  The third peak 
centered at 345K is smaller and likely comes from the denaturing of residual contacts left 
after the β-helix unfolding. 
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Figure 4.2 Specific Heat of the αC Structure: The specific heat of the fibrin α-C region 
β-helix structure was calculated by running a series of simulations at different 
temperatures.  WHAM (See appendix A.6.1was then used to calculate the specific heat 
using equation A.6.1.  Peaks in the diagram correspond to unfolding transitions. 
4.2.4 Comparing properties of the αC computational structure with known 
experimental data 
 Experimental evidence suggests that the αC region plays an important role in 
fibrin fiber polymerization and elasticity, yet the structure of the αC region has been 
difficult to pin down. (13, 145)  In this work, we have presented a structure for the αC 
domain arrived at through homology modeling and molecular dynamics simulations that 
may solve several of the current structural conundrums.  The entire αC region consists of 
an unstructured αC connector region (a.a. 221-391) followed by a loose β-helix structure 
(a.a. 392-522), and a second unstructured region (a.a. 522-610).  The most interesting 
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part of the structure is the β-helix which makes sense of several other experimental clues, 
but has not been observed in crystallography studies.  (12, 162)  
  Several groups have reported seeing “extra nodules” in EM studies of both 
human and bovine fibrin and fibrinogen and have attributed this structure to the αC 
domain. (150, 151)  The location of the nodule(s) seems to vary based on sample type 
and pH, but they are typically seen either adjacent to the central region of the molecule or 
near the outer D-domains.  They are not seen with every molecule imaged, but generally 
the nodules appear smaller than the C-termini of the β and γ chains which measure 5nm 
in diameter. Thus, the β-helix structure, which measures approximately 2nm in diameter 
is consistent with the size and existence of the extra nodules. 
 82 
 
 
Figure 4.3 β-hairpin vs. β-helix:  (A) shows the bovine fibrin β-hairpin structure found 
by Burton et al. in their NMR studies of truncated αC domains.(153)  Between the two 
Cysteines(yellow), the structure folds back on itself forming hydrogen intra-chain β-
sheets. (B) Identifies amino acids Cys442-Cys472 within our αC homology model.  The 
open circle structure is stabilized by β-sheet formation with amino acids outside the 
immediate sequence (442-472) as can be seen in Figure 4.1. 
 Recent NMR data has shown that both bovine and human fibrinogen exhibit β-
sheet structure in the αC domain.  Work by Burton et. al in on recombinant αC fragments 
indicated that bovine fibrinogen exhibited a β-hairpin structure based around the di-
sulfide bond (See Figure 4.3). (152, 153)  Studies on a truncated bovine αC fragment 
indicated a second loose β hairpin located in the hydrophobic region beyond the di-
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sulfide bond, in while a longer αC fragment indicated an undefined or flexible region in 
that space.(152, 153)  Corresponding work on human αC fragments indicate similar β 
sheet structures, although with more structural flexibility.  (14) 
 The structure for the human αC region derived using DMD shows intriguing 
similarity in β sheet structural features, indicating a high significance for our homology 
model.  The structure consists of a loose β-helix structure, one side of which contains five 
parallel β sheets holding the helix together, while the opposite side of the helix consists 
of non-bonded, flexible regions, in the middle of which lies the di-sulfide bond (between 
β-sheets coils 2-3).  In the NMR studies, hydrogen bond contacts were able to be 
assigned in the β hairpin structure of the bovine αC domain fragments. (152)  
Corresponding contacts and β sheets were not able to be identified in the human αC 
domain fragments using NMR due to larger flexibility of the human fragments, but the 
authors estimated β sheet regions using homology modeling to correspond to amino acids 
444-452, 456-464, 475-480, 485-494.(14)  In the β-helix structure on the other hand, β-
sheets are observed in amino acids 393-397, 429-432, 434-438, 460-464, 466-470, 482-
486, 488-492, 512-515, and 518-522.    
 The similarities and differences between the two structures (β hairpin vs. β-helix) 
can be examined in several ways (See Figure 4.3).  First, there is a large amount of β-
sheet forming potential in the αC domain (residues 392-522).  Between the two structures 
over 50% of all amino acids participated in β sheet formation in one or the other 
structure.  This also means that 50% of the amino acids did not participate in structural 
formation.  This combination of β-sheets intertwined with flexible regions is possibly the 
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reason the structure of the αC domain has been difficult to pin down in crystallographic 
studies. 
 It is important to realize that the NMR derived β hairpin is not necessarily 
incompatible with the β-helix structure.  In the β-hairpin, the amino acids between 
Cys442 and Cys 472 (the di-sulfide loop), fold back on each other and form hydrogen 
bonds with themselves.(152)  If instead, this structure was opened up into a circular shape 
and allowed to interact with amino acids outside that immediate sequence, the circular 
structure could form into a three dimensional solenoid type shape by winding amino 
acids above and below the initial circle (Figure 4.3).  It is possible that the αC region can 
form either a β hairpin or a β-helix depending upon whether the initial folding 
interactions stabilize it in a pinched hairpin or a circular shape.  This may in part be 
driven by the length of the region on either side of the di-sulfide loop.  The hairpin may 
have been more prevalent in the NMR studies due to the fact that truncated recombinant 
αC regions were used. (152)  NMR studies on the full length αC region of both bovine 
and human fibrinogens were not able to deduce an exact structure. (14, 153)   This also 
might explain why not every EM structure of the fibrinogen molecule displays an “extra 
nodule”, although it more likely has due do with protein-surface effects.   Perhaps some 
form hairpins, which are less electron dense and may not be obvious in an electron 
micrographs, and some form β-barrels which show up as 2nm structures floating in space 
next to bulk molecule.  β-hairpin vs. β-helix structure formation may also be pH 
dependent as work done on the αC region in the past has been performed over a wide 
variety of pH’s.  (145, 163) 
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 The β-helix structure can also help explain the non-covalent oligomerization of 
fibrin αC domains.   Previous reports have suggested that β-hairpin swapping is a relevant 
mechanism for αC multimerization.(152)  A similar type of domain swapping mechanism 
could explain oligomerization with the β-helix structure.  The helix consists of structured 
β-sheets on one side, and flexible non-bonded regions on the other side.  Since these 
chains are not bound in the β-helix structure, but do have hydrogen bonding potential as 
explained above, these flexible chains would be able to form intermolecular hydrogen 
bonds with other αC domains, stabilizing the flexible regions of the β-helix and allowing 
for oligomerization.  Previous circular dichroism (CD) measurements have indicated that 
upon oligomerization, the αC regions increase in regular structure, a result that would be 
expected in β-helix domain swapping.(14) 
 The thermal stability of the β-helix structure was tested by running a series of 
simulations at various temperatures.  The specific heat and hence the unfolding 
transitions of the structure can then be deduced using the WHAM method. (161)  The 
main peak in the Cv  vs. Temperature plot for the β-helix centers around 45
o
C, indicating 
a melting temperature (Tm) between 40-50
o
C (See Figure 4.2).  This is in good agreement 
with previous fluorescence and CD thermal denaturation measurements.   A 2002 paper 
by Tsurupa et al. for the full length human αC fragment (at pH 8.0 in 150mM NaCl Tris 
buffer) indicated a Tm  around 42
o
C. (145)  A recent paper by the same author, indicated 
a melting temperature of 24
oC for truncated αC fragment hAα425-503 (conc. 6.3mg/ml, 
pH 7.4, 150mM, NaCl Tris buffer) and a Tm of 40
oC for αC fragment hAα392-610 (conc. 
1.9mg/ml, pH 7.4, 150mM, NaCl Tris buffer).(14)  Interestingly, in the CD studies, Tm of 
the longer fragment is 15
oC higher than hAα425-503.  This number could be due to a 
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slightly higher number of oligomers in solution (6% vs. 15%), but also could be due to 
the presence of β-helix structures in hAα392-610, not seen in hAα425-503. 
 Finally it is important to understand how the β-helix model reconciles with the 
known binding and cross-linking sites in the fibrin(ogen) αC region.  It has known 
binding sites for tPA, fibronectin and plasmin(ogen) as well as cross-linking sites for 
factor XIIIa, and α2-antiplasmin.  The tPA and plasminogen binding sites are known to 
reside on Lys residues within amino acids 392-610, and are only present in fibrin, not 
fibrinogen; however they are not competitive. (164)  The β-helix structure provides a 
model for these binding sites as the nearly every Lys in the β-helix resides in the flexible 
region of the helix (Lys413, Lys 418, Lys421, Lys427, Lys444, and Lys457).  α2-
antiplasmin cross-links to Lys303 in the αC connector region, and has recently been 
shown to non-covalently interact with the αC domain.  It was additionally shown that α2-
antiplasmin was not competitive with tPA or plasminogen in binding.(165)  The 
fibronectin binding site on the other hand is revealed in the αC connector region upon the 
conversion of fibrinogen to fibrin. (166)  It is not clear that the β-helix structure would 
affect this site, unless it blocks binding in the fibrinogen state.   
 FXIIIa induced ligation serves to stabilize fibrin fibers and strengthen blood clots.  
It has previously been shown that three Gln residues (221, 237 and 328) (29) and at least 
13 Lys donor residues can participate in FXIIIa reactions within the αC region, however 
not all Lys residues contribute in equal amounts to ligation.  Lys556 and Lys580 account 
for 50% of Lys donors, while Lys539, Lys508, Lys418, and Lys448 contribute an 
additional 28%.  The last 22% is split amongst Lys601, Lys606, Lys427, Lys429, 
Lys208, Lys224 and Lys219. (30)  Because the αC region contains 23 potential Lys 
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donor sites, this means that an additional 10 Lysines are inert to FXIIIa.   These data 
indicate some selection mechanism for FXIIIa, and the β-helix structure for the αC 
domain suggests a possible solution.   Lys556 and Lys580 are the first two active Lys on 
the C-terminal side of the β-helix (Lys562 and Gln563 are adjacent and apparently 
inactive), while Lys539, Lys508, Lys418, and Lys448 are each the outermost Lys in their 
respective coil within the loose portion of the β-helix and line up vertically in the 
structure.  Thus, a donor selection mechanism could be that FXIIIa first searches for the 
β-helix structure (in fact, a recent report has highlighted Glu396, a residue in the first coil 
of the β-helix, as being a key residue for the binding of FXIIIa to the αC region.(167)  
Upon finding the structure, the enzyme moves towards the C-terminal portion of the 
molecule.  The first readily accessible donor sites are Lys 556 and Lys 580, which are 
used 50% of the time.(30)   A smaller portion of the time, a donor Lys within the β-helix 
structure is available to be used for cross-linking.  While only a hypothesis, this selection 
mechanism could be tested with site-directed mutagenesis. 
The structure and interactions of the αC region is made more interesting by the 
recent proposal that the αC region, and the αC connector region in particular is 
responsible for the remarkable extensibility and elastic properties of fibrin fibers. (77, 78, 
82, 85)  If this is so, then the structure and intermolecular interactions of the αC regions 
will put a limit on the extension available to the fibrin fibers. 
4.2.5 Conclusions 
In conclusion, using homology modeling and discrete molecular dynamics, we 
have shown that the human fibrin(ogen) αC domain can fold into a compact β-helix 
structure that is thermodynamically stable at physiological temperatures.   The structure 
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may help to solve many previously unresolved questions about the αC domain fold.  The 
β-helix is of similar size to the “nodules” reported in EM images, contains both a 
structured and unstructured side which may explain the difficulty in crystallizing it, and 
thermally denatures at temperatures similar to those seen in previous calorimetry 
experiments.(14, 150, 151, 153) 
4.3 The Unfolding Energy Barrier of the αC Domain  
4.3.1 Methods 
 To further probe the stability of the β-helix structure of the αC region, we have 
used steered discrete molecular dynamics (SDMD) simulations to unfold the αC region of 
the molecule under force.  Appendix A.6.2, gives an overview of SDMD techniques.  To 
apply these techniques to the αC domain structure of amino acids 196-610 of the fibrin α-
chain, the Cα carbon of Ser196 in the N-terminal region was fixed in space.  The Cα atom 
of the C-terminal residue (henceforth referred to as PP for Pulled Point) was pulled at 
constant force towards a fixed end point (FEP) 1200Å away.  The simulations were 
performed in a rectangular box of dimensions 200Åx200Åx3000Å with periodic 
boundary conditions.  An Andersen thermostat (See Appendix A.3.2) was used to 
maintain room temperature (300K) for the simulation.(126)  Constant-force pulling is 
achieved by applying a discretized step-function with a constant energy drop, dE, at the 
distance step of dR (0.1Å) between the PP and FEP. A step drop of -0.1kcal/0.1Å 
corresponds to a pulling force of 70pN.  Simulations were run at constant forces of 5pN, 
10pN, 15pN, 20pN, 25pN, 50pN, 70pN, 100pN, 150pN, and 300pN. 
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4.3.2 Patterns in Unfolding the αC domain 
 Calculating the critical force of unfolding for the αC region is slightly different 
than that of structured proteins such as discussed in subsequent sections.  Unlike a folded 
protein where the force is distributed throughout the structure, when pulling on a natively 
unstructured protein, the natively unstructured part stretches first before unfolding will 
occur.  Additionally, the direction of the applied force is important because the 
orientation of the structured region of the molecule with respect to the pulling direction 
affects how the molecule behaves.  Direction, of course, is also important when pulling 
on a structured proteins, however in the case of structured proteins certain pulling 
directions are often more interesting due to their physiological relevance.  In this study, 
the αC region was pulled from one direction, so we only probe one small region of the 
entire unfolding phase space.  In future studies, it would be ideal to run a series of 
simulations pulling from different directions. 
 For an ideal (or freely jointed) polymer chain fixed at two ends, with end to end 
length    the average restoring force <   > to pull the chain into the state with maximum 
entropy (S) is given by(168): 
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where P(    is the end to end probability distribution which follows a guassian 
distribution.  For a chain of N links of length l, at extensions not approaching the contour 
length of the fiber, this reduces to: 
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(4.2) 
Thus, throughout the pull, the unfolding force will constantly be working against a type 
of entropic force supplied by the velocity exchange algorithm in the Andersen thermostat.   
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Figure 4.4 Unfolding the αC region at 25pN:  Shown are five snapshots from a 
simulation of unfolding the αC region using 25pN of constant force.  The C-terminus, 
where the force is applied is colored in red, while the N-terminus is colored in blue.  At 
12ns, the loose bundle on the C-terminus of the β-helix comes loose.  At 26ns, the β-helix 
is reduced to β-sheet coils, and the repeat region is collapsing into a loose globule state.  
At 52ns, the N-terminal portion of the β-helix unfolds, and by 75ns, nearly all tertiary 
structure is gone. 
4.3.3 Calculating the Unfolding Energy Barrier of the αC Region 
 As described above, unlike unfolding a mostly structured protein domain, 
unfolding the αC region likely has a significant entropic contribution to the energy barrier 
in addition to the enthalpic barrier due to two natively unstructured regions.  The energy 
required to unfold the αC region can be calculated by integrating the stretching force over 
the stretching distance required to unfold: 
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 FdxG  (4.3) 
For the C-terminal portion of the molecule, and a stretching length before unfolding of 
17nm (observed in simulation), the integral becomes: 
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Substituting N=410 and l=0.3nm yields U=43pN·nm.   
 In stretching simulations the the β-helix unfolds one coil at a time, with unfolding 
force of 10-20pN.  Assuming an unfolding distance of 2nm, and a conservative critical 
force estimate of 25pN, unfolding the β-helix requires an additional 50pN·nm of energy.  
Stretching beyond this point will eventually lead to non-linear behavior force behavior of 
an ideal chain, typically modeled by the worm-like chain (see equation 2.3).  Assuming a 
persistence length of 0.8nm (reasonable for an unstructured polymer), the αC can be 
stretched safely to 70nm before strong non-linear behavior occurs; again using eqn. 4.4 
and integrating from 17nm to 70nm gives an additional energy barrier of 
253pN·nm.(100)  Thus, one can stretch αC region to 70nm of extension for a total energy 
output of 346pN·nm (~50kcal/mol), but only 50pN·nm of that entire energy barrier 
actually arises from unfolding the β-helix. 
4.4 The Unfolding Energy Barrier of the Coiled Coil Region Probed by DMD 
 Previously the coiled-coil region of the fibrin molecule was probed using constant 
velocity steered molecular dynamics.(68)  While the force-extension curves of these 
simulations provided an interesting comparison with AFM measurements, the simulations 
were run at velocities of 2.5-5m/s, much higher than experimental parameters.  Thus, the 
forces were greatly inflated (1-3nN).  To probe the stability of the coiled coil region of 
the structure at realistic forces and to compare its stability to that of the αC region, we 
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used steered discrete molecular dynamics (SDMD) simulations to unfold the isolated 
coiled-coil region of the molecule at constant force.   
4.4.1 Methods 
The coiled-coil structure was extracted from PDB structure 3GHG.(12)  Specifically 
amino acids α27-200, β58-198, and γ14-130 from 3GHG were used to generate the initial 
structure for the simulation.  Each chain of the coiled-coil structure consists of 111 amino 
acids surrounded on each end by one (or more) Cystein residues.  At the C-terminal end 
of the coiled-coil, three di-sulfide bonds, between αCys161-γCys135, αCys165-βCys193, 
and γCys139-βCys197 link the three chains together.  Correspondingly, at the N-termini 
of the molecule, di-sulfide bonds between αCys45-γCys23, αCys49-βCys76, and 
βCys80-γCys19 connect all three chains.  Because of these di-sulfide bonds, all three 
chains of the coiled coil must unfold together.  To pull on the coiled coil in the 
longitudinal direction, while generating minimal lateral forces, additional atoms (AP’s for 
attachment points) were placed approximately 5nm beyond each of the Cystein clusters at 
the ends of the region.(See Figure 4.5)  αCys45, βCys76, γCys19, were fixed at constant 
initial distance to one AP; αCys165, βCys197, γCys139 were fixed to the opposite AP 
and also allowed to oscillate.  Di-sulfide bonds in the structure where parameterized with 
square well potentials in the same manner as Ding, Dokholyan 2008.(158)  Similar to the 
αC region simulations, one final atom (the Fixed End Point FEP) was placed an 
additional 400Å beyond the C-terminal or N-terminal AP.  One of the AP’s was then held 
stationary while the other was pulled at constant force towards the FEP.  The simulations 
were performed in a rectangular box of dimensions 100Åx100Åx2000Å with periodic 
boundary conditions.  An Andersen thermostat (See Appendix A.3.2) was used to 
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maintain room temperature (300K).(126)  Constant-force pulling is achieved by applying 
a discretized step-function with a constant energy drop, dE, at the distance step of dR 
(0.1Å) between the PP and FEP. A step drop of -0.1kcal/0.1Å corresponds to a pulling 
force of 70pN.  Simulations were run at constant forces of 25pN, 70pN, 100pN, 150pN, 
225pN, 300pN, 400pN, 500pN, 700pN, and 1000pN. 
 
Figure 4.5 The Structure and Force Attachment Points for the DMD Simulations:  
In all images, di-sulfide bonds are colored in yellow, the α-chain is green, the β-chain in 
red, and the γ-chain in bule.  A) The coiled-coil structure was generated from pdb 
3GHG.(12)  Attachment points (AP’s) were located approximately 5nm from each end of 
the coiled coil, and where pulled towards the fixed end point.  B) The γ-γ interface was 
generated from PDB structure 1FZC.(34)  The triple-α-helix on the far left was held 
constant during the simulations.  C)  A:a unbinding interface was generated from PDB 
structure 2FFD.(169)  The GPRV knob-A mimic is colored in purple.  The β-C terminus 
was not included in the simulation. 
4.4.2 Results 
 The Bell model can be applied to protein unfolding lifetimes under constant force.  
In this model, the average protein lifetime ηB is given by(170): 
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where ηB is the unfolding time for a protein under a given force (F), ηo is the inverse of the  
energy well escape attempt frequency of the protein (~10
-13
s), ΔGB is the unfolding 
energy barrier in the absence of force, and xu is distance between the unfolded energy 
state and the top of the unfolding energy barrier. (See Figure 4.6)  Applying a constant 
force to a protein can be seen as lowering the energy barrier for unfolding.  At the point 
where F*xu ≈ΔGB, the probability for the protein to be found in the folded and unfolded 
state are equal.  The force at which F*xu ≈ΔGB has been termed the critical force FC. 
 
Figure 4.6 Unfolding Energy Barrier:  Protein folding and unfolding can be thought of as 
an energy landscape.  In its folded state, the protein resides at the lowest free energy.  The 
energy required to kick it out of its folded state is the unfolding energy barrier (ΔGB) and 
the extension in length to reach to height of the energy barrier is (xu).  By applying a 
constant force to a protein, one is essentially reducing the energy barrier by an amount 
F*xu.  At the critical force (FC), the protein is equally probable to be found in a folded or 
unfolded state. (Reprinted with modifications from Kesner, B.A., Ding, F., Temptle, 
B.R., Dokholyan, N.V. “N-terminal Strands of Filamin IG domains act as a 
Conformational Switch Under Biological Forces” Proteins 2010, 78:12-24. Used with 
Permission from John Wiley and Sons. © 2009) 
 To estimate the critical force for coiled-coil unfolding, the simulations were 
allowed to run for 1,000,000 DMD time units (corresponding to 50ns), and then the 
protein length vs. force was plotted (See Figure 4.7).  The plot indicates that the protein 
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remains folded at 100pN of force, but at 150pN the coiled coil region has unfolded a 
length of 12nm.  This distance corresponds to the distance needed to unfold the triple 
helix portion of the coiled coil (Figure 4.8).  This provides an estimate for the critical 
unfolding force (FC) of the coiled coil of 125±25pN which is fairly consistent with the 
94pN reported by Brown et. al in AFM experiments.(75)  An estimate of xu can be made 
by making a histogram of the time series of end-to-end distances of the coiled coil during 
extension at 100pN and 150pN of force (on either side of the critical force).  Because the 
protein is unlikely to remain at the top of an unstable maxima in the energy landscape, xu 
can be approximated as the extension at which the coiled-coil is least likely to reside 
(Figure 4.8).  Using an xu of 1.5nm gives a ΔGB of 187.5pN·nm (27kcal/mol or 45kBT), 
indicating a fairly high stability.  To further refine this critical force value, a series of 
simulations should be run at a constant force of 125pN with different initial velocities.  A 
series of unfolding trajectories will be generated and the critical residues in the unfolding 
process can be determined, allowing for further refinement of both FC and xu.  The part of 
the coiled coil with a 4
th
 coil was only observed unfolding in simulations at forces above 
225pN, indicating a critical force between 150pN and 225pN.  Extending the fourth coil 
can result in an additional 9nm of extension, giving a total extension for the coiled-coil 
region of 21nm. 
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Figure 4.7: Coiled coil unfolded distance vs. Force: (Top) End to end distance 
(calculated as the distance between γCys19 and αCys161) after ~50ns was calculated for 
runs at each force.  The critical force estimated to lie between 100pN and 150pN of force 
given the sudden jump in protein length at this juncture.  At 150pN the triple helix of the 
coiled coil was unfolded, but the 4
th
 coil remained folded.  At higher forces, the 4
th
 coil 
unraveled as well. (See Figure 4.8) (Bottom) Histogram of the end-to end distances of the 
coiled-coil during the 100pN run (remained folded) and the 150pN run (unfolded).  The 
critical unfolding length (xu) can be estimated as the place of lowest frequency 
occurrence of end to end lengths because the protein resides at the top of an unstable 
energy landscape (Figure 4.6).  Given the distributions, it appears that the critical distance 
occurs at 195Å extension.  Assuming an unstretched coiled-coil length of 180Å gives 
xu~15Å of extension. 
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 These simulations also predict an intra-chain α-helix to inter-chain β-sheet 
hydrogen bond re-orientation upon unfolding of the coiled-coil region (See Figure 4.8).  
While this transformation has been speculated due to the similarity of the coiled coil 
structure to that of keratin, these simulations provide the first computationally based 
prediction of the effect.(65, 67)   As discussed in Ch. 3, these results constrain the coiled 
coil region in its functionality as a reversible spring.  Simulations are currently ongoing, 
but after 100ns of simulation time in the absence of force, the energy of the β-sheet 
conformation appears stable indicating that the region may not re-fold into the coiled coil 
structure after the removal of force. 
 
Figure 4.8 α-helix to β-sheet transition: As the α-helical coiled-coil region is stretched, 
the first part to open is the “kink” in the middle.  Next, the N-terminal portion of the 
coiled-coil opens, and finally, the C-terminal portion with a 4
th
 coil unravels.  
Interestingly, as the triple-helix unravels, inter chain β sheets begin to form.  As can be 
seen in the plot on the right, The coiled-coil structure transitions from intra-chain contacts 
to inter-chain contacts indicating the α-helix to β-sheet transition.  We define a contact 
when the distance between two Cβ carbons is less than 7.5Å. 
4.5 Unfolding of the γ Regions of the Fibrin Molecule 
 Unfolding of the γ-C region (γ-nodule in other language) was proposed by Averett 
et al. as a potential mechanism for fibrin extension.(71, 72)  In an elegant series of AFM 
experiments, they demonstrated that breaking the A:a interaction involved four separate 
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force rupture events, each with a characteristic unfolding length, critical force, and 
energy barrier.  They proposed the pattern could be explained by the following series of 
events: the first force event involved the γ-C region of the protein detaching from the 
surface, this was followed by two unfolding events in the γ-C region of the molecule with 
characteristic lengths of 6±2nm and 17±6nm respectively, finally, the 4
th
 event 
represented the rupture of the A:a interaction which occurred at lower forces due to the 
previous unfolding events.  After finding the same pattern in several fibrin fragments, the 
authors concluded that they saw no evidence of coiled-coil unfolding in the A:a rupture 
pattern.(71)  To investigate the relative stability and unfolding patterns of the   γ-C 
regions we performed two sets of DMD simulations.  In the first set of simulations, we 
investigated the γ-γ interface between two fibrinogen molecules.  In the second set of 
simulations we investigated the unfolding pattern associated with pulling on the A:a 
interaction. 
4.5.1 Methods for SDMD simulations of the fibrin γ-γ interface 
 The original structure was taken from the γ1-γ2 crystal structure published as 
1FZC in the protein data base, where γ1 and γ2 are the γ-C termini of two adjacent 
molecules (referred to in this section as M1 and M2).(34)  The FXIIIa ligation site 
located in amino acids γ398-411 was not present in the crystal structure.  The residues 
γ398-γ411 were added to both γ1 and γ2 by creating a peptide bond between γGly397 and 
γGln398.  An additional covalent-type bond potential was then added between γ1Gly399 
and γ2Lys406 and γ2Gly399 and γ1Lys406 to represent the iso-petide bond formed from 
FXIIIa ligation.  The parameterization for both the peptide bond and iso-peptide bond are 
similar to those used in Ding, Dokholyan 2008.(159)  Di-sulfide bonds in the structure 
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where parameterized with square well potentials in the same manner as Ding, Dokholyan 
2008.(158)    Ca
2+
 binding pockets were simulated as Zn
2+
 binding pockets because the 
DMD all atom force field currently does not include Ca
2+
 parameterization; the 
assumption being that having an ion bound in the pocket is better than none at all.(158)  
Zn
2+
 constraints were modeled by assigning distance constraints between each metal 
atom and the corresponding metal-coordinating atoms in the fibrin Ca
2+
 binding pockets 
observed in the crystal structure.  Simulations were run with and without additional salt 
bridge constraints in the A:a and B:b binding pockets.  In simulations performed without 
the additional salt bridge potential, the A knob mimic (GPRP) and the B knob mimic 
(GHRP) were observed to immediately leave the binding pocket. This indicates that 
hydrogen bonds play a minor role in the A:a and B:b interactions. To mimic the salt 
bridge and ensure that the peptides stay bound, the salt bridge was modeled as an infinite 
square well potential between the NH2
+
 arginine in GPRP and the delta oxygen of the 
γAsp234.  Similar constraints were applied for each binding pocket.  The 1FZC crystal 
contains a partial coiled coil crystal structure starting at α119, β151, and γ97.  To speed 
up the simulation, the atoms in the coiled coil region of M1 were fixed in place and not 
allowed to fluctuate.  Force was applied to the coiled coil region of M2 in a similar 
manner as described before.  The Cα carbons of α119, β151, and γ97were fixed at 
constant distance to an attachment point (AP) approximately 5nm beyond each of the 
Cα’s.  (See Figure 4.5)  One final atom (the Fixed End Point FEP) was placed an 
additional 400Å beyond the AP.  The simulations were performed in a rectangular box of 
dimensions 120Åx120Åx1800Å with periodic boundary conditions.  An Andersen 
thermostat was used to maintain room temperature (300K).(126)  Constant-force pulling 
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is achieved by applying a discretized step-function with a constant energy drop, dE, at the 
distance step of dR (0.1Å ) between the PP and FEP.  Simulations were run at constant 
forces of 25pN, 70pN, 100pN, 150pN, and 300pN. 
4.5.2 Methods for SDMD simulations of the fibrin γ-C terminus unfolding 
 The original structure was taken from the crystal structure published as 2FFD in 
the protein data base.(169)  Di-sulfide bonds in the structure and Zn
2+
 (substituted for 
Ca
2+
) binding pockets where parameterized with square well potentials as described 
before.(158)    The A-knob mimic GPRV was bound in the hole-A binding pocket using 
an infinite square well potential in a similar manner to section 4.5.1.  The reasoning for 
this was based on results from AFM measurements indicating a sequence of 4 unfolding 
events before the A:a rupture.(71)  It was therefore assumed, that forcing the peptide to 
stay bound in the pocket should allow visualization of all unfolding events.  To speed up 
the simulation, residues β199-459 were omitted, based on the assumption that 
interactions with the β-C domain did not influence the A:a binding pocket. The 2FFD 
crystal contains a partial coiled coil crystal structure starting at α126, β157, and γ96.  
Force was applied to the Cα carbon of Val4 in the GPRP peptide in a similar manner as 
described before.  One final atom (the Fixed End Point FEP) was placed an additional 
400Å beyond the AP.  The simulations were performed in a rectangular box of 
dimensions 300Åx300Åx1200Å with periodic boundary conditions.  An Anderson 
thermostat was used to maintain room temperature (300K).(126)  Constant-force pulling 
is achieved by applying a discretized step-function with a constant energy drop, dE, at the 
distance step of dR (0.1Å ) between the PP and FEP.  Simulations were run at constant 
forces of 25pN, 50pN, 70pN, 100pN, 150pN, and 200pN. 
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4.5.3 γ-C and γ-γ unfolding energy barriers 
 The results presented in this section are preliminary as simulations of both the γ-γ 
interface and the γ-C region are ongoing; however patterns of unfolding that have already 
emerged are presented here.  Simulations on the γ-C region predict a specific sequence of 
unfolding based on the relative energy barriers associated with the unfolding.  First, 
simulation results from forced stretching of the γ-γ interface will be presented. 
 As can be seen in Figure 4.9, the weakest link in the γ-γ structure is actually the 
interface between the two molecules.  At all force levels simulated, the γ-γ interface 
comes apart.  Due to the direction of applied force combined with the γ-γ cross-linking, a 
torque is generated on the region after the interface separation, causing the γ-C and β-C 
regions in both molecules to propeller up into a position perpendicular to the coiled-coil.   
When the original γ-γ dimer crystal structure was presented, the authors noted that a 
crevice existed between the two molecules and the buried surface area came to only 
750Å
2
 indicating only a small contribution to the polymerization free energy.(19)  An 
important work on protein oligomerization energies by Janin et al. indicated an average 
of 1 hydrogen bond per 200Å
2
 of binding surface area; so in retrospect, it is not 
surprising that the γ-γ interface is weakly bound.(171)  One particular residue, γArg275 
has been implicated as being important in end-to end oligomerization, however it does 
not appear to play a role mechanically stabilizing the interface.(19)  While these 
simulations do not allow an exact calculation of the critical force, given that even at 
25pN, the γ-γ interface comes apart within 20,000 DMD time units (~1ns), the critical 
force for stretching this region may be as low as 5-10pN.  It should be noted that within a 
fibrin protofibril, additional constrains from the A:a and B:b interactions would only 
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allow 4nm of separation between the interfaces (due to the lengths of the knob-A 
polypeptide chains) before larger forces would be required to stretch to molecule further.  
 
Figure 4.9  Unhinging of th γ-γ connection under force:  While in the crystal structure, 
the γ-γ region appears stable, upon the application of force, even at 25pN as this series of 
simulations takes place, the first part of the structure to stretch is the γ-γ interface.  After 
the initial separation, a torque generated by the FXIIIa ligation, rotates the β and γ-C 
domains perpendicular to the coiled-coil.   
 Additional simulations have been used to test the mechanical de-stabilization of 
the γ-C region resulting from forces applied to the A:a interaction.  Because the DMD 
force field does not include long range electrostatic interactions, it did not properly 
account for the salt bridge binding that holds the A-knob peptide mimic in the binding 
pocket.(159)  As described in the methods, this was overcome by using an infinite square 
well potential to keep the A-knob bound.  The downside of this method is that knob 
unbinding will not be observed in the simulations; however, these simulations do provide 
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a vehicle to probe the sequential γ-C domain unfolding measured/predicted by recent 
AFM experiments. (71, 72)  
 
Figure 4.10: Step Heights between γ-C unfolding events:  To quantify an unfolding 
event, we tracked the distance between γCys153 and the Cα carbon of the Gly1 in the 
GPRV peptide.  These residues were chosen based upon the observation that γCys153 
forms a di-sulfide bond which stabilizes the “bottom” of the γ-C structure, and tracking 
the height of Gly1 would roughly correspond to the AFM measurements of Averett and 
coworkers.(72)  (A) The top table shows the step heights between plateaus in the 
separation vs. time curve for each force.  The γ-C domain did not unfold at 25pN of force 
and was not included.  (B) Representative separation vs. time plot for the γ-C region 
under 200pN of applied force.  Distances were measured from levels of steady plateaus in 
the curves as represented from the black lines.  Separations were measured based on the 
distance between the average heights in the plateaus.  
 Intriguingly, simulation results after 25ns of DMD simulation indicate a 
sequential unfolding of the γ-C region under force similar to that measured by Averett et 
al.(71)  A series of images depicting sequential unfolding are represented in Figure 4.11.  
Analysis of the step heights of the separation vs. time curves as seen in (Figure 4.10) 
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show a distribution of step heights at different forces.  At each force, the first event of 15-
20Å separation did not correspond to an unfolding event in the movies but rather an 
adjustment of the A-knob within the binding pocket.  At each force above 50pN 2-3 
distinct unfolding events were observed.  The table has been adjusted in an attempt to line 
up unfolding events by separation distance.  The second and third unfolding events 
ranged from 20-30Å of separation. If the two events were combined into one event (the 
reasoning will be motivated below), then the average separation for steps 2 and 3 would 
be one with an average separation of 59±13Å.  Finally, at forces above 70pN, a 4
th
 event 
was present with an average separation of 168±8Å.  These results are remarkably similar 
to experimental results.  In AFM experiments testing the stability of the A:a interaction, 4 
distinct force peaks were observed.  The first was attributed to the protein lifting off the 
surface, the second two were assigned as protein unfolding events prior to A:a rupture 
and weakening the A:a bond, and the 4
th
 event was attributed to the unbinding of knob A 
from the binding pocket.  The relative separations between these three events were 
110±60Å, 60±20Å, and 170±60Å.(72)  Comparing these results with our own indicate 
that our second and third separation events could be the third and fourth unfolding events 
captured in the AFM experiments.  It’s possible that the first event in the AFM 
experiments involved the β-nodule which was not included in our simulations for 
simplicity.  It must be remembered that only one simulation was performed at each force, 
but the similarities are intriguing. 
 The critical force for each event can be determined by plotting the time needed to 
reach the unfolding event vs. force applied as seen in Figure 4.11.  Linear Fits can be 
applied to determine the intersection between the barrierless region where the protein 
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unfolds without hindrance and the barrier region.  This intersection provides the critical 
unfolding force for the event.  The critical force for events #2-3 was 74±7pN, and for 
event #4 was 89±21pN.  Uncertainties are reported as standard errors and were calculated 
by a simple monte carlo algorithm as described in Kesner et al, and should be reduced 
upon additional simulations at each force.(172)  In terms of relative stability, the coiled-
coil region was not observed unfolding at forces below 150pN, consistent with the coiled 
coil unfolding measurements and indicating a higher stability for the coiled coil region 
than the γ-C region.   
 While these simulations results are preliminary, they do indicate similarities with 
the AFM data.  A second series of simulations performed near the critical force value for 
each event with a variety of randomized starting velocities will allow a characterization 
of the important amino acids in the unfolding events, and will give a better 
characterization of the critical force values.  In both the experiments done by Averett et 
al. and these simulations, γ-C unfolding is observed before coiled-coil unfolding and the 
critical force values for unfolding are lower for the γ-C region, indicating that the γ-C 
region would unfold prior to coiled-coil stretching.(71, 72)  It is not clear how to 
reconcile this with the AFM measurements by Lim and Brown indicating coiled-coil 
unfolding; neither paper described the AFM tip velocities, so it is not possible to do a 
direct comparison with the Averett force values.(68, 75)  We are currently collaborating 
with Kellie Beicker to pursue follow up measurements of coiled-coil unfolding at 
constant force. 
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Figure 4.11 Forced Unfolding of the γ-C domain:  Images on the right depict 
sequential unfolding of the γ-C domain through application of 100pN of constant force at 
the A:a interface.  After 3.3ns, the first unfolding event is observed where one part of the 
region separates from the rest.  After 10.1ns, a second unfolding event occurs.  After 25ns 
the γ-C region contains three distinct domains with β-sheet structures separated by 
unstructured polypeptides.  The distance between the first (containing the knob binding 
pocket) and second structures is ~6nm.  The distance between the second and third is 
~16nm.  The plot on the right can be used to estimate the FC for each event.  Time before 
unfolding events #1 and #2 are plotted as a function of applied force.  For each event, 
there is an approximately barrierless region where the unfolding occurs rapidly, and a 
region with a barrier, where the unfolding time for the event is observed to rise.  For 
forces in which no unfolding events occurred, the unfolding time is registered as 25ns.   
The intersection of fits in the barrier and “barrierless” unfolding regions represents the 
critical force of unfolding.  Event #1, represented in black has Fc=74±7pN, and for event 
#4 Fc=89±21pN. 
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 4.6 The SLαCK Molecular Model for Fibrin Extension 
 The results of these simulations, combined with the known experimental 
mechanical data provide a more complete view of the molecular underpinnings of fibrin’s 
mechanical properties.  We now propose a new model for fibrin extension, which we 
refer to as the SLαCK model (Straightening of molecules, γ-C Ligation site separation, 
Alpha (α)-C extension, γ-C unfolding /Coiled-coil extension, Knob unbinding); the 
main mechanism for extension in the SLαCK model comes from extending the loose αC 
domains (See Figure 4.12).   
 In order to develop a model for the mechanical properties of the fibrin fiber, one 
must first start with a model of the molecular connections within the fiber.  Here I will 
briefly lay out our understanding of the molecular packing inside the fiber.  The fiber 
consists of protofibrils in lateral registry in parallel across the diameter of the fiber.(44)  
The protofibrils vary in length from 1 to approximately 20 monomers within the fiber, 
and the distribution of lengths is bimodal (with peaks at 1 molecule and 20 molecules 
towards the end of polymerization) as described by Weisel et al.(99)  Lateral contacts 
between protofibrils are strong enough to keep the fiber in registry without applied force, 
but weak enough that the fiber behaves as a loose bundle of protofibrils, rather than a 
close-packed bundle of protofibrils.(82)  Protofibrils have an inherent twist to them and 
may wrap around the fibrin fiber.(45, 46)  The αC domains connect the protofibrils both 
in series (we assume due to their long lengths) and in parallel down the length and across 
the diameter of the fiber.(144)  The αC domains can be cross-linked with FXIIIa, or can 
associate with unbinding forces of up to 50pN in the absence of FXIIIa.(73, 154) 
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Protofibrils are assembled in a double-stranded, half-staggered arrangement due to A:a 
and B:b knob:hole interactions.(99)  The γ-C termini within the protofibril are cross-
linked by FXIIIa, but likely associate in the absence of cross-linking.(34, 42)  With the 
discovery of elastomeric fibrin sheets, it’s possible that this model needs adjustment, but 
for the present report, we will assume the above polymerization model for fibrin 
fibers.(49)  
 Given this structural model for the fibrin fiber, the SLACK extension model 
proceeds naturally from the results of the simulations combined with other experimental 
data.  The first phase of SLαCK is the straightening out of the fibrin molecules and 
protofibrils within the fiber.  Others have estimated that this could generate up to 20% 
fiber strain or 9nm of extension.(83)  Next, in the “L” phase the γ-C:γ-C interface 
between monomers in the protofibril stretches out.  This was observed at all forces in the 
DMD simulations of the γ-γ interface discussed in section 4.5.3.  Because the A:a and 
B:b associations constrain the γ-γ interface, this can only generate 4nm of extension 
(~8% strain) without unfolding the γ-C domain.  However, this separation may be enough 
to disrupt lateral contacts between protofibrils, as they are believed to be weak 
anyways.(82)  Both the “S” and “L” phases of SLαCK should be reversible in the 
absence of force, as no protein unfolding occurs. 
 The third step is extension of the αC domains between protofibrils.  Both our 
model and NMR fragment derived models for the αC domain indicate loose β-sheet 
structures.(14)  The results from our DMD stretching experiments indicate that the folded 
αC domain can unfold at forces as low as 10pN, while the natively unstructured portions 
of the αC region stretch as an entropic spring (spring constant of 0.3pN/nm).  A few 
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experimental based assumptions can allow a rough estimate of the extension of the fibrin 
fiber allowed by αC mediated protofibril sliding. 
 The main αC ligation sites are Lys556 and Lys580 along with Gln328 and Gln366 
(Gln221 and Gln237 have also been implicated), indicating that α-polymers are primarily 
ligated by interactions with Lysines on the C-terminal side of one αC domain and Gln on 
the N-terminal side of another αC domain.(29, 30, 155)  Take for example a chain cross-
linked between α1Lys580 and α2Gln326 where α1 and α2 represent two separate αC 
regions.  The total extension length for α2 would be 326-200 (the α-chain coiled coil ends 
at amino acid 200) =126 amino acids; the total extension for α1 would be 580-200-
30=350 amino acids (the extra 30 comes from amino acids Cys442-Cys472 which are 
linked by a di-sulfide bond and do not extend).  Using an acid length of 0.3nm indicates 
that this cross-linking sequence could account for 140nm of extension.  Using α1Lys556 
and α2Gln221 (the shortest of the combinations) allows for 105nm extension, while the 
longest combination (α1Lys580 and α2Gln366) allows for 155nm of extension.   
 Assuming a simple model of protofibrils in series within the fiber, a distribution 
of protofibril lengths as measured at the 0.75 lag phase by Weisel et al.(99) and an αC 
length of 140nm, allows for fibrin strains of 75%.  Assuming different distributions of 
protofibril lengths (such as that measured by Weisel et al. at the 0.5 lag phase), combined 
with different combinations of cross-linking can give fiber strains ranging from 50% up 
to 150%.   Similar reasoning can be applied to un-crosslinked αC domains interacting 
non-covalently.   As noted earlier, non-specific αC domains can interact with binding 
forces of up to 50pN, allowing moderate extensions (~120nm) of the αC region before 
irreversible αC domain unbinding would occur.  It should be noted that within the fiber, 
 110 
 
the αC domains are often found in large chains called α-polymers which have a more 
complex cross-linking pattern than the simple two chain model described above.(160)  In 
spite of this, most of the potential Lys donors are located in α411 and beyond indicating 
an extension of at least 100nm per α-polymer chain  
 It seems then that the “α” phase of the SLαCK model can generate somewhere 
around 100% fiber strain in both ligated and unligated fibers while only requiring a 
force/protofibril of ~10pN at low extensions.  This is in good agreement with the 
force/monomer calculations in Chapter2. In total, the S, L, and A regimes of the SLαCK 
model can account for ~130% reversible extension of the fibrin fiber.  Fully cross-linking 
all αC regions at multiple cross-linking points would serve to reduce the available 
extension of the αC region, and generate a stiffer fiber as observed in equation 4.2, which 
may explain the results of Liu et al.(67)  An intermediate level of cross-linking which 
provides stabilization between αC domain interactions without greatly decreasing the 
available αC contour length may provide an intermediate range where the fibers are more 
extensible than uncross-linked fibers while retaining the same stiffness as uncross-linked 
fibers, potentially explaining the apparent contradiction between (66) and (67). 
  As the αC regions stretch to higher extensions, WLC-like strain stiffening will 
increase the required pulling force to greater than 70pN to stretch the αC regions further.  
At this point the force required to stretch the αC region is higher than that needed to 
unfold the γ-C or coiled-coil regions leading to the “C” phase of the SLACK model.  
Results from the simulations in chapter 4, indicate that the coiled-coil region has a higher 
critical force than the γ-C region of the molecule (125pN vs. 74pN and 89pN).   This is in 
agreement with the Averett et al. report finding that γ-C unfolding likely precedes coiled-
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coil unfolding,(71, 72)  but is contradicted by AFM measurements on the fibrin molecule 
and fibrinogen oligomers indicating that the coiled-coil region unfolds at 60pN and 95pN 
of force respectively, which were lower than the Averett values for the γ-C region (~ 
100pN-200pN).(68, 75)  Given our simulation results that the unfolding energy barriers 
are within 20-50pN, it seems possible that a portion of the molecules unfold via the γ-C 
region and a portion unfold the coiled-coil region.  While it is possible that the “C” phase 
could allow for an additional 200nm of extension, it is likely that fiber failure as 
explained in the “K” phase will occur prior to this. 
 The “K” phase of the SLACK model refers to knob-hole unbinding which will 
occur after the sequential unfolding of the γ-C domain and lead to fiber failure.(71) 
Estimates of the force per fibrin molecule inside a fibrin fiber at the point of breaking (as 
explored in section 2.3.7 Force per Monomer) are consistent with A:a unbinding.(71)  
A:a unbinding and potentially coiled-coil and γ-C unfolding (the timescales of a few 
seconds may be too fast for a 400 amino acid protein segment to re-fold, see (173) and 
chapter 3.4 An α-helix to β-sheet transition for a discussion on re-folding timescales) 
would result in plastic deformation and irreversibility in fiber extension.   
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Figure 4.12: The SLαCK model for Fibrin Fiber Extension:  Our view of the packing 
in the fibrin molecule is described in the text.  In the “S” phase the molecules straighten 
within the protofibrils.  In the “L” phase, the γ-γ interface separates, while still being 
constrained by the A:a interaction.  In the “A” phase the αC regions between the 
protofibrils stretch.  The “C” phase comprises of some γ-C regions and some coiled-coils 
unfolding. And the “K” phase refers to knob unbinding resulting in fiber failure.
  
 
Chapter 5.  Stiffening of Individual Fibrin Fibers Equitably Distributes Strain and 
Strengthens Networks 
5.1  The Mechanical Properties of Fibrin in the Context of Biopolymer Networks 
 We now turn our attention to the highest rung of the mechanical hierarchy, the 
fibrin network.  Fibrin networks belong to a class of biological materials that display a 
remarkable and diverse set of mechanical properties including high extensibility, non-
linear elasticity (strain stiffening) and negative normal stress (59, 61, 63, 74, 79, 174-
179). Though these behaviors have been well characterized in macroscopic studies, an 
understanding of their molecular and fiber-level origins has only recently begun to 
develop (74, 80, 178, 180).    To construct a complete multi-scale picture of network 
behavior, a thorough characterization of microscopic properties must be accompanied by 
an understanding of how they conspire to produce the emergent bulk response under 
stress: How do the single fiber properties translate into the bulk properties of the 
network? 
Materials strength - the maximum stress a material can withstand before failure - is 
particularly dependent on microscopic mechanical and geometrical details. Failure occurs 
at points of concentrated stress or points of mechanical weakness; it is determined by 
extreme values in the range of microscopic properties rather than in their average values.  
This is in contrast to properties, such as elastic moduli, which are amenable to a mean 
field analysis.   A thorough understanding of how a fibrin network fails – a question of 
profound biomedical as well as materials interest – requires a detailed look at how 
individual fibrin fibers stretch, how they distribute strain, and ultimately how they fail.  
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Modeling studies focusing on the mechanics of biopolymer networks identify two 
phenomena responsible for a network’s response to stress: stiffening behavior of the 
constituent fibers and geometrical rearrangement of the fibers (74, 80, 81, 181). The 
balance struck between these two mechanisms depends in large part on the flexibility of 
the fiber segments comprising the network.  Models of semi-flexible fibers – fiber 
elements with persistence lengths comparable to their contour lengths - show that 
stiffening of a network can arise from the entropic stiffening of the constituent fibers 
comprising the network (80). On the other hand, models of stiff fibers show that 
stiffening develops from a geometrical reorientation and transition from bending at small 
strains to enthalpic stretching at larger strains (81).   While these models have been 
successful at describing network behavior at low strains, (80, 180) the question of how 
the stiffening and re-arrangement of individual fibers affects stress and strain distribution 
and ultimately the overall network strength at high fiber strains, has received less 
attention.   
Recent experimental work has begun to bridge the gap between bulk macroscopic 
properties and their origins at the individual fiber level.  Advances in micro and 
nanoscale interrogative techniques have enabled mechanical studies of fibrin at the single 
fiber (65, 66, 77, 182) and molecular scale (68, 71, 75). These studies revealed that 
individual fibrin fibers possess remarkable elastic properties; they are capable of 
reversibly stretching as much as three times their original length, and can more than 
quadruple their length before breaking (65, 66, 77).  We also report here direct 
measurements that show fibrin fibers themselves exhibit non-linear elasticity.  The 
molecular origins of these properties are still an open question, but recent studies have 
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implicated several different regions of the fibrin molecule as possible sources for fibrin’s 
extensibility including the coiled-coil region, (68, 74, 75) the globular γ domain (71), and 
the αC connector region (77).  Further investigation is needed, but it is clear that the 
fibrin fibers themselves exhibit elastomeric behavior: low elastic modulus in stretching 
(MPa) and very high extensibility (>300%).  
Within fibrin networks, microscopic measurements of filament re-orientation and 
alignment under stress have been made both at low strains in a shear cell (178, 180) and 
at high tensile strains (74).  At high network strain, the fibers have aligned in the 
direction of the stress, and fiber stretching is the dominant deformation mechanism.  
Consequently, the elastomeric properties of the individual fiber dramatically affect 
network deformation in this regime, and play a direct role in determining network 
strength: failure originates ultimately at a single fiber (or branch point). Thus, network 
strength is determined by the maximum strain individual fibers can withstand.   
Determining how strain is shared among the constituent fiber segments in a network 
under imposed stress is therefore crucial to understanding failure modes of networks and 
their strength.  We describe here that strain stiffening of the individual fibrin fibers 
produces a dramatic shift in strain distribution and effectively strengthens fibrin 
networks.  
5.2 Materials and Methods    
5.2.1 Fluorescent Microscopy Applied to Fibrin Fibers 
 For observation and manipulation of fibers, the coverslips were placed face up on 
an inverted Nikon Diophot microscope with epifluorescence illumination (Nikon Diaphot 
200, Southern Micro Instruments, Atlanta, GA), and imaged using a rhodamine HQ filter 
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set (Chroma Technology, Rockingham, VT) and a 1.3 or 1.4 NA 100X oil objective.  
Images were recorded using a high speed Cooke PCO 1600 camera with C-link and 
recorded with CamWare (Cooke Corp., Romulus, MI).   
5.2.2 Fibrinogen Preparation 
  All experiments used recombinant human fibrinogen produced in Chinese 
Hamster Ovary (CHO) cells (97, 183).  Fibrin clots formed with recombinant human 
fibrinogen are indistinguishable from clots formed with plasma fibrinogen.  Recombinant 
fibrinogen was used in this study because it is free from other blood coagulation factors, 
in particular, FXIII (97).  Fibrinogen purity and homogeneity was assessed by SDS 
polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analyses.  Fibrinogen 
function was assessed through thrombin-catalyzed polymerization monitored by 
turbidity, and FXIIIa-catalyzed crosslinking monitored by SDS-PAGE (184).  
5.2.3 Growing Fibrin Networks on Structured Surfaces 
Fibrin fibers and networks were assembled in situ onto Norland Optical cured 
structured surfaces as described in chapter 2.  Briefly, a polydimethylsiloxane (PDMS) 
stamp with 20 m wide and 10 m deep channels was placed on a small drop of Norland 
Optical #81 (an ultraviolet-light-curable optical adhesive) in the middle of a 24 x 50 mm 
1.5 coverglass (Corning, Lowell, MA).   The adhesive was polymerized with long 
wavelength ultraviolet light for 2 minutes, and the stamp was peeled off, leaving a cured 
structured surface (SS).   
Before use, the SS was cleaned for 2 additional minutes in a UV Cleaner, and a ring 
of silicon grease was applied with a cotton swab to confine fibrin assembly to the SS.  
Fibrinogen, stored at 0.6 mg/mL, thrombin (human -thrombin, Enzyme Research Labs, 
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Indianapolis, IN), stored at 222 U/mL, and Factor XIII (human plasma FXIII, Enzyme 
Research Labs), stored at 68 g/mL at -80oC were thawed rapidly and placed on ice.  
Fibrinogen and FXIII were diluted to 0.04 mg/mL and 0.1 g/mL respectively in 20 mM 
HEPES, 150 mM NaCl, pH 7.4 (HBS), and one half the final volume needed to cover the 
SS (usually 8-10L) was pipetted onto the surface.   Thrombin was diluted just before 
use to 2 U/mL in HBS with 10 mM CaCl2, and an equal volume was added to each SS 
and mixed by gently pipetting up and down several times.  Final concentrations of 
reagents were: 0.02 mg/mL fibrinogen, 1.0 U/mL thrombin, 0.05 g/mL Factor XIII in 
HBS, 5 mM calcium.   
Coverslips with fibrin reactions were placed in Petri dishes with a small square of wet 
paper towel to prevent drying, and incubated at 37
o
 for 2 hours.  Thrombin catalyzed the 
conversion of FXIII to FXIIIa and fibrinogen to fibrin forming crosslinked fibers as 
evidenced by gel electrophoresis.  The reaction solution was removed and the samples 
washed twice with HBS.  24 nm volume-labeled red fluorescent carboxyl-coated 
microspheres (Stock comes at 2% solid in water; Invitrogen- Molecular Probes) were 
diluted 1/10,000 in HBS and added to each SS; samples were incubated for 5 minutes, 
washed with HBS, and used for experiments.   
Samples were prepared with and without FXIII which is converted into FXIIIa in the 
presence of thrombin and calcium. Samples without FXIII were prepared in the same 
manner, without the addition of FXIII and incubating for only 15 minutes.   
5.2.4 Stretching Networks with an AFM  
The atomic force microscope (Explorer, Veeco Instruments, Woodbury, NY) rests on the 
manipulation stage of the optical epifluorescence microscope enabling simultaneous 
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AFM manipulation and optical data acquisition.  Both OMCL-AC240TS-W2 (Olympus, 
Micro Cantilever) and RC150VB Biolever (Olympus, Asylum Research) AFM 
cantilevers (SiN) were used for manipulation.  A detailed description of our setup and 
measurement can be found in prior publications (65, 66). Briefly, force data was 
determined through calibration of the lateral deflection signal. The angular optical 
sensitivity of the twisting mode is the same as for the bending mode given we have a 
geometrically symmetric quadrant photodiode and similar gain settings for each quadrant.  
The twisting mode optical sensitivity in deflection units is then determined using the 
specific geometry (length, tip length) of the cantilever.  The lateral cantilever spring 
constant was calculated from cantilever/geometry and SiN materials constants.  The AFM 
tip was controlled using the Nanomanipulater software (3rdTech, Inc. Durham, NC).   
The tip was set down inside the network and moved in one direction at 1µm/sec in 75nm 
increment steps to stretch the network.   To facilitate the tracking of individual fibers 
using Video Spot Tracker software [Computer Integrated Systems for Microscopy and 
Manipulation at UNC-Chapel Hill (http://www.cismm.org/)], networks containing 10-30 
distinct fibers all around 1-10 microns in length and in the same plane of focus were 
selected for manipulation.  Networks were stretched until failure of the pulled fiber; but 
when analyzing the data the network was considered to fail at the first rupture of any 
junction or fiber, not just the pulled fiber.  Figure 5.1 depicts a diagram of the setup.  
Fiber diameters were determined with AFM topographical imaging.  Fibers extending 
onto the ridge surface were located with fluorescence imaging. The AFM tip was 
engaged in proximity to the fiber and local imaging was performed.  
 119 
 
 
Figure 5.1 Experimental setup: (a-b) Side and bottom views depicting the AFM and a 
fibrin network suspended between ridges.  (c-e) Three time point snapshots of a network 
undergoing deformation due to AFM manipulation.  (f-h) Model network deformations at 
equivalent points to (c-e). 
5.2.5 Network Strain measurements 
Strain measurements on individual fibers within each network were calculated using 
video data recorded during the network manipulation. (See Figure 5.2) Strain was 
calculated for each fiber, measuring the change in the distances between junctions.  In 
both FXIIIa ligated and unligated networks, fibers junctions were not observed sliding or 
slipping along the fibers during the pull; instead junctions appeared fixed with respect to 
the fiber.  Data were only collected from samples for which fiber attachments to the ridge 
boundaries were fixed throughout the stretching.  The fibers are adhered to the ridge 
through non-specific adhesion. Given the relatively low forces involved in the pulling 
experiments vs. the relatively high adhesive forces of the fibrin to the ridge, it is not 
surprising that they typically maintain fixed boundary attachments.  Fibers pulled by the 
tip were assumed to converge to a point, for comparison with simulations.  Manual 
distance measurements using the line segment measurement tool in the ImageJ 
(http://rsbweb.nih.gov/ij/) software package supplemented the automated software, 
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especially for junctions that Video Spot Tracker had difficulty tracking.  Usually 4-8 
fibers per network were tracked;  the fibers tracked were selected based on original fiber 
length, focus, position relative to glue stamped surfaces and point of pull . We did not 
track fibers attached to the surfaces.  Fiber strain was then plotted as a function of AFM 
tip movement.  The derivative of the strain vs AFM step plots, dubbed the strain fraction, 
was calculated by taking the average slope between 10 points on strain vs AFM step data.  
(See Figure 5.2) The slope was then smoothed using the Matlab R2007b (The 
MathWorks, Natick, MA) rloess function.  
5.2.6 Using Webslinger to Simulate Network Stretching 
Networks were simulated using Webslinger (http://www.cismm.org/), a quasi-static 
mass-spring simulation which uses Euler integration with small time steps and damping 
to solve the system of partial differential equations governing a network of springs.  After 
each step, the system is allowed to relax to equilibrium, and that solution is used for the 
initial conditions of the next step. 
 Arbitrary nonlinear spring behavior was specified by providing force-strain curves 
and rest lengths for each spring.  For each experimental network geometry, a mesh model 
of the same geometry (node location accuracy within 150-200 nm) was created by hand 
from the video file image (Figure 5.1).  Wall boundary nodes were simulated as 
immovable, but freely rotating pivot positions.  The mesh node corresponding to location 
of the AFM tip was moved along the same trajectory taken by the tip in the experiment. 
(Figure 5.1)  Patterns of fiber strain distribution within the simulated networks were then 
compared to those seen in the fibrin network experiments.  Two force-strain curves were 
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used for the comparison with fibrin data, a linear model and a worm-like chain force 
model.   
5.3 Results and Discussion 
5.3.1 Results from Stretching Fibrin Networks 
  Using a combined fluorescence and atomic force microscope (AFM), we stretched 
fibrin networks to failure and measured tensile strain of individual constituent fibers.  
Focusing on small, (5-30 fibers) two dimensional fibrin networks suspended between 
micro-printed channels, we obtained a complete view of network geometry during 
deformation (Figure 5.1). For each network, the AFM tip was placed next to a fiber 
located at the periphery of the network, and that fiber was pulled in a direction parallel to 
the channel axis (Figure 5.2 a-d). Usually networks were pulled to the point of failure, but 
in some instances, networks slipped off the tip before failing and elastically recovered 
their original structure.  Additionally, several experiments were performed where the 
network was stretched out twenty microns and then stepped back to its original position 
with no observable damage. These results indicate that network deformations were 
reversible for fiber strains at least equal to 1.0.   
Five to ten fibers in close proximity to the point of pull were selected for strain 
measurements.  The tensile strain of each tracked fiber in the network was plotted as a 
function of AFM tip movement (Figure 5.2e, Figure 5.3).  At low strains, there was a 
noticeable transition regime in which all fibers began stretching more per incremental 
AFM tip movement.   This is a geometrical effect; the fibers reorient, aligning in the 
direction of the applied force before entering a tensile stretching mode.  When the most-
strained fibers in the network reached strains above 1.0, there was a noticeable decrease 
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in strain per incremental AFM tip movement.  That is, the change in strain with respect to 
tip movement decreased for the most-strained fibers (blue trace, Figure 5.2f).  This 
derivative or “strain fraction”, reflects the share the overall network deformation taken on 
by each fiber per incremental AFM step.  Accompanying the decrease in strain fraction of 
the most strained fibers, the strain fraction of lesser strained fibers commonly increased 
(green and cyan traces, Figure 5.2f).  The two potential sources of this behavior are 
network geometry and individual fiber properties. In the former, the strain share (the 
distribution or “sharing” of the overall network deformation among the individual fibers) 
among fibers shifts as the network architecture reorients and gradually aligns in the 
direction of the applied force. Alternatively, the non-linear elasticity of the individual 
fibers redistributes the strain share as some fibers stiffen relative to the others. These two 
phenomena are not mutually exclusive and could both be contributing factors.  
To assess the potential contributions of fiber non-linear elasticity to network 
deformation, we measured the force elongation behavior of individual fibrin fibers using 
a similar experimental approach (also see (65, 66)).   Individual fibers were suspended 
between micro-printed channels and force data were obtained from calibrated lateral 
deflection of the AFM cantilever.   The data showed a clear transition from low stiffness 
and linear elasticity at low strain to much higher stiffness at strains at or above 1.0 
(Figure 5.4).  This characteristic strain-stiffening force vs. elongation relation was used to 
quantitatively inform modeling of our network data.  
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Figure 5.2 Network Strain Measurements:  (a-d) Images from a video of network 
deformation.  (a)  The original network geometry displaying a color map of which fiber 
strains are plotted in frames e-f.  (b-d) Fiber nodes in the network were selectively 
tracked, and fiber strains were calculated using the distances between the nodes.  The 
colored lines in c-d show tracking data tracing the motion of network junctions 
throughout the deformation.  e) A plot of individual fiber strain vs AFM tip movement.  
Each color represents the strain vs. AFM tip movement for one fiber corresponding to 
frame (a).  f)  The strain fraction (derivative of strain with respect to tip movement, or 
slope, of plot in e.  The circled data in the lower left of the plot in (e) indicates the 
stretching transition where fibers are reorienting and beginning to stretch. The other 
circles on the right side highlight a concave downward trend in the strain plot (e) and the 
corresponding decrease in the strain fraction (f) for the most strained fiber (blue trace).   
Note also that the strain fraction of the green and cyan traces trend upward in the strain 
fraction plot at high AFM tip movement.  These trends indicate that as the most strained 
fiber stiffens, it transfers strain share to the less strained, softer fibers. 
5.3.2 Network Modeling 
To separate the effect of network geometry from the effect of the non-linear stiffness 
of the constituent fibers, experimental results were compared with quasi-static mass-
spring simulations.  Each experimental network was modeled a by a simulated network of 
equivalent geometry.  AFM stretching was replicated by incrementally moving the point 
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(a mass node in the model) corresponding to the AFM/fiber contact in the experiment.  
AFM imaging of fibers extending onto the structured surface ridges indicated an average 
diameter of 80 ± 20 nm (we found no statistical difference between ligated and unligated 
clots).   However, due to the limited feasibility of accurately determining fiber diameters 
within the network before the pull (fibers suspended between the ridges could not be 
imaged with the AFM and the SEM preparation would alter network mechanical 
properties), we have assumed that all fibers have equal diameter.  Though the equal 
diameter assumption is not ideal, it is supported by fluorescent confocal microscopy and 
SEM studies of in vitro clots that show a relatively narrow variation in fiber diameter 
(15-30% (63, 64)). As a consequence of this assumption, each fiber segment has a 
common force vs. strain relation.  Two force extension models were implemented: a 
linear springs model and a non-linear strain stiffening model. 
  Within the linear springs model, each fiber segment is a linear spring with a spring 
constant inversely proportional to its original length (as is the case for an ideal spring), k 
= κ/Lo, where plays the role of spring constant in a force vs. strain relationship.   This 
provides each fiber segment with the same force vs. strain relation, regardless of its 
length (F=κε).   
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Figure 5.3 Experiment vs. Simulations: a-c) Fiber strain traces for a particular 
experimental network and for simulations of equivalent WLC and linear model networks.  
d-f)  Plots of the strain fraction corresponding to plots a-c.   The experimental strain and 
strain fraction data show a much closer correspondence to the WLC model than to the 
linear network particularly for the most strained fibers (blue, yellow, green) at high AFM 
tip movement.  Two predominant features contrast the experiment and WLC model data 
from the linear model. First, the linear model shows much higher maximum strain (blue 
trace, c) then either experiment (a) or WLC model (b).  Second, within the strain fraction 
plots, the most strained fiber (blue trace) shows a clear decrease above tip movement of 
15 microns for both the experiment and WLC model, while the linear model shows no 
such increase.  The strain fractions of the fibers in the linear model approach constant and 
highly dispersed values indicating each fiber takes on constant and inequitable strain 
share.   The strain fraction of the experimental and WLC model fibers converge into a 
much narrower range at high AFM tip movement indicating that strain share is 
transferring from the most strained to the lesser strained fibers, more equitably 
distributing strain throughout the network.   
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We modeled the non-linear single fiber force vs. extension behavior (Figure 5.4), 
using an ideal chain model known as the worm-like chain (WLC), in accordance with our 
αC stretching model described in 2.3.3   
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Where, L is extension, T is temperature, P is persistence length, and Lc is the contour 
length, or the length of maximal fiber extension.  The persistence length, P, is a measure 
of the bending rigidity of the chain (the fiber in our case).  The contour length, Lc 
determines the shape of the force vs. extension curve, most importantly, the onset of 
strain stiffening. The red WLC fit in Figure 5.4, combined with the discussion in  
Chapter 2. Evidence that the αC Region is the Origin of the Low Modulus, High 
Extensibility, and Strain Stiffening in Fibrin fibers, show that the Marko-Siggia WLC is a 
more than adequate analytical expression for modeling the single fibrin fiber mechanics.   
Alternative force extension models that have been very successfully applied to semi-
flexible biopolymer networks such as actin (185) don’t fit our fibrin fiber data as well as 
the Marko-Siggia WLC.   
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Figure 5.4 Single fibrin fiber force curve: Inset: a-d) depict a single suspended fiber 
stretched to breaking (d) by an AFM tip. Plot: Black point depict single fibrin fiber force-
strain data determined by calibrated lateral AFM force measurement. The geometrical 
aspects of the measurement were taken into account to convert raw AFM force data to 
fiber tensile force. The strain of the fiber was determined from the calibrated video data.  
The red trace depicts the WLC fit using two fitting parameters: the persistence and 
contour lengths.  
In the context of eqn. 5.1, each fiber having identical diameter corresponds to a 
common persistence length, P.   Because P simply changes the force scale of the force vs. 
extension properties, its value will not affect the distribution of strains within a network 
(though it will affect the magnitude of the force required to strain it).  On the other hand, 
the contour length parameter, Lc, does significantly affect the stretched network 
configuration and strain distributions, and is the parameter that was varied to best match 
our experimental observations.      
To give each fiber a common force vs. strain relation, we modified eqn. 5.1 to 
provide force as a function of strain. 
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Lc/Lo is the adjustable parameter that determines the onset of strain stiffening. Using 
(Lc/L0) = 5 (meaning the fibers would reach their contour lengths around strains of 4.0, 
although they fail before this point) provided the best correspondence to the experimental 
network strain distributions (see Table 5.1).  This contour length comes not from bending 
and straightening of the fiber itself, but from stretching out of internal molecular scale 
flexible segments within the sub-fiber structure. 
5.3.3 Network Strain Distribution Narrowing 
 A set of fibrin networks were stretched to the point of breaking and the strains of 
the constituent fibers were analyzed.  For each experimental network, the distributions of 
fiber strains were compared to those from equivalent linear and WLC model network 
simulations.  Figure 5.3 compares the experimental and simulated strain data for a 
representative network.  The experimental and WLC strain distributions differ markedly 
in several respects from the network of linear springs.  First, the strain of the most 
strained fiber (blue trace) in the linear model is significantly higher than in the 
experimental data or in the WLC simulation at large AFM tip movement (Figure 5.3, a-
c).   Second, the strain fractions of the most strained fiber in both the experimental data 
and WLC simulation reach a maximum and then decreases above strains of ~1.0, whereas 
no maximum is seen in the linear model (Figure 5.3, d-e).  These differences were 
pronounced in all networks studied.  The absence of decreasing strain fraction in the 
linear simulations indicates that this effect is due to the non-linear force vs. extension 
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properties of the constituent fibers rather than to the generic effect of reorientation and 
alignment of the fibers.   
Strain distributions were compared at two points: “intermediate strains”, where the 
AFM had moved 15μm from its original location, and “high strains”, where the network 
failed (See inset of Figure 5.5).  The intermediate strain point was chosen to fall just 
within the expected pre-stiffening linear elastic regime for all fibers.  Figure 5.5 shows 
the strain distributions for nine different networks of FXIIIa-ligated fibers at both 
intermediate and high strains.  Though the variations in results from network to network 
indicate that the distribution of strains depended on the specific network geometries, 
strong trends bridging all measured networks emerged from the analysis.  
  At intermediate strains (Figure 5.5 top) the model and experimental data were 
statistically similar. Within uncertainties, the maximum strain (strain of most strained 
fiber) and the standard deviation in strain agree for the experiment, WLC, and linear 
model (see Table 1).  These results are consistent with the expectation for intermediate 
strain: all fibers were within the linear regime of elasticity (for experiment, WLC and 
linear model networks).  
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Figure 5.5 Ligated network strain distributions : A compilation of model vs. 
experimental strain distributions for nine different network geometries formed with 
FXIIIa ligation. Each dot in the plots indicates the strain of a fiber within a network.  The 
shaded bars underneath the data points are simply guides to the eye to emphasize the 
strain ranges.  Measurements were made after 15 μm of AFM movement (intermediate 
strain, top plot) and at the point of network failure (high strains, lower plot) (see inset).   
At intermediate strains there are clear variations, but no clear trends distinguish the 
experiment and models.  At high strains, the linear model shows much higher maximum 
strain for all networks and lower minimum strain than for all but two of the experimental 
networks. There is much closer correspondence between the experimental and WLC 
distributions (see Table 5.1 for statistical analysis).  
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On the other hand, the data and models showed distinct differences in the high strain 
data (Figure 5.5 bottom).  The linear distribution had higher maximum strain in all cases 
and the lowest minimum strain for most of the networks.  Comparing the most-strained 
fibers of each network, there was on average 31±6% higher maximal strain in the linear 
model as compared to experiment, whereas there was only a 3±4% difference  between 
the WLC model and experiment (Table 1).  As a measure of the narrowness of the strain 
distributions, we calculated the standard deviation in fiber strain for each network. The 
average standard deviation in the experimental data was 30% less than that of the linear 
network (1.1 vs. 0.82), and was still 20% lower when removing the most and least 
strained fiber in each network from analysis. This finding indicates the narrowing of the 
strain distribution occurred network wide and was not due exclusively to the behavior of 
the most-strained fiber.  The experimental networks behaved in a manner much more 
consistent with the WLC model at high strains, which indicates, not surprisingly given 
the single fiber data (Figure 5.4), that the most strained fiber in each network experienced 
significant strain stiffening prior to failure.  As the network transitioned from the linear 
regime to the strain stiffening regime, the non-linear elasticity of the most-strained fibers 
reduced the maximum fiber strain as compared to a linear network, narrowing the strain 
distribution and preventing strain from being concentrated into only a few fibers.   
Though the gross features of the strain distributions showed good agreement between 
experiment and WLC, there are discrepancies in a fiber by fiber comparison.   This 
discrepancy may be largely due to assumptions in the model, in particular, the use of a 
universal fiber diameter.  
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As a control, model networks composed of linear springs of varying spring 
constants were also tested vs. the experimental results (See Figure 5.6).  While the 
distribution of strain is altered by varying fiber stiffness within the network, the decrease 
in strain fraction at high strain seen in the experimental networks does not occur.  Instead, 
the strain fraction of fibers with a linear force-extension relation approaches a constant 
asymptotic value regardless of stiffness. Thus, for a network of fibers of linear but variant 
stiffness, once the fibers align in the direction of the pull, each fiber assumes a constant 
share of the strain.  
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Figure 5.6 Linear springs with different stiffness: To determine whether strain 
distribution shifts require fibers with non-linear stiffness or can occur in linear networks 
of fibers of variable stiffness, we ran a series of simulations varying the stiffness of the 
most strained fiber while holding the stiffness of all other fibers constant.  Panels (a-f) 
show the results of these simulations for one network geometry (corresponding to Figure 
5.3).  Panel (a) and (b) display the results from the worm-like chain modeling and from a 
simulation where all fibers were modeled as linear springs with the same stiffness 
respectively.  In (c-f) the same simulation was run as in (b), except the stiffness of the 
most strained fiber (a-b, blue trace) was increased by: 10% in (c), 20% in (d), 100% in (e) 
and 500% in (f) while keeping all other fibers at the original stiffness.  As the results 
show, the distribution of strains shifts: in figure (f) the blue fiber is no longer even the 
most strained fiber, but in no simulations is there any hint of the strain fraction decrease 
observed in the WLC model (panel (a)).  Instead, for all fibers following a linear force 
extension behavior, the slope of the strain vs. tip movement plot asymptotically 
approaches a constant value.  This fact held true for all network geometries tested.  This 
leads us to conclude that the strain distribution narrowing effect comes from non-linear 
force extension behavior of the fibers, not differences in stiffness. 
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Physiological fibrin networks are formed in the presence of the transglutaminase 
FXIIIa, which incorporates covalent bonds between monomers - a process known as 
cross-linking or ligation.  All of the experiments and data described thus far (Figure 5.5) 
reflect work on ligated fibers and networks.  Studies investigating the effect of FXIIIa 
ligation on clot structure and mechanics reveal that ligated clots are stronger and more 
resistant to plasminogen mediated dissolution (lysis) (10) than their non-ligated 
counterparts (63).  In addition, ligation also affects the mechanics of the individual fibrin 
fibers in both stiffness and extensibility (64, 66).  As a comparison to the work with 
ligated networks, networks formed without FXIIIa were also stretched to gain insight into 
the mechanical influence of ligation. (Figure 5.7 and Table 1)  These networks failed at 
significantly lower strain values than their ligated counterparts (max strain 1.82 ± 0.11 
unligated, 2.56 ± 0.18 ligated). However, the same trends were observed at high strains: 
maximum fiber strains and strain standard deviations were lower for the experiment than 
in the linear models (16% and 17% lower respectively) and in agreement with the WLC 
model.  
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Figure 5.7 Unligated network strain distributions:  A compilation of model vs. 
experimental strain distributions for nine network geometries formed without FXIIIa 
crosslinking.   
5.3.4 Discussion 
 These studies indicate that strain stiffening of individual fibers plays a significant 
role in the larger scale response of fibrin networks.  A closer look at the details in the 
plots of Figure 5.3 lends insight into the mechanisms responsible for the lower maximum 
strain and narrowing strain distribution of the fibrin networks as compared to the linear 
models.   For the linear model, the fiber strain fraction vs. AFM tip movement curves 
asymptotically approach a constant value at high strain (Figure 5.5f), indicating each 
fiber supports relatively constant share of the strain.  For networks of strain-stiffening 
fibers, the most strained fiber’s plot trends downward indicating that the strain is shunted 
from areas of high strain (which have become relatively stiff) to areas of lower strain 
(which are relatively soft). This allows the maximum fiber strain for a given imposed 
network deformation to be significantly lower for the strain stiffening system than for the 
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linear network model.  The failure of the most strain fiber is a crucial event as it relates to 
clot strength.  This initial failure will further distribute stress that may lead to severe 
strain concentrations and a cascading catastrophic failure of the entire network. The 
stiffening of the individual fibers distributes strain throughout the network, preventing the 
strain from being concentrated in the few lead fibers and allowing larger imposed 
network deformations to be accommodated by the network prior to fiber failure; the 
network is therefore effectively strengthened (See Figure 5.8).     
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Figure 5.8 The Network Strengthening Mechanism of Strain Stiffening: Strength is 
defined as a material’s ability to withstand force before failing.  To determine whether 
strain stiffening of individual fibers increases network strength, simulations of networks 
composed of linear fibers (left side of figure) and strain stiffening fibers (right side) were 
run, and the forces required to pull the networks was compared.   As can be seen in the 
top plots, the distribution of strains in the network is compressed in the WLC networks.  
If one assumes that fibers fail around strains of 2.5, it becomes obvious that the WLC 
networks can be stretched an additional 7 microns before the first fibers cross the 
breaking strain threshold (dashed line).  If one looks at the forces corresponding to the 
point where fibers begin failing, the WLC networks can withstand nearly double the force 
before fiber failure.  This is clear evidence that strain stiffening does indeed increase 
network strength.  Interestingly, looking at the two force curves, it can be seen that the 
linear model network exhibits two linear regimes of stiffness (likely corresponding to a 
transition from network re-orientation to stretching), while the WLC network is 
continually non-linear.  This behavior is evident in experimental fibrin network behavior 
as observed in Figure 5.9.   
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Figure 5.9 Force vs. Displacement of a fibrin network: Top:  The force vs. AFM Tip 
Movement plot for a fibrin network manipulation.  Four points are highlighted (a-d) 
corresponding to the four network displacement images shown at the bottom. The yellow 
arrow in figure (a) highlights the initial location of the tip.     The abrupt force decrease  
at point (d) corresponds to the first fiber failure within the network.  The red circle 
highlights the fibers that have snapped between frames c and d as evidenced at point (d) 
on the force plot.  The force data shows the stiffness of the entire network during the 
deformation.  The stiffness changes once the fibers align in the direction of the pull, and 
at high strains the network stiffens due to the strain stiffening of fibers within the 
network.  In simulations of linear network deformations, the high strain network 
stiffening was not observed; instead, force-extension is linear (See Figure 5.8).   
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Our results underlined the importance of FXIIIa ligation on network strength (64).  
Fibers within ligated networks reached strains 30% higher than those in unligated 
networks; this result is consistent with previous measurements on single fibers (65, 66).   
Here however, we showed that FXIIIa ligation has a direct affect on fibrin network 
strength. Though biochemical factors affect many important aspects of fibrin clots (e.g. 
fiber diameter, cross link density etc.), attention must be paid to how these factors affect 
the mechanics of the constituent fibers.  Subtle biochemically induced changes in the 
force vs. extension behavior of the individual fibers may have profound influence on 
overall clot mechanics.   
 This work also sheds light on the question of relative fiber strength vs. junction 
strength (66).  Ligated networks failed first at junctions ~30% of the time, fibers ~40% 
with 30% of videos inconclusive (n=12).  Unligated networks failed first at junctions 
~45% of the time and fibers ~45% with 10% of videos inconclusive (n=9).  In addition, 
the average value for the breaking strain of the most strained fibers in the network 
(2.56±0.18 FXIII, 1.85±0.11 non-FXIII) agreed within uncertainties with published 
values taken from single fiber measurements of fibrin extensibility (3.32±0.71; 2.17±0.47 
FXII, 2.26±0.52 non-FXIII) (66, 77).  Although sample sizes are small, this data indicates 
that fibrin fibers and junctions have comparable strength.  More comprehensive work is 
needed to quantify the strength of fiber junctions and validate this small data set. 
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5.4 Conclusion 
 To our knowledge, these are the first measurements attempting to quantify how 
individual fiber strains are distributed in a network.  We have demonstrated that the fiber 
strain stiffening measured in  
Chapter 2. Evidence that the αC Region is the Origin of the Low Modulus, High 
Extensibility, and Strain Stiffening in Fibrin fibers and characterized by the αC stretching 
model plays an observable role within a deforming network:  strain stiffening equitably 
distributes strain in the network. As fibers are stretched, they become stiffer than any 
surrounding fibers at lower strains; this allows the more strained, stiffer fibers, to 
distribute the strain load to the less strained fibers and reduce strain concentrations.  As 
network strength is directly related to the failure of individual fibers with the network, 
this reduction of strain concentration effectively strengthens the network.  This non-linear 
regime of fiber elasticity is achieved prior to network failure and is relevant to 
understanding fibrin network strength.  In addition, FXIIIa ligation directly affects 
network strength by increasing the extensibility of individual fibers within a network.  
The strain concentration reduction effect may be an important mechanism in vivo, 
enhancing blood clot strength under the high shear conditions of the blood stream.   
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   INTERMEDIATE           
NETWORK STRAIN 
   HIGH 
NETWORK STRAIN 
 
 
FXIII 
 
Max 
fiber 
strain 
% 
change 
in max 
fiber 
strain  
Avg.  
fiber 
strain  
Fiber 
strain 
Std. 
Dev.  
Max 
fiber 
strain 
% 
change 
in max 
fiber 
strain 
Avg. 
fiber 
strain  
Fiber 
strain 
Std. 
Dev. 
Experiment 1.09±.10 ------ 0.443 0.373 2.56 
±.18 
------- 1.223 0.816 
WLC 1.04±.10 -4±5% 0.414 0.355 2.58 
±.09 
3  ± 4% 1.223 0.854 
Linear  1.09±.11 1±6% 0.419 0.374 3.31 
±.17 
31 ±6% 1.300 1.119 
 
Non-FXIII 
   
 
 
    
Experiment 0.90±.08 ------- .428 .356 1.82 
±.11 
------ 0.922 0.626 
WLC  0.84±.05 2±7% .400 .294 1.88 
±.09 
4 ± 4% 0.920 0.623 
Linear  0.87±.05 1±7% .403 .304 2.11 
±.14 
17 ± 7% 0.936 0.728 
Table 5.1: A comparison of network properties of 18 networks stretched in these 
experiments:  9 networks were ligated by FXIII, and 9 were not.  Intermediate network 
strain is defined as the point where the AFM had moved 15 μm; High network strain is 
defined as the point of network failure.  Qualitative differences were observed in the 
behaviors of the two types of networks, especially in the values of the most strained 
fibers of the network (bold) and the standard deviations.  Uncertainty values are listed as 
standard errors.  Max fiber strain:  The average value of the most strained fiber in every 
network.  % change in max fiber strain:  On a fiber to fiber basis, the average percent 
change between the most strained fiber in the experimental network with the most 
strained fiber in the corresponding model network. Avg. strain: The average fiber strain 
over all of the networks.  Fiber strain Std. Dev. :  The standard deviation in fiber strains 
over all networks.   
 
  
 
Chapter 6. Summary and Future Directions 
6.1 Conclusions and Physiological Relevance 
6.1.1 The Material Properties of Fibrin 
 In this project we have explored the mechanical properties of fibrin across its 
entire structural hierarchy in an attempt to create a bottom up understanding of fibrin 
mechanics.  It is claimed that Isaac Newton once said “If I have seen further, it is only by 
standing on the shoulders of giants.”  In the same manner, this work does not stand alone, 
but arises from the shoulders of the giants.  The basis for this work comes from three 
previous observations about fibrin mechanics: 1) Fibrin fibers have remarkable elasticity 
and extensibility(66), 2) the extensibility of fibrin fibers appears directly related to the 
length of the tandem repeat region in the αC region of the fibrin molecule(95), and 3) 
fibrin networks strain stiffen.(53, 54, 79, 174)  With this basis we’ve proceeded to 
produce a mechanical model for the fibrin fiber and fibrin networks based on the 
mechanical properties of the fibrin molecule, particularly the αC region. 
 In chapter 1, the groundwork was laid for the development of a molecular model 
for the fibrin fiber.  The model must include as many as possible known details about 
fibrin structure, polymerization and the topology of interactions between molecules.  In 
addition, the model must incorporate the known mechanical properties of the fibrin 
molecule.  A comparison was made between the known mechanical properties of fibrin 
fibers and the simplistic models for fibrin extension.  In each case, the models were 
incomplete in their description of the mechanical properties of the fibrin.   
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 In chapter 2, the mechanical properties of fibrin fibers with and without FXIIIa 
cross-linking were explored.  Fibrin fibers strain stiffen at strains above 100%, and have 
an average modulus of 1MPa for unligated fibers and 2MPa for ligated fibers at low 
extensions rising to 6MPa and 10MPa respectively at the point of failure.  This stiffness 
is in line with other elastomeric materials such as rubber and elastin. (92, 125)  A simple 
mechanical model was proposed based on modeling the αC region of the molecule as a 
worm-like chain, and thinking of the fiber as a series of stiff and soft spring in series and 
in parallel down the fiber.  While the model fit the data well, it did not include other parts 
of the fibrin molecule and did not comment on modes of plastic deformation or fiber 
failure. 
 Besides the mechanical properties of the fibrin fiber, the dynamical properties of 
the fiber could play an important role in the fiber’s response to force.  In addition, 
measuring fibrin fiber dynamics could clarify potential molecular mechanisms of 
extension.  The recoil dynamics and their potential molecular sources were described in 
chapter 3.  Using an AFM and high frame rate fluorescence photography, the elastic 
recoil of fibrin fibers was measured.  It was discovered that the fibers exhibited two 
regimes of elasticity: 1) An initial fast recoil which occurred on timescales of 500µs, and 
a slower tensing regime on the order 1-10 ms.  The 500µs timescale eliminates protein re-
folding as a mechanism for the fast regime, but the 1-10ms regime could involve protein 
folding. (133)  The fast regime likely comes from an entropic recoil of an unstructured 
polypeptide such as the αC region.  This could also come from a stretched coiled coil, but 
DMD simulations indicate the coiled coil stretches into a stable interchain β-sheet 
conformation which prevents the recoil; based on simulations and experiments of other 
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materials such as keratin, if this α-helix to β-sheet transition should be irreversible if it 
occurs in fibrin, eliminating the coiled-coil hypothesis altogether.(120, 121) 
 To probe the mechanical stability of additional parts of the fibrin molecule, we 
performed a series of steered discrete molecular dynamics simulations.  First a homology 
model of for the αC region was generated.  Then the αC model, the coiled-coil region, 
and the γ-C and γ-γ interface were stretched under force.  The results of these simulations 
indicate a stablility hierarchy for the fibrin molecule, with the γ-γ interface opening at the 
lowest forces, followed by αC unfolding, then γ-C stretching and finally coiled coil.  
These results prompted a new mechanical model for the fibrin fiber deemed the SLαCK 
model.  As can be seen in Table 6.1, the SLαCK model is able to account for most known 
mechanical properties fibrin. 
 Finally, to test the role of individual fiber mechanics on network mechanics, a 
series of tests stretching fibrin networks were performed, and the individual fiber strain 
was tracked as a function of network strain.  The fiber strain results were compared to 
model networks of linear and strain stiffening fibers.  The results indicated that fiber 
strain stiffening plays the role of reducing stress concentrations and more equitable 
distributing force throughout the network.  Thus, strain stiffening, which in the SLαCK 
model arises primarily from stretching out the fibrin αC regions, plays a role of 
strengthening fibrin networks.  The mechanical properties of the individual monomer, 
therefore manifest themselves at the highest level of the fibrin hierarchy, the network 
level.  This knowledge could provide insight in how to design stronger biopolymer 
materials in the future. 
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Table 6.1:  A comparison of the potential models for fibrin mechanical properties 
with the SLαCK model: A green circle represents a molecular, fiber level, or network 
level property that is explained by the model, a red filled circle represents a property that 
is not explained by the model, a red open circle represents a property that may be 
explained by the model but needs more investigation and a black open circle represents a 
property not addressed by the model. 
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 The results from these investigations on all levels of the fibrin hierarchy lead to 
the conclusion that fibrin is a very remarkable material.  Fibrin fibers are one of the most 
extensible materials in nature, and yet can recover their taut conformation on ms 
timescales after stretching.  The molecule itself contains an unstructured region, a coiled 
coil region, and a globular region, each of which may play a different mechanical role in 
the fiber.  Fibrin networks have an inherent strengthening mechanism built in by the 
strain stiffening properties of individual fibers.  Taken as a whole, fibrin as a material 
appears designed to function in a dynamic environment in which continued resilience 
after multiple loading and unloading cycles is required.   
6.1.2 Physiological Relevance 
 While this work has shown that fibrin has amazing materials properties that can 
be understood on all levels of the fibrin hierarchy, it is important to step back and analyze 
the physiological relevance of these properties.  Stresses are applied in blood clots 
through the shearing of blood at the walls of blood vessels.  The wall shear stress for a 
Newtonian fluid like blood can be obtained with the simple relation: 
 W  (6.1) 
Where    is the shear rate parallel to the wall surface and µ is the fluid viscosity.  The 
viscosity of blood is approximately 4x10
-3
 Pa·s, and the shear rate in arteries can range 
from 200s
-1
 up to 100,000s
-1
 in severe areas of stenosis (constricting of the arteries due to 
disease such as atherosclerosis).(1)  These correspond to wall shear stresses of 0.8 – 
400Pa.  Fibrin fibers constitute only 0.25% of the total clot volume in physiological clots, 
and this value may range as low as 0.0025% based on fibrin’s polymerization 
properties.(8) Assuming a fiber modulus of 1MPa, these shear stresses generate clot shear 
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strains of to 0.03% to 1600%, a huge range.  These simple calculations indicate that fibrin 
stretching does not play a large role in hemodynamic response under normal shear rates, 
but plays an increasing role at higher shear rates in areas of stenosis.  Interestingly, it’s 
been noted that at low shear rates blood clots consist mostly of red blood cells and fibrin, 
while at high shear rates, platelet aggregation dominates thrombus formation.(186-188)   
 Nature is rarely design optimized for a set of properties such as high extension 
and strain stiffening that go unutilized. (86, 189)  In the above calculation, an implicit 
assumption was a uniform distribution of stress throughout the network.  If this is not the 
case, then locally within a network, stress concentrations could require larger fiber 
extensibilities.  In this case, the mechanism of network strengthening arising from fiber 
strain stiffening described in Chapter 5 may play an important role in clot viability.  
Another important reason for fibrin elasticity could come from the polymerization of 
networks under flow conditions.  It was recently shown using in vitro studies that 
networks formed under shear rates as low as 20s
-1
 show a nearly complete fiber 
alignment in the direction of flow.(50, 190, 191)  The ability of αC domains to interact 
and stretch may play an important role in fibrin network formation under flow.  Finally, 
after clot formation, platelets drive a retraction process in which the clot can shrink in 
volume by more than an order of magnitude.(192)  Platelets induce retraction with a 
fibrin fiber loading rate of 10Pa/minute, which could lead to significant fiber 
deformations over the course of several hours.(193)  We can conclude from this brief 
analysis that the extreme mechanical properties of fibrin may not play a role under 
normal shear rates, but could play a role in high shear rates, during clot formation, and 
during clot retraction.   
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6.2 Future Directions  
6.2.1 Measuring the mechanical properties of recombinant fibrinogen variants 
 The work in this study has highlighted the potential mechanical role of various 
parts of the fibrin molecule.  These studies must be followed up by work on both the 
single molecule level, fibrin level, and network level.  As has been discussed earlier, 
fibrin is a complex hierarchical material, and the mechanical properties on the single 
molecule level could affect higher level properties in different ways.  The effects of each 
part of the fibrin molecule can be tested by forming fibers and networks with mutated 
variants of the fibrin molecule.  There are many naturally occurring mutants of fibrin, 
some of which have little effect on the efficacy of blood clotting, and others that are 
greatly deleterious to the normal functioning of the coagulation cascade.  Two fibrinogen 
variants, γ’ and αE, actually compose 8% and and 1% respectively of the total fraction of 
fibrinogen molecules in normally functioning adults. (194-196)  While it is possible to 
find naturally occurring fibrinogen variants with specific mutations to the fibrin coiled-
coil, γ-nodule, and αC regions, these mutations are often heterozygous with the altered 
fibrinogen unable to polymerize or sometimes even be assembled.(11, 197, 198)  A more 
specific method would be to make the fibrin proteins recombinantly, targeting specific 
amino acids for mutation. 
 Two main parts of the molecule that could be tested with recombinant protein 
technology are the αC region and the coiled-coil parts of the molecule because of their 
relatively “simple” folds.  Presumably the simplest part of the molecule to test would be 
the αC region, as it can be shortened or lengthened in the repeat region without affecting 
any folding (although admittedly, with such a large protein it is difficult to predict the 
exact consequences of any alterations in amino acid sequenc).  We have already begun 
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working with two recombinant proteins with altered αC regions, Aα251 (25) and a 
human-chicken hybrid (HC) protein.  In Aα251, the amino acid sequence of the α chain 
was truncated after amino acid 251.  In the human-chicken hybrid fibrinogen, the α chain 
contained amino acids 1-197 of the human fibrinogen molecule, and amino acids 198-490 
of the chicken fibrinogen molecule.  Surprisingly, Aα251polymerized into fibers fairly 
normally, and fibers had extensibilities similar to fibers composed of normal human 
fibrin molecules.  On the other hand, fibers composed of the HC protein polymerize 
abnormally as can be seen in both turbidity and electron microscopy measurements, and 
additionally the fibers were very inextensible. 
 This work needs to be followed up with several additional recombinant proteins 
targeting the αC region.  I would suggest generating fibrinogen molecules with the 
following characteristics:  1) Aα199, where the α chain will consist of amino acids 1-199 
of the human α chain sequence.  This will eliminate any ambiguity arising from Aα251, 
because the known crystal structure of the fibrinogen molecule truncates at amino acid 
200.  Additionally, Aα251 contains potential cross-linking sites in Gln200, GLn221, 
Gln223, Gln237 and Lys206 Lys208, Lys219, Lys224, and Lys230 which would be 
eliminated in Aα199, isolating the effects of FXIIIa cross-linking to the γ chain.  2)  A 
Chicken-human hybrid molecule consisting of amino acids ch1-196 of the chicken 
fibrinogen α chain, and hu196-610 of the human α chain.  This will serve as a good 
comparison to the human-chicken hybrid data.  In addition, we can compare it to the 
mechanical properties of purely chicken fibrin fibers.  It should be noted that this variant 
may not polymerize correctly since the HC protein produced morphologically different 
fibers.  3)  Hu-tdr, which will consist of amino acids hu1-220 juxtaposed with amino 
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acids hu392-610 of the human α-chain.  This takes out the unstructured tandem repeats 
section of the human α-chain.  It is expected that this molecule will lose the majority of 
its extensibility.  4)  Hu+2tdr, which will consist of hu1-220, 20 repeats of the 13 amino 
acid sequence “RSGPGSTGNW,” terminated with amino acids hu392-610 of the human 
α-chain.  In so doing, we will generate a fibrinogen molecule with double, the number of 
tandem repeats in the normal human molecule.  If the extension of fibrin fibers comes 
from this region, Hu+20tdr fibrin fibers should be much more extensible than their 
counterparts.  5)  Hu-Cys, which will consist of the full human α chain, except Cys442 
and Cys472 will be replaced with Ser442 and Ser472.  The main bond holding the αC 
domain structure will be removed; this may prevent the formation of secondary structure 
in the αC domain, and prevent specific intermolecular interactions between αC regions of 
neighboring molecules and have an influence on the extensibility of un-crosslinked fibrin 
fibers.  
 Creating recombinant fibrinogen with an altered coiled-coil region is tricky, but in 
principle is do-able as well.  Typically, coiled coils form out of a specific sequence of 
seven amino acids, often called the heptad repeat (abcdefg)n.  In this sequence, residues 
in the a and d positions tend to be non-polar such as Leucine or Valine, and are 
positioned in the hydrophobic core between the α-helices. Residues in the e and g 
positions are usually charged, and are involved in inter-strand interactions, and amino 
acids in the b, c, and f positions are hydrophilic and exposed outward towards the 
solvent.(199-201)  Fibrin’s coiled-coil structure is more loose than many other known 
coiled-coil domains, with numerous “stutters”,(200) nonetheless, great care would need 
to be taken in order to add or subtract amino acids from the α, β, and γ chains of the 
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coiled-coil structure and still retain its correct folding pattern.  Each chain of the fibrin 
coiled-coil region (α, β, and γ) consists of bookend Cysteins with 111 amino acids in 
between the Cysteins. (202)  One should be able to add one or more heptad repeats to 
each chain between the Cysteins and retain a coiled-coil structure while extending its 
length.  A potential risk in this proposal is that adding an additional heptad repeat could 
twist the molecule in such a way the γ-γ interface or the A:a, B:b knob hole interactions 
are hindered altering polymerization.  Thus, this is a high risk high reward protein.    
 Finally, our simulations indicate that removing the di-sulfide bond between 
γCys153 and γCys182 could result in an additional 87Å of extension in the γ-C region 
before A:a unbinding.  It is not obvious that the γ-nodule would fold properly if these 
residues were mutated.  In fact fibrinogen variant Matsumoto IV, has a 
γCys153→γArg153 heterozygous mutation which prevents fibrinogen assembly.(197)  In 
spite of this, it may be possible to substitute a polar residue of similar size to Cysteine 
such as Serine and still achieve a similar fold.  This would be another high risk-high 
reward fibrin variant, but would provide a model for future A:a knob-hole binding 
studies.  
 In these studies I have suggested a series of mutational studies which would 
provide good models for each phase of the SLαCK model of fibrin assembly.  These 
experiments are risky, but if successful would test several of the hypothesis in our current 
model of fibrin mechanics.  
6.2.2 Cryo-Electron Microscopy of Fibrin Fibers and Fibrin variants 
 As discussed in the introduction, the structure of fibrin fibers has been studied 
for nearly 60 years, but it is important to note that all of the data provided so far, be it by 
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EM or x-ray crystallography has been taken under dry conditions.  As shown by Voter 
and Erickson, the fiber contains 80% water;(43) thus, the majority of the assumptions 
made about the crystalline structure of fibrin fibers, is based on dried out specimens.  
Since the formative work by Yang e. al. in 2000, little work on the fiber structure has 
been pursued.(47)  In addition, the discovery of fibrin sheets under tension has called into 
question the protofibril twisting model for fiber tension.(49)  These unresolved questions 
from the previous model combined with new questions arising from mechanical 
measurements demand a re-investigation of the fibrin fiber structure. 
 The structural model of fibrin fibers needs to be re-investigated at this point 
with an emphasis on understanding the structure of hydrated fibrin fibers, rather than 
dried out fibrin fibers.  In 1994, Baur and Ogendal published a paper on light scattering 
of fibrin fibers during plasminogen dissolution.  In the paper they show one panel of 
images taken on fibrin fibers using Cryo-Electron Microscopy (Cryo-EM)(9).  The 
images show a banding banding pattern within the fibers, but no quantitative results were 
reported and no follow up work seems to have been pursued.     
 We have begun a full tomographic study of the fibrin fiber structure using 
Cryo-Electron Microscopy techniques.  Cryo-EM is a type of transmission electron 
microscopy in which a frozen hydrated sample is studied.  The advantage of Cryo-EM is 
that samples can be studied without being stained, fixed or dried.  Cryo-EM conditions 
are obtained by flash-freezing an aqueous specimen in a cryogen like liquid ethane.  If 
done quickly enough, water undergoes a phase transition in which the molecules are 
immobilized without crystallizing; this state is referred to as vitrious water.  In Cryo-EM 
tomography, one takes a tilt series of low electron-dose images on the same part of the 
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sample.  Using the Central Projection Theorem developed by Crowther in 1970, one can 
then take the Fourier Transform of each of the two dimensional tilt-series images, and 
develop a three-dimensional re-construction of the sample embedded in the vitrious 
water.(203)   
 Cryo-EM tomography has already solved several structural models of 
biopolymer-like materials.  In one beautiful study by Nicastro et al., Cryo-EM was used 
to identify the packing of microtubules inside the axoneme, as well as identify Dyenine 
motors frozen in place between the microtubules.(204)  In another, Schmid et al. 
investigate the actin packing within the acrosome, and show that it deviates significantly 
from standard, un-packed actin.(205)  These studies have lead us to believe that the three 
dimensional structure of fibrin fibers could also be studied using Cryo-EM techniques. 
 In so doing, we hope to answer the following questions:  1) How are the 
protofibrils packed together and where does water fit into the structure?  2) What are the 
lengths of the protofibrils with fibers?  3)  How do larger molecules like FXIIIa fit into to 
fiber, while still allowing for lateral registry?  4)  Where do the αC domains reside within 
the structure?  5)  What is the native persistence length of a protofibril within the fiber 6) 
Where are the locations of the native contacts between protofibrils? 7) Some fibers do not 
readily exhibit banding in EM images, are these fibers structurally different? 8) If the 
fibers are crystalline, how is this broken at branch points? 9) Is there a potential 
mechanism for tension generation in the arrangement of protofibrils within the fiber. 
 At this point, in collaboration with the National Center for Macromolecular 
Imaging (NCMI), we have successfully obtained a reconstruction of one segment of a 
fibrin fiber. 
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Figure 6.1: Segmenting protofibrils within a Cryo-EM fibrin fiber section: The 
above images represent the first preliminary results from fibrin fiber segmentation from 
Cryo-EM tomography.  What appear to be protofibrils within the fiber can be identified 
with this method.  Many more reconstructions must be made and images averaged before 
molecular resolution might be obtained. 
 While the results are exciting, we have been able to obtain isosurfaces of protofibrils 
within the fiber, this work must be repeated and refined over several fibers in order to 
obtain atomic resolution.   Additionally, it would be useful to extend this work to look at 
recombinant fibrin fibers such as those formed by Aα251, or even better, the proposed 
variant Aα199 which would unambiguously show how protofibrils will pack in the 
absence of the αC region. 
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6.2.3 FIONA/FRET Studies of Single Molecules within Fibrin Fibers 
 A series of studies that were discussed during my time at UNC, but were not 
successfully pursued, involved using single molecule fluorescence techniques to study 
the motion of fibrin molecules within fibers during extension.  Two of the most 
successful single molecule fluorescence techniques are Fluorescence Imaging with One-
Nanometer Accuracy (FIONA) (206) or FIONA-like techniques and Fluorescence 
Resonance Energy Transfer (FRET).(207, 208) I will briefly describe the two techniques, 
some possible applications to the fibrin question, and some ways to overcome drawbacks. 
 FIONA is a technique in which a 2-D Gaussian profile is fit to the fluorescent 
point spread function (PSF) of an individual fluorophore in an image:   
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where (xo, yo) is the centroid of the point source, N(x,y) and N(xo,yo) are the counts (or 
photons collected) at pixel (x, y), and at the centroid position (xo,yo) on the CCD (Charge-
Coupled Device) detector, ζx and ζy are the width of the point spread function in the x and 
y directions, and B is the baseline fluorescent intensity.  The goal is to determine the 
mean value of the distribution (N(xo,yo)) and its uncertainty(ζx and ζy).  FIONA has been 
used to localize individual fluorophores with 1nm accuracy.(206)   
 Due to the Raleigh criterion discussed in Appendix B: Optical Microscopy 
Techniques fluorophores need to be spatially separated by 200nm or more to use FIONA.  
Since fibrin fibers are 45nm long, true FIONA may not be applicable, however a 
technique that piggy-backs off FIONA, called NAnometer-Localized Multiple Single-
molecule (NALMS) fluorescence microscopy, allows spatial resolution of multiple 
fluorophores within 200nm. (209)  With the NALMS technique, one applies a 2-D 
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Gaussian fit to a fluorescent region in an image.  NALMS then uses the fact that all 
fluorophores eventually photobleach to resolve multiple fluorophores within the same 
region.  When one fluorophore bleaches, the center of the Gaussian fit will adjust to 
incorporate only the remaining fluorophores.  This will continue until all fluorophores 
have bleached; at this point one can use trigonometry to back out the location of each of 
the original fluorophores based on the movement of the center of the Gaussian fit after 
each photobleaching event.   
 NALMS could be used in fibrin fibers by placing fluorophores in specific 
locations within the fiber.  For example, one could make recombinant fibrinogen 
molecules and add an additional Cysteine to the end of the β-chain of the molecule.  This 
location is in the D-domain, but not near any Ca
2+
 or known ligand binding sites, so it 
should not affect polymerization.  A fluorophore such as Cy3,(206) could then be 
specifically attached to the free Cysteine, using a second Cysteine as a linker.  As a side 
note, free Cysteines are likely to lead to intermolecule di-sulfide bond formation, so care 
must be taken in the labeling and purification to eliminate any unwanted fibrin aggregates 
originating from the free Cysteines.  The initial distance between fluorophores would 
measure about 35nm, sufficiently distant to localize with NALMS.  Fibrin fibers could be 
created using a mixture of non-labeled fibrinogen molecules and labeled fibrinogen 
molecules so as to spot label the fiber.  As the fiber is stretched, all of the molecules in 
the fiber would be stretching in some fashion.  When one of the Cys-tagged fluorophores 
bleaches, the distance between the two fluorophores could be measured.  One could then 
get a distribution of distances between fluorophores for all of the molecules making up 
the fiber at different time points.    
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The trick with FIONA-like techniques is to have a strong fluorophore signal 
above the background fluorescence in the sample and to have long-lasting fluorophores.  
Typically these techniques use TIRF illumination, which only travels 100nm into a 
sample and exponentially decays over the 100nm.  TIRF provides a low background 
signal, but since fibrin fibers are only ~100nm thick themselves, parts of the fiber will not 
receive much illumination.  Tests would have to be performed using multiple 
illumination techniques to see if one could generate a high enough signal to noise ratio to 
use FIONA-type techniques.(207) 
FRET is a technique which exploits the fact that a donor fluorophore can transfer 
energy to an acceptor fluorophore non-radiatively if they are within a certain distance 
(called the Förster Radius), and their excitation and emissions spectra overlap. (210) The 
FRET technique can measure distances, by exciting a donor fluorophore and measuring 
whether or not fluorescence light is emitted in the acceptor fluorophore wavelength; if it 
is, then FRET is occurring, if it is emitted only in the donor fluorophore’s wavelength 
then the molecules are too far apart and FRET cannot occur.  There are many so-called 
FRET pairs, i.e. two fluorophores that emit at different wavelengths and can exchange 
energy via FRET.  The FRET efficiency depends on the Förster Radius to the sixth 
power: (207) 
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and thus dies off very rapidly beyond the Förster Radius.  The Förster Radius is 
technically defined as the distance at which the FRET efficiency is 50%.
 
When FRET is used in single molecule experiments, TIRF illumination is used to 
maximize the signal to noise ratio; this would pose difficulties to fiber stretching 
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experiments due to the diameter of fibers.  Recently however, FRET has been used to 
measure protein unfolding in fibronectin fibers using a confocal microscope.(211)  This 
work indicates that a similar experimental setup could be used for fibrin fibers. 
Recombinant fibrinogen molecules could be generated with specific FRET pairs 
at locations in the coiled-coil or αC region, designed such that the pairs can FRET in an 
un-strained state, but will not FRET in a stretched state.  The labeling of large proteins 
for FRET is non-trivial, but several techniques such as the Split Intein technique 
proposed by Yang, et al. may be applicable to the fibrinogen case.(212)  If these proteins 
can be generated, then pulling on fibers and measuring the FRET signal for various 
labeling schemes should give an unambiguous measurement of what part of the fibrin 
molecule is stretching. 
6.2.4 Single Molecule AFM Studies of Fibrin(ogen) Dynamics 
Previous studies have measured the unfolding of fibrinogen molecules, fibrinogen 
oligomers and fibrin protofibrils using the AFM pulling at constant velocity.(68, 75)  
However, in constant velocity mode, the force applied changes constantly over a wide 
range of forces, creating a complex time series of unfolding events that can sometimes be 
difficult to interpret.  Mechanical unfolding, is a force dependent process, so a more 
detailed look at the unfolding pathway of a protein can be obtained by applying a 
constant force (Force Clamp mode).(170)  We have recently begun force clamp 
measurements on the fibrin molecule, but at the time of writing, the data were not ready 
for publication. 
In the results of the coiled-coil unfolding simulations (Chapter 4.), we showed 
that there is an α-helix to β-sheet transition undergone by the coiled coil and this β-sheet 
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transition prevents an immediate relaxation back into the coiled-coil conformation.   
These results tested experimentally by measuring the collapse dynamics of the coiled-coil 
after forced extension.  This technique was recently used by Berkovich et. al to study the 
refolding of ubiquitin and I27 proteins. (213)  In these studies the proteins were unfolded 
step-wise in an AFM force clamp mode, and then the force was reduced or quenched 
altogether, and the proteins were allowed to refold.   The authors measured two distinct 
re-folding lengths, and characteristic times over which those lengths were reached. 
For fibrin monomers, our simulations would indicate that re-folding does not 
immediately happen after the force quench, but rather the protein will stay in an 
elongated β-sheet conformation.  This could be probed further by making measurements 
at various PH’s or temperatures.  Both the coiled-coil and β-sheet conformation should be 
less stable at PH’s to either extreme of 7.4 or temperatures above 40 degrees. 
Another property of interest is the intrinsic viscosity of the individual fibrin 
molecule.  It has been shown that the whole fibrin fiber is viscoelastic,(67) meaning that 
it exhibits both elastic and viscous components when stretched.  However, it has not been 
determined what gives rise to the viscoelastic behavior of the fibrin fiber.  Recently, an 
AFM based technique has been developed to measure the viscoelastic behavior of 
proteins by stretching the proteins while undergoing driven oscillations.(214)  This 
approach has been applied to unstructured polypeptide chains as well as the myosin 
coiled-coil. (215, 216)  They’ve shown that the internal friction of the protein can be up 
to seven times greater than solvent-protein friction, but at the same time the internal 
friction of a folded protein is significantly higher than an unfolded poly-peptide. (214, 
216, 217)  This experiments could be repeated for the fibrin coiled coil-structure and the 
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αC region of the fibrin molecule.  One would expect significantly different internal 
viscosities between the two regions, and this in turn could lead to a deeper understanding 
of the viscoelastic behavior of the entire fibrin fiber. 
6.2.5 Developing a Coarse-Grained Model for the Fibrin Fiber 
 Discrete Molecular Dynamics has provided a powerful tool to probe the 
molecular origins of fibrin(ogen)’s mechanical properties.  In so doing, we have been 
able to measure the relative stability of most parts of the fibrin(ogen) molecule providing 
a step by step description of what parts of the molecule should stretch under force.  DMD 
falls under the methods category of a coarse-grained model as it uses simplified 
interaction potentials to simulate the reaction evolution of the system.  In spite of these 
simplifications, the fibrin molecule is so large that simulating the entire fibrinogen 
molecule containing 28,400 atoms and 2923 amino acids for ~50ns of real time 
dynamics, will take approximately 1 year at our current computer speeds (estimate based 
on current speed of an ongoing simulation).   
 The next steps in generating a computational model of the fibrin fiber will involve 
additional coarse-graining of the fibrin molecule.  The goal should be moving towards a 
hierarchical simulation of the entire fiber.  The first level of coarse graining could involve 
simulating each amino acid as a virtual bead that interacts with a specific potential 
corresponding to its particular amino acid type.  Simplified amino acid representations 
have been employed in DMD simulations in the past, and understandings of the 
interaction potentials for simplified amino acids have become more sophisticated in 
recent years.(218, 219)  Recently, the coarse grained MARTINI force field was used to 
simulate the extension of vimentin trimer with results consistent with experiments.(114, 
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220)  The same approach could be used in DMD to simulate a fibrin quatramer (~12,000 
virtual amino acids).  This would be a good building block for understanding the 
mechanics and inherent flexibility of a fibrin protofibril. (See Figure 6.2) 
 
Figure 6.2 Successive Levels of Coarse Graining: An all molecule model of the fibrin 
fiber can be built starting with the simulation results from this work.  The next step would 
be to do a protofibril level simulation with each amino acid being represented as a 
parameterized bead.  The next level could parameterize the whole molecule as seven or 
eight different beads with different mechanical properties corresponding to results from 
the all atom simulations.  Finally, a fiber level model could be generated by creating a 
virtual bead that represents the entire molecule and adding iteraction terms that could be 
parameterized from the lower level simulations.  
 From the protofibril level simulations, the next step would involve simulating a 
series of protofibrils connected via αC domain chains.  Additional coarse-graining must 
be employed to make these simulations computationally reachable.  In this work, we have 
characterized the mechanical properties of most of the individual fibrin molecule, 
indicating that we could virtualize the molecule as a set of beads corresponding to the 
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mechanical properties of each of the individual part of the molecule.  For example, a 
coiled coil could be represented as a two state (folded and unfolded) virtual bead with an 
energy barrier of 1.8nN·nm separating the two states.  While not mechanical models, 
similar protein coarse graining has been applied to membrane proteins in simulations of 
vesicle fusion.(221)  This approach could be extended even further to simulations of 
whole fibers composed of virtual beads representing fibrin molecules linked into 
protofibrils within the fiber.  Assuming a 10µm fiber with a diameter of 100nm, 
approximately 16,000 individual fibrin molecules are packed into one fiber.  At each 
level of simulation, the mechanical properties of that level could be carefully 
parameterized to represent the properties of a virtual bead at a higher level.  By 
simulating a full fibrin fiber, a complete understanding the effects of the hierarchical 
topology of the fibrin fiber on the fibers mechanical properties can be achieved. 
6.2.6 Measuring the effects of other blood coagulation factors on Fibrin’s 
mechanical properties 
 Fibrin network formation is the final step of the blood coagulation cascade which 
itself exists within the larger framework of Hemostasis.  Thus far, our mechanical 
measurements have been performed using only fibrin, thrombin and FXIII as variables.  
Future work should expand the single fiber measurements to include additional blood 
plasma components.  We have recently begun investigating the role fiber diameter in 
fibrin lysis times.  As an unexpected corollary, we’ve observed in repeated experiments, 
that as a fiber is lysed, it loses tension before fully breaking (See Figure 6.3). 
(experiments ongoing by I. Bucay).  Interestingly, in these experiments we’ve also 
observed the lysing and loss of tension in fibrin sheets.  Continuing these experiments 
 163 
 
with recombinant fibrinogens such as Aα199 (proposed) or Aα251 may shed light on the 
mechanism of tension within fibrin fibers by eliminating the αC-region from 
consideration. 
 
Figure 6.3: Fiber Tension Loss: The above time series of images was taken after 
addition of 20μM plasminogen and 100pM tPa.  During the time series the fiber slowly 
loses tension as it is being lysed. 
6.2.7 Testing for and α-helix to β-sheet Transition under stretching 
 The MD simulations described in 
Chapter 3. Fibrin Fiber Recoil Dynamicspredict an α-helix to β-sheet transition in fibrin 
during stretching.  This prediction should be tested experimentally.  The model tests for 
this have been performed on keratin fibers.(120, 128)  Kreplak et. al recently used Wide 
Angle X-ray Scattering (WAXS) to probe the transition in keratin fibers.  To our 
knowledge, no one has attempted this with fibrin fibers, but based on Small Angle X-ray 
Scattering (SAXS) results from fibrin gels, WAXS should be applicable as well. 
 Another technique would be to use a die such as congo red which creates a green 
birefringence when interacting with amyloid β-sheets.(119, 222)  This was successfully 
used by Fudge et al. to measure the α-helix to β-sheet transition in hagfish slime 
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threads.(119)  Measurements could be performed in a glass shear cell which would allow 
network visualization throughout the extension.(82, 178)  If a coiled-coil to β-sheet 
transition does occur, then an increase in birefringence should be measurable.  Since 
fibrin has native β-sheet structure, fibrin fibers will exhibit some inherent birefringence 
unlike keratin, but a difference in birefringence should be measurable if a large transition 
occurred. 
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Appendix A: An Overview of Molecular Dynamics Methods 
A.1 Molecular Dynamics:  A Primer 
 This entire appendix is meant to be used as a brief primer on MD methods.  It is 
in no way meant to be complete, but it is presented here in the hopes that those following 
after me may have some basis for continuing my work.  The first section discusses 
general MD methods, and the assumptions behind MD.  Later, I describe in a bit more 
detail, the method and equations governing Discrete Molecular Dynamics (DMD) which 
was used to generate the results in Chapter 4.  For additional resources on molecular 
dynamics the reader is directed to one of many good books on the subject.(223) 
A.1.1 An Brief History to Molecular Dynamics  
Molecular Dynamics (MD) is a form of computer simulation in which simplified 
models of atoms are allowed to interact for a period of time via various approximations 
of chemical and/or quantum mechanical forces, giving a view of the motion and 
evolution of the system.  While initially applied to liquids, (224-226) MD simulations are 
now often applied to proteins and other biomolecules in an attempt to understand their 
motions in physiological settings. 
Levitt and Warshel initiated molecular dynamics simulations on proteins in 1975 
using Bovine Pancreatic Trypsin Inhibitor (BPTI) as a model system; they showed that 
unfolded chains of simplified amino acids would roughly collapse into the native BPTI 
conformation. (227)  This work was followed up by Cooper (228) and McCammon et al. 
who simulated the dynamics of the atoms in BPTI, about the average structure, showing 
that proteins thermally fluctuate about an equilibrium structure and are not rigid. (229) 
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 Since these seminal works, molecular dynamics simulations, have demonstrated 
many remarkable protein processes including protein folding pathways,(230-233) ligand 
binding,(234) normal mode oscillations,(235) forced protein unfolding, (68, 172, 236) 
and ion channel regulation. (237)  In addition, MD simulations are currently being used 
for medical applications such as rational enzyme and drug design. (238) 
A.1.2 The Basic Molecular Dynamics Mechanism 
 At its most basic level, the molecular dynamics method is simply an iterative 
application of Newtonian mechanics (or other types of mechanics such as Langevin (see 
below)) to a system of interacting particles.  The force on each particle (i) in the system is 
given by: 
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vd
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 (A.1) 
Where V is the potential energy of the system and  i is the gradient of the potential 
energy applied to the i
th
 particle, mi is the mass of the i
th
 particle, ai is the acceleration of 
the i
th
 particle, vi is the velocity of the i
th
 particle, xi is the position of the i
th
 particle, t is 
time, and d/dt and d
2
/dt
2
 are the first and second derivatives with respect to time.  The 
future position at time (τ) of every particle (i) in the system can then be calculated based 
on the starting positions (xo) and velocities (vo) of all the particles in the system using: 
oioiii xvax

  2)(  (A.2) 
Typically for MD simulations, the starting positions are based upon a known crystal 
structure, and the initial velocities are assigned randomly from a Maxwell-Boltzmann 
distribution at a given temperature.(223) 
 The potential energy of the system is sum of all the particle-particle interactions 
as well as solvent-particle interactions between the N particles.  Because of this, it is 
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impossible to solve the Newtonian equations of motion analytically.  Instead they must be 
solved iteratively, using numerical methods.  Typically this is done by picking a time 
step, and then using an integration algorithm to solve for the position, velocity, and 
acceleration of each particle after that time step.  The potential energy landscape must 
also be iteratively updated after each time step.  There are many numerical integration 
algorithms each with benefits and disadvantages.  An example of one is the Velocity 
Verlet method:(239, 240) 

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 (A.3) 
All integration methods lose accuracy over the course of many time-steps as they use cut-
off Taylor series expansions to approximate the positions, velocities, and accelerations of 
all the particles in the simulation.(241)   
 MD simulations evolve for S steps of dη, to reach the chosen simulation time η.  
Choosing the correct dη is important, as longer time steps can speed up simulation time, 
but miss important phenomena that occur on faster timescales. Usually dη is chosen to be 
smaller than the fastest timescales of interest.  For protein simulations, dη often chosen to 
be 1fs (10
-15 
s).(236, 242)   
A.1.3  Potential Energy or Force Field calculations in MD  
 The most important part of the molecular dynamics method is calculating the 
potential energy (V) of the system, from which the acceleration can be derived and 
Newton’s equations follow (Eq.A.1).  The total potential energy of the system of N atoms 
is the sum of the potential energies of each individual atom. 
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The potential energy of each individual atom is given by the sum of all of the different 
interactions that the atom will encounter.   
...,,,,, solveleciVDWitorsibendistrii VVVVVVV   (A.5) 
Here, a brief description of the basic potential energy terms will be given as described by  
Höltje in one reference on MD techniques(243), and later a detailed description of the 
potential energy terms for a specific type of MD simulation, Discrete Molecular 
Dynamicis will be provided.   
Vi,str is the bond stretching potential energy term.  It describes the resistive force to 
an atom moving out of its lowest energy state or unstretched (resting) position.  It is 
typically described as a harmonic potential with Vi,str = 0.5kstr(r-ro)
2
 where kstr is the 
stretching spring constant, ro is the rest length, and r is the atomic displacement from the 
rest length. 
Vi,bend is the angular potential energy term.  It describes the resistive force to 
covalently bound atoms bending with respect to one another.  It is typically described as a 
harmonic potential with Vi,bend = 0.5kθ(θ-θo)
2
 where kθ is the bending spring constant, θo is 
the angular rest length, and θ is the angular displacement from the rest length. 
Vi,tors is the dihedral potential energy term.  Dihedral angles are typically in found 
in conformations of 180
o
 or 0
o
 for Cα-Cα interactions, or 180
o
, -60
o
 or 60
o
 for side chain 
dihedrals.  The potential energy terms is often expressed as a cosine function:  Vi,tors = 
0.5kθ[1+cos(nθ-θo)] where 5kθis the dihedral spring constant, n is the number of energy 
minima, θ is the torsion angle, and θo is the rest or reference angle. 
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Vi,VDW is the Van der Waals potential energy term and is typically described using 
the Leonard Jones potential.  a square well version of the Lennard-Jones (LJ) 
potential[(244): 
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where bij = bi + bj and is the Van der Waal radius between the i
th
 and j
th
 particle and εij is 
the interaction strength, and ri and rj are the positions of the i
th
 and j
th
 atom. 
 Vi,elec is the electrostatic potential term, governed by Coulombs law: 
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where Qi and Qj are the charges of the i
th
 and j
th
 atom, and ε is the dielectric constant. 
 Finally, the Vsolv term describes the potential energy for interactions with the 
solvent molecules.  Solvent can either be included explicitly (including a representation 
of individual water molecules), or implicitly where the solvent is represented as a 
continuous medium.  Including explicit water molecules requires much more 
computational time as all of the above potential terms must be calculated for each atom in 
the water molecules.  In addition, simulations are limited to a small box of solvent 
molecules, and this can lead to boundary condition effects.  Implicit solvation is less 
expensive computationally, do not suffer boundary condition effects, and usually give 
better sampling of conformational space.  The downside is that they do not include 
viscosity, and come with the price of making a dramatic simplification to discrete solvent 
structures.(244)  Different implicit solvation representations have been proposed, each 
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with trading off between computational time and exactness.  Below I will briefly describe 
some of the prominently used implicit solvation models. 
 One of the first implicit solvation models was the accessible surface area (ASA) 
model, proposed by Eisenberg and McLachlan in 1986. (245)  In this model, the free 
energy of solvation is calculated for a protein based on the accessible surface area of each 
of the atoms in the protein. 
 
i
iisolv ASAGG )( (A.8) 
where (ΔG)i is the free energy of solvation (atomic solvation parameter) of the i
th
 atom 
and ASAi is the accessible surface area of the i
th
 atom. 
 A similar way to calculate the solvation potential was derived by Lazaridis and 
Karplus (LK or EEF1) in 1999.(246)  In it, the free energy is calculated by using the 
reference free energy of a fully exposed small molecule, and calculating the free energy 
difference of all other atoms around the fully exposed molecule, assuming the solvation 
free energy density is given by a Gaussian function. 
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where the parameters are defined as: volume of atoms (V), correlation length (λi) and 
atomic radius (ζ).  In their paper Lazaridis and Karplus estimated values for each atom 
type.(246)  Using the LK solvation model is only 50% slower than a vacuum simulation. 
 The other main type of solvation model comes from the Poisson-Boltzmann  (PB) 
equation.(244)  It is an electrostatics model that calculates the interactions of each of the 
atoms with a continuous solvent with a position dependent di-electric constant. 
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Where ni
o
 is the number density of the counterions of type i in the protein, Qi is the 
charge of the counterions of type i, and kBT are Bolzmann’s constant and temperature 
respectively.  Solving the exact PB equation can be very computationally expensive for 
large proteins, thus in practice approximations to PB are typically used. 
 An approximation to the Poisson-Boltzman model is the Generalized Born (GB) 
approximation. (247)   In the GB model, the protein is represented as a hard sphere with 
an internal dielectric constant. 
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where ε is the dielectric constant of the solvent Qi and Qj are the charges of atoms i and j, 
and bi is the effective Born radius of the i
th
 atom.  (247)  The Born radius is the effective 
radius of the atom in a given solute.  It characterizes the amount of burial of the atom 
within the molecule, and must be known precisely to have a good approximation of 
Vsolv.(248-250) 
A.2 The foundation of the MD method:  statistical mechanics 
A.2.1 A review of statistical ensembles 
 Ideally during a simulation, one would like to measure macroscopic properties 
about the system as a whole.  In order to do this one must apply methods learned in 
statistical mechanics.  The molecular dynamics method is based in statistical mechanics, 
the branch of physics that applies probability theory to predict the macroscopic 
thermodynamics of systems based on the microscopic properties their constituent 
particles.(251, 252)  In this section, a brief overview of statistical mechanics will be 
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presented, followed by a discussion on how this can be applied to molecular dynamics 
methods.  The basic idea behind statistical mechanics is to be able to extract 
macroscopic properties of a thermodynamic system, such as energy and entropy, 
from ensemble averages of the behaviors of all of the particles comprising the 
system.  The first concept in statistical mechanics is that of the microstate.  A microstate 
(Ω) is a specific microscopic configuration of a thermodynamic system, such as one 
snapshot orientation of all of the atoms comprising a protein.  All of the microstates taken 
as a whole consist of a thermodynamic ensemble of possible states; and within the 
ensemble, each microstate will be visited during the course of the systems’ fluctuations 
with a certain probability.   Using statistical mechanics, one can calculate macroscopic 
properties of the system based on the average fluctuations of the particles through each 
microstate.(252) 
 There are three types of ensembles typically described in statistical mechanics, 
and each ensemble carries certain assumptions and governing which thermodynamics 
properties can be calculated.(252)  The microcanonical ensemble describes a completely 
isolated system having constant energy, number of particles, and volume.  The 
macroscopic function that best describes this ensemble is entropy, as the energy is always 
constant.  The equilibrium state of the system will be the one in which the entropy is 
maximized and the entropy (S) is defined as: S=kBln(Ωn(E)). Where Ω(E) corresponds to 
the total number of microstates with the given ensemble energy. 
 The second type of ensemble is the canonical ensemble.  In the canonical 
ensemble, the number of particles, the volume, and the temperature are fixed, meaning 
the system is in thermal equilibrium with its environment, but has local energy 
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fluctuations.  Within the canonical ensemble, the probability P(Ω) of the system visiting 
any particular microstate (Ω) is governed by the Boltzman distribution:         
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             Where the denominator is a normalizing constant called the partition function (Z) 
defined such that the sum over all the probabilities for the system to be in each possible 
microstate is 1 and β is defined as 1/kBT where kB is the Boltzmann constant.  Here the 
probabilities and partition functions are defined in discrete terms due to the 
correspondence in molecular dynamics simulations, but they can also be defined in 
continuous terms. 
 The partition function turns out to be the most important quantity in statistical 
mechanics.  It contains information on how the probabilities are “partitioned” among the 
various energy microstates of the ensemble, and from the partition function most of the 
average macroscopic properties of the ensemble can be calculated.  Any average property 
of interest (X(Ω)) can be calculated via: 
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Ones of interest for molecular dynamics simulations are the following(252): 
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Here H is the Helmholtz free energy, E is the internal energy, and Cv is the specific heat. 
 The third type of ensemble is not as useful for molecular dynamics, but it is called 
the grand canonical ensemble.  In the grand canonical ensemlbe, the volume, 
temperature, and chemical potential are held fixed, where chemical potential is the 
change in free energy of the system with respect to particle species.  Based on this 
definition, it is easy to see why protein molecular dynamics simulations often do not use 
the grand canonical ensemble, because typically the number of atoms in a protein is 
fixed. 
 One other property that can be derived from statistical mechanics is the system 
temperature.  The equipartition theorem tells us that(251): 
TNk
f
E Bthermal 2
 (A.19) 
Where N is the number of particles, and f is the degrees of freedom.  This turns out to be 
particularly useful for molecular dynamics simulations where N is known. 
A.2.2  The ergodic hypothesis 
 With this basic background in statistical mechanics, it is now time to see how 
statistical mechanics can be applied to molecular dynamics simulations, specifically 
molecular dynamics applied to a protein model.  For more details, the reader is referred to 
an excellent online MD tutorial produced by users of CHARMM which was followed in 
these derivations.(241)  Proteins consist of linear chains of amino acids in a specific 
 175 
 
sequence that fold into a three-dimensional structure.  In MD, a protein is reduced to the 
atoms that constitute the amino acids of the protein, with interaction potentials assigned 
between the atoms based on known electric and quantum mechanical interactions (a more 
in-depth look at these potentials will come later).  The system is assigned an initial state 
of positions and momenta for each atom, and then allowed to evolve over time and 
sample various microstates of the system.  Each microstate can be defined by the 
positions (x
N
=x1,x2…xN) and momenta (p
N=
 p1,p2…pN) of the N atoms in the protein in a 
particular configuration.  The ensemble average of a property of interest X (such as 
energy) is then defined as (using A.14): 
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Where the double sum (it’s actually 3N sums, one for each dimension for N particles) is 
carried out over all atomic positions and momenta, X(x
N
,p
N
) is the X microstate where all 
of the particles are in corresponding positions x
N
 and momenta p
N
, and P(x
N
,p
N
) is the 
probability to be in the microstate defined by (x
N
,p
N
) (equation A.12).  This sum is nearly 
impossible to calculate for an MD simulation, since the simulation would have to pass 
through all possible states of the system, and would take an enormous amount of 
computational time.  This leads us to the basic assumption of molecular dynamics: the 
ergodic hypothesis.(253)  The ergodic hypothesis states that that over long time scales, all 
micro-states within the same energetic phase space will be equally sampled by the 
system.(254, 255)  Thus, the statistical ensemble averages are equal to time averages of 
the molecular system or: 
timeensemble
XX  (A.21) 
The time average of a property of interest can be defined as: 
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However, simulations cannot be carried out to infinite time either, so in practice the time 
average for an MD simulation is calculated by: 
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Where S is the number of time steps in the simulation.  In order for molecular dynamics 
simulations to make experimentally relevant predictions, S must be large enough to 
approximately satisfy the ergodic hypothesis. 
A.2.3  Statistical ensembles in MD 
 Before starting an MD simulation, one must first decide what properties about the 
system are of interest, this in turn will determine which type of statistical mechanics 
ensemble can be applied to the simulation system.  One parameter of thermodynamic 
interest in an MD simulation is the temperature.  Using the Equipartition theorem (Eqn. 
A.19), temperature in an MD simulation can be defined as: 
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  The equations of motion for molecular dynamics are typically formulated for a 
microcanonical ensemble (NVE) where N, V, and E are held constant while temperature 
and pressure are allowed to fluctuate.(223)  This is due to energy conservation assumed 
in Newton’s equations.  Simulations run under these conditions are useful for 
investigating a constant-energy surface within the ensemble, but one must know a-priori 
what energy surface to investigate, as energy will be an input to the simulation and will 
fluctuate around an assigned value.  The energy will drift due to the integration 
algorithms used, but in general will fluctuate around a constant value. 
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 Often times however, in real systems, energy conservation is not nearly as 
important as keeping things at a constant temperature or pressure.  Thus, different 
parameters must be added to Newton’s equations to adjust the ensemble accordingly.  In 
a canonical ensemble (NVT) MD simulation, temperature is held constant while the 
energy and pressure are allowed to fluctuate.(223)    
A.3 Generating a Canonical Ensemble 
 For simulations requiring constant temperature or constant pressure, a 
“thermostat” or “barostat” must be added to the simulation to add or remove energy to 
keep these conditions constant.  This write-up will briefly discuss some common 
thermostats used in MD simulations.  In particular, the reader’s attention is drawn to the 
Anderson Thermostat which is used in DMD simulations. 
A.3.1Woodcock Thermostat 
The first attempt at isothermal molecular dynamics was done by a velocity re-
scaling method proposed by Woodcock in 1971.(256)  After every time-step he proposed 
that the velocities be re-scaled by a factor fα(t) given by: 
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Where Nα is the number of particles and ir  is the velocity (time derivative of the position 
r) of each particle.  The issue with this approach is that it does not allow fluctuations in 
temperature. 
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A.3.2  Anderson Thermostat 
The concept was extended by Andersen in 1980 who proposed to include a 
stochastic element in the process. (126)  At each step, a stochastically chosen set of 
particles would undergo an instantaneous “collision”, adjusting the momentum of those 
particles.   This process is meant to replicate collisions with an external heat bath.  No 
collision is actually calculated, but rather instead, after every time step a fraction of the 
particles exchange their velocities with a new set of velocities randomly chosen from a 
Gaussian distribution of velocities at the prescribed temperature.  The strength of the 
thermostat can be adjusted by changing the mean rate at which each particle suffers a 
stochastic collision (ν).    The probability of a collision is governed by a poison 
distribution:  
)exp()( ttP   (A.26) 
Where P(t)η is the probability that a collision will happen between t and η.  In this way, a 
canonical ensemble can be achieved.  The downside is that the particle trajectories are not 
continuous.  This process is generally referred to as the Andersen thermostat. 
A.3.3 Berendsen Thermostat 
A third mechanism of velocity re-scaling was proposed by Berendsen et al. in 1984. (257)  
The system is supposed to be weakly coupled to a heat bath at some constant 
temperature.  At each step the velocities are scaled such that the rate of change of the 
temperature is proportional to the difference in temperatures between the system and the 
bath: 
 179 
 
 )(
1)(
tTT
dt
tdT
o 

 (A.27) 
where η is the coupling constant.  Thus after each time step, the velocities can be rescaled 
by a factor of λ, v λv where λ is defined as: 
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This is equivalent to adding a friction coefficient to the velocities of order (1/τ)(To/T-1).  
The advantages of the BT are that it is easy to implement, and can be adjusted to rapidly 
bring a system to a desired temperature using a strong coupling constant τ.  The biggest 
disadvantage is that it does not correctly re-produce a canonical ensemble, so time-
averaged properties cannot be calculated.  Thus, it is often used to bring a system to a 
desired temperature, after which point a canonical thermostat is used. (258)  
A.3.4 Nose-Hoover Thermostat 
Because of the discontinuity of the Andersen thermostat, Nose (1984) and Hoover 
(1985) proposed a thermostat based on coupling the system to an external heat bath.(259, 
260)  The Nose-Hoover thermostat is typically derived in terms of Hamilton’s equations 
of motion. (260) The coupling is typically achieved by adding an additional time scale 
degree of freedom (s), and a conjugate mass (Q) and momentum (ps) to the Hamiltonian 
(Total System Energy).  They also introduced virtual variables (r,p,t) which are related to 
the real variables (r’,p’,t’) by: 
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The augmented Hamiltonian is given by: 
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where g is the number of degrees of freedom.  Thus, while the momenta are scaled by s, 
the particle coordinates are not.  The resulting equations of motion are: 
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Thus the quantity ps/Q acts as a friction coefficient for particle motion.  It can also be 
seen that s is not constant, but rather fluctuates with particle velocity.  Thus, the time 
scaling is not constant, so the trajectory is not sampled at even time intervals.  The trick 
with the NHT is to use the appropriate friction constant Q.  If this is not chosen to overlap 
with natural system frequencies, the NHT can act very slowly, or the temperatures can 
oscillate very rapidly, in either case the system energy will drift due to the accumulation 
of numerical errors . (258) The advantage of the NHT, is that Nose was able to show that 
the microcanonical distribution in the virtual variables is equivalent to a canonical 
distribution in real variables.  The equations of motion can be re-formulated in of real 
system variables, and are time reversible, unlike the Andersen Thermostat. 
A.3.5 Langevin dynamics 
 A third type of thermostat using a friction coefficient and a stochastic collision 
term deriving from the equations of Langevin Dynamics.(261)  The basic idea of 
Langevin dynamics is that a particle is moving through a continuum of small “fictional” 
particles generating a drag force γv.  The particles are also exhibit thermal fluctuations.  
The equations of motion of such particles would be given by: 
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Where η(t) is a “noise” force which produces a random kick in the particle position 
similar to a stochastic random walk.  The function η(t) is given by a Gaussian distribution 
at the desired temperature: 
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Thus, with each step the particle position and velocity are scaled by both the friction and 
the random noise term.  Given that the temperature is related to the particle velocities by 
Eq. A.24, the temperature of the system can be controlled by adjusting γ and η(t).  
Langevin dynamics can reproduce a canonical ensemble. (258) 
A.4  Molecular Dynamics of “Large” Systems 
 The calculation of the potential energy of the system at each step is typically the 
most computationally expensive task of the molecular dynamics method.  Using the 
Verlet integration method and a stand potential energy function, the computational time 
A.24(real time on a computer) required to simulate a system scales as N
2
 where N is the 
number of particles.(262)  On the other hand, the simulation time required (the physical 
time need to be captured in the simulation) depends on the phenomena to be explored.  
Chemical reactions happened on the order of femto (10
-15
) seconds, amino acid side chain 
motions happen on the order of nano (10
-9
) seconds, while protein folding can occur on 
timescales of (10
-6 
to 10
1
 seconds). (263)  So, as N increases, simulating longer timescale 
phenomena, such as protein folding, becomes impractical in computational time. 
 In order to get around this problem, coarse-grained models have been developed 
to either simplify the potential energy terms or reduce the number of particles in the 
simulation and speed up the computational time.  One common way for this to be done is 
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the united atom approximation, whereby several atoms or even several amino acids are 
grouped together and represented by an effective particle (bead).(264)  The interaction 
potential energy between these effective particles is empirical and must be generated 
from protein structures, experimental data, all atom molecular dynamics simulations, or 
physics.(265-268)  In spite of their limitations, effective bead approximations have given 
relatively good structural predictions of the folding of large proteins.(269) 
 Another useful technique for large molecules is the so-called Gō model named 
after Nobuhiro Gō.(270, 271)   Gō models are typically applied to questions of protein 
folding.  The basic assumption is that the only the interactions that matter for protein 
folding are those present in the native structure.  In this case, one defines a set of contacts 
from the native structure, and then allows an unstructured chain of the same amino acid 
sequence re-fold into the native state.  In doing so, Gō models are able to simplify the 
potential energy term significantly allowing for faster simulations.  In spite of this Gō 
models have been able to give reasonable predictions for folding energy barriers, and can 
sample multiple folding pathways. (230-233) 
 The other useful coarse-grained approach is using simplified potential energy 
terms, the most successful of which is discrete molecular dynamics (DMD).  The basic 
idea behind DMD is to extend accessible simulation time by using longer integration 
steps due to approximating interaction potentials as square wells. (272, 273)  The DMD 
algorithm uses conservation of energy and momentum combined with the ballistic 
equations of motion (non-Newtonian), to speed of simulation time by a factor of 10
8
-
10
9
.(264)  The results presented in this work, have all relied on the all-atom DMD 
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method, so the next section will describe the method, and energy potential assumptions in 
detail. 
A.5 All Atom Discrete Molecular Dynamics (AADMD) 
 This section will provide a more detailed overview of the AADMD method 
because the method has been used to generate the results detailed in  
Chapter 4.  Unfolding Energy Barriers of the Coiled coil, γ-γ and αC region of the Fibrin 
MoleculeIt begins by describing the equations of motion in DMD and then describes the 
basic potential energy terms currently employed by the Dokholyan lab AADMD 
program. 
A.5.1 DMD Equations of Motion 
 The DMD method was first used by Zhou and Karplus,(272) and was 
implemented by Dokholyan et al. in a Gō model study of a simple protein.(264)   The 
idea is to model the atoms as hard spheres of unit mass.  The interaction potentials 
between any given pair of atoms are approximated as finite square wells (See Eq. A.35 
and Figure A.1) where the depth of the well is determined empirically.  “Neighboring 
interactions” such as bonds, bond angles and dihedral angles are modeled as an infinitely 
high square wells.  The potential energy of the whole system is given by:(273) 
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Where ε is the empirically calculated potential well depth, ao is the radius of the atomic 
hard sphere, and ac is the empirically defined potential cutoff length, and ji randr

 are the 
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positions of the i
th
 and j
th
 atoms respectively.  During the simulation the atoms evolve 
with constant velocity until encountering a potential. Here, Δij is the native contact map, 
which equal 1 if the two atoms in contact in the native state, and 0 if the two atoms are 
not in contact in the native state. The cutoff distance ac is used to define a contact.  At that 
point the velocity changes instantaneously in accordance with the ballistic equations of 
motion (not Newton’s equations of motion).  The ballistic equations of motion are 
defined as follows: (274) 
 )()()( tvtrtr iii

 (A.36) 
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where η is defined as the minimum time between collisions as described by equation 
A.43, and imp /

 is the change in velocity of the ith particle during the collision.  The new 
velocities can be calculated through the conservation of energy, and momentum: 
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If the combined kinetic energy of the particles is high enough, i.e. if: 
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the particles can escape the potential well. If they remain in the well, then: 
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DMD simulations evolve as a series of collisions, where a sorting algorithm is used after 
each step to determine the next collision.  The time between the next collision for any 
two particles can be calculated using: 
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and η, the time between collisions as defined in eq. A.36 is found using the minimum tij 
for each step.  Because a constant integration time step is not used in DMD, η is not exact 
from collision to collision.  In spite of this, an approximate correlation to real time can be 
made using KE=0.5mv
2
.  Assuming a mass of a hydrogen atom (2×10
−27
 kg), a distance 
of 0.1nm between collisions, and an energy of 1 kcal/mol gives an average time step of ~ 
50 femtoseconds.   
A.5.2 AADMD Potential Energy Terms 
 All-Atom DMD simulations of proteins include all heavy atoms and polar 
hydrogen atoms of amino acids.  The amino acids are connect via three different 
constraint potentials: covalent bonds between consecutive atoms (i, i+1), angular 
constraints between nearest neighbor atoms (i, i+2), and dihedral constraints between 
next nearest neighbors ( i, i+3). (159)  The covalent bands and bond angles are modeled 
as infinite square well potentials with effective bond lengths dij and θij (where dij and θij 
are the distance and angle between the i
th
 and j
th
 atom) respectively which are allowed 
vary by ζd,ij and ζθ,ij (See Figure A.1).  Dihedral angle potentials are modeled as multi-
step well defined by a set of distance parameters (dmin, do, d1, d2, dmax).  The dihedral 
distance parameters are determined empirically by a search of the all dihedral interactions 
in a database of protein structures and can be found in the supplemental material of Ding 
et al. 2005.(218)  
 The DMD non-bonded terms include Van der Waals interactions, implicit 
solvation, and hydrogen bond interactions.  Each will be described in brief detail.  Van 
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der Waals interactions are defined using a square well version of the Lennard-Jones (LJ) 
potential: 
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where bij = bi + bj and is the Van der Waal radius between the i
th
 and j
th
 particle and εij is 
the interaction strength.  For the solvation term, DMD uses the Lazaridis-Karplus (LK or 
EEF1) solvation model.(246)  Here the solvation energy is defined as: 
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where the parameters are defined as the reference solvation energy (ΔGfree), volume of 
atoms (V), correlation length (λ) and atomic radius (ζ) and are all taken from Lazaridis 
and Karplus (Lazaridis et al., 1999).(246)  The discretization of Equations A.44 and A.45 
can be done by characterizing a hardcore cutoff distance, do, followed by a series of 
potential steps defined by di, and εi where di,is the distance of the step and εi is the energy 
associated with the step (See Figure A.1).  The cutoff distances for LJ and LK 
interactions are defined to be 0.65nm, and bij and εij and all LK parameters are defined 
empirically; a table of the discretized parameters used in all atom DMD can be found in 
the supplemental material of Ding et al. 2005.(218)   
 Hydrogen bond (HB) interactions depend on distance and angle between atoms.  
In AADMD, hydrogen bond formation is calculated using the reaction algorithm 
proposed by Ding et al. (275)  The method involves the formation of a HB between 
acceptor (A) and Donor Hydrogen (DH) atoms if they come within a certain distance of 
each other (0.42nm) and meet certain energetic requirements.  If the HB reaction does 
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occur, then the atom type changes from A to A’ and DH to DH’; A’ and DH’ cannot form 
hydrogen bonds with other atoms, and there is a potential energy gain εHB between the A’ 
and DH’ atoms.  In addition, orientation (angle) potentials are included between A’ and 
the donor atom D, as well as DH’ and X (the heavy atom attached to A’). (See Figure 
A.1)  In order for an HB reaction to occur, the total kinetic energy of A and DH must be 
greater than εHB, otherwise the atoms do not change their types and undergo a ballistic 
collision. If the reaction is successful, then A’ and DH’ interact with other atoms 
according to the interaction parameters related to their new types.  The total potential 
energy change is given by: 
),(),'(),(),'( kkk
i j
kHB YDHEYDHEYAEYAEE   (A.46) 
Where E(A’,Yk) represents the energetic interactions between A’ and all other (k) non 
HB-participating atoms (Y); E(A,Yk) represents the original energetic interactions 
between A and all other (k) atoms and so on.  Because hydrogen bonding is affected by 
solvation, a correction term is included in the Lazaridis-Karplus (LK) solvation model, 
such that hydrogen bonded atoms have a weaker solvation energy (ΔGfree=3.85kcal/mol) 
than their non hydrogen bonded counterparts (ΔGfree=5.85kcal/mol), and hydrogen bonds 
buried in the core of the atom have different ΔGfree’s than hydrogen bonds exposed on the 
surface.  All hydrogen bonding potential energies, for each type of atomic interaction are 
determined empirically; a table of the parameters can be found in the supplemental 
material of Ding et al. 2008. (159) 
 AADMD simulations performed at constant temperature are done so using an 
Andersen thermostat (See above).  The strength of the thermostat can be controlled by 
adjusting the frequency and number of particles that have their velocities re-scaled. 
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Figure A.1: DMD Potential Energy Terms: DMD employs discretized potential energy 
terms.  As can be seen in (A) continuous potentials are approximated by a series of 
square well potentials (red). (B) Hydrogen bonds are simulated by changing the “atomic 
type” from DH to DH’ and A to A’.  Hydrogen bonded vs. non-hydrogen bonded atoms 
have different solvation free energies as described in the text.  (C-E) show potential 
energy terms for other types of potentials. (Reprinted with modifications from Ding, F., 
Tsao, D., Nie, H., Dokholyan, N.V. “Ab Initio Folding of Proteins with All-Atom 
Discrete Moleculaar Dynamics” Structure 2008, 16(7):1010-1018. Used with Permission 
from Elsevier Limited. © 2008) 
A.6 Calculating free energies from MD simulations 
A.6.1 The Weighted Histogram Analysis Method (WHAM) 
In molecular dynamics simulations, a primary goal is to calculate the free energy 
landscape of the system.  Free energies can be analyzed in two ways: 1) Calculating 
potential mean force (PMF), which is roughly equivalent to the free energy of the system 
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along a specific coordinate.  [From the PMF most thermodynamic quantities can be 
derived](276)  The other approach is to calculate the free energy differences between two 
states in the system.  (161, 277, 278)  While approach (2) is useful if a protein is known 
to reside in two primary conformations, it is often more interesting to study the PMF of a 
protein system as it evolves dynamically. 
The challenge of MD is to sample enough of the protein conformational space to 
generate and accurate PMF, given the often high energy barriers separating parts of the 
space.  Parallel Tempering molecular dynamics is one way of sampling more 
conformational space.  This method involves running S copies (called replicas) of the 
system, randomly initialized, at different temperatures.  The entire simulations can 
carried out at these varying temperatures if the temperature differences are small and 
there is energy overlap between systems, or the configurations can randomly be chosen to 
be exchanged between temperatures.  The second technique is called Replica Exchange 
Molecular Dynamics (REXMD).  (279, 280) The challenge is then to generate a general 
PMF for the entire protein system from the various temperature runs, as information 
about the unfolding barriers is contained in the high temperature data and information 
about the low energy folded state is contained in the low temperature data. 
 The weighted histogram analysis method (WHAM) is a technique to combine 
data from multiple simulations at different temperatures (and/or biasing potentials) in 
order to obtain the PMF of the general system.  The WHAM technique is carried out 
using a specific reaction coordinate of interest (such as the protein RMSD), and an 
unbiased PMF can be generated along that reaction coordinate.(281)  The generalized 
WHAM method was first developed by Kumar et al., (161) and has subsequently been 
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modified to specific simulation cases by a variety of groups.  (281-284)  Here, I will 
follow the generalization of Gallicchio and Levy to lay out the basic WHAM theory. 
(284) 
 In statistical mechanics, the free energy can be found by taking the natural 
logarithm of the partition function:  F=-kBTln(Z).  Correspondingly, the PMF of a system 
is given by:  
)),(ln()( ExPTkxPMF ooB (A.47) 
Where, P
o
(x,E) is defined as the probability density of the system along reaction 
coordinate x at temperature To. (161) 
 Suppose that we want to generate the PMF at room temperature (To).  Assume 
that “S” number of simulations have been run on a given set of protein state replicas 
(i=1…S).  The replicas were run at S different temperatures ranging from Ti=1 to TS.  It is 
also possible to have additional biasing potentials Vi(x) where x is the reaction coordinate 
of interest.  For each replica simulation, the results of the unbiased potential energy E and 
the reaction coordinate x can be separated into B and C numbers of bins respectively as 
the simulations evolve.   Choosing the limits of the B and C to be sufficiently large to 
contain the highest and lowest data points, one can generate a two dimensional histogram 
of the energy states (Ek ;k=1…C) and reaction coordinate states (xj; j=1…B).  Thus for a 
given REXMD simulation, one can generate S such 2-D histograms.  The indexing can 
get complicated, but I’ll represent the count in the jth x bin and kth E bin in the ith replica 
simulation as ni(j,k).  Thus ni(j,k) tells us how many times at a given temperature the 
simulation was in reaction coordinate state x and energy state k.  The goal is to estimate 
the unbiased probability density of states of the ensemble at temperature To: P
o
(x,E).  
Based on our histograms ni(j,k), we can estimate the biased density of states for any given 
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temperature run:
 
),( kjpi .  This can be related to the unbiased density of states at 
reference temperature To , ),( kjp
o
 
by the following relation(284): 
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and ),( kjci is the biasing factor which accounts for the effect of the temperature and any 
biasing potentials:
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(A.50) 
In simulations, there are also usually correlations between the counts in the 
ni(j,k)histograms, so in practice, each ni(j,k) is reduced by a factor gi(j,k)=1+2ηi(j,k) 
where ηi(j,k) is the correlation time of the simulation in the (j,k) bin of simulation i.  In 
practice, the gi(j,k) factors are difficult to compute, but Kumar et al. showed that picking 
gi(j,k) values different by a factor of 10, only changed the respective relative PMF’s by 
about 2%, so choosing a reasonable value for gi(j,k) such as 1.0 typically suffices, or even 
ignoring the gi(j,k)’s altogether is typically ok. (161)
 
 In order to calculate ),( kjpo , Bayes theorem of conditional probabilities can be 
used and the maximum likelihood method can be applied. Bayes’ theorem states that(282, 
285):  
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Where )|(
~
BAP  is the conditional probability of A, given B; )(
~
AP is the unconditional 
probability of A, meaning it doesn’t take into account any information about B;  )(
~
BP is 
the unconditional probability of B; and )|(
~
ABP is the conditional probability of B, given 
A. 
To find ),( kjpo we first to calculate )),(|),((
~
kjpkjnP ii , the conditional probability of 
observing a particular set of counts ni(j,k) in the histogram, given a particular set of 
probabilities ),( kjpi .  Assuming a multinomial distribution for ni(j,k), allows the 
conditional probability to be defined as(284): 
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Using this, estimates of ),( kjpo can then be determined by maximizing the likelihood 
function )),(( kjpL i  with respect to the unbiased probabilities:  
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Doing this leads to two simultaneous nonlinear equations for ),( kjpo and if  : 
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Where Ni is the total number of counts in the i
th
 histogram.  Equations (9) and (10) are 
together called the WHAM equations.(161, 284)   They are typically solved iteratively, 
choosing reasonable an initial value for each of the fi’s, substituting that into equation (9) 
and solving for the ),( kjpo ’s, and then using those values to re-solve for the fi’s.  The 
process is repeated until converging to a constant value.  Finally the PMF can be solved 
for using equation (1): 
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In addition to PMF(x), we can also generate a Specific Heat (Cv) profile for the 
simulation as a function of temperature.  The partition function is given by:(161)       
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Finally using the definition of Cv (A.18) we arrive at:
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A.6.2 Steered Molecular Dynamics (SMD) to calculate unfolding energy barriers 
 Many proteins such as actin, titin and fibrin are designed to respond to forces.(78, 
100, 175)  Because of this, there is an interest in the scientific community to understand 
the unfolding pathways of these proteins, to understand how natural materials are able to 
withstand high physiological stresses.  Beautiful single molecule experiments using the 
atomic force microscope, laser tweezers, and fluorescence techniques such as FRET 
(Fluorescence Resonance Energy Transfer) have begun to explore the unfolding 
pathways of these proteins.(75, 100, 286)  However, most of these techniques can only 
measure differences in distances between the folded and unfolded state under force, and 
the orientation of the unfolded state can only be speculated.  Because of this, a new MD 
technique called steered molecular dynamics (SMD) has been developed to “watch” a 
protein unfold under force. 
 SMD was first developed by Izrailev et al. to study the biotin-avidin un-
binding,(287) but has now been used on many force-related proteins such as fibrin, titin, 
and fibronectin.(68, 236, 288)  SMD is typically performed in “constant velocity” mode, 
where one end (N or C terminus) of the protein is held fixed, and the other end is 
constrained by a harmonic spring to a pull-point, and the pull-point is moved with a 
constant velocity in a given direction.  The force exerted on the protein is then F=kh(vt-
xo) where kh is the harmonic spring constant, v is the velocity, and xo is the original 
position of the pulled atom.(236)  Experiments performed in this way are similar to AFM 
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experiments, where an AFM tip of given spring constant is pulled away from the surface 
at a given velocity.  The downside of this technique, is that while AFM experiments are 
performed on the order of seconds, with pulling speeds in the 20nm/s-2000nm/s 
range,(103) MD simulations typically last 1-100ns.  In order to unfold a protein on these 
timescales, pulling rates of m/s must be used, much faster than experimental rates, and 
likely faster than most physiological processes.  Thus, while the shape of the force curve 
in an SMD simulation, will often match the shape of an experimentally unfolded protein, 
the magnitudes of the forces will be off by orders of magnitude.(68)  In addition, the 
unfolding pathways may be altered under these extreme conditions. 
 Because of this, a new SMD technique of unfolding a protein at constant force has 
recently been used in combination with Discrete Molecular Dynamics (DMD).(172)  In 
constant force mode, one end of a protein is held fixed, and the other end is constrained 
to a pull-point at a constant distance. A constant force is then applied to the pull point in a 
given direction by applying a discretized step-function with a constant energy jump, dE, 
for every distance step, dr, taken in that direction.  The force can then be calculated as 
dE/dr; a force of 70pN can be generated with dE = 0.1kcal/mol and dr=0.01nm. 
 The average time that a protein can withstand a given force can be estimated by a 
Bell equation:(170) 
 
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where ηB is the unfolding time for a protein under a given force (F), ηo can be thought of 
as the time between energy well escape attempts, or the reciprocal of the oscillation 
frequency of atoms in a solid, ΔGB is the unfolding energy barrier in the absence of force, 
and xu is distance between the unfolded energy state and the top of the unfolding energy 
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barrier (See Figure 4.6).(172)  One way to think of applying a constant force to a protein 
is that you are lowering the unfolding energy barrier ΔG, giving the protein a greater 
probability to escape the folded conformation.   There should exist then, a critical force, 
Fc where the lowered unfolding energy barrier is comparable to the free energy of protein 
in its folded state, and it is equally probably to see the protein in a folded or unfolded 
state.  By running a series of simulations at various constant forces, one can estimate Fc 
by looking for the ηB for each simulation and finding the force where ηB begins increasing 
exponentially (See Figure 4.11). 
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Appendix B: Optical Microscopy Techniques 
 Optical microscopy is a powerful and widely used technique to observe samples 
at higher magnifications.  Optical microscopes date back to the early 1600’s, perhaps 
being invented by Galileo Galilei; and at their simplest level can consist of visible light, a 
lens, and an image capturing device (ranging from the human eye to sophisticated 
cameras).  Modern microscopes typically consist of a series of lenses designed to 
optimize illumination and resolution for a particular sample.  In this paper it will be 
impossible to discuss the many techniques used in modern microscopy.  The reader is 
referred one of many reviews for more details.(289)  In this section, some basic concepts 
in optical microscopy will be presented, and a focused section on fluorescence 
microscopy will be presented.  The goal is to provide an elementary background for the 
experimental techniques used in this research, as well as suggesting techniques which 
could be used for future studies on fibrin.   
 Figure 5.1 shows the basic components of a transmission light microscope.  It 
consists of a light source, several sets of filters, a condenser lens to focus the light onto 
the sample, an objective lens to collect and magnify light coming off the sample, and a 
detector to capture the image.  Light passing through the sample, either passes through 
the sample undisturbed, or diffracts off of the specimen.  Abbe, who developed 
microscope theory in the late 19
th
 century still used today, developed that idea that 
microscope specimens can be treated as complex diffraction gratings with openings of 
various sizes.  The greater the number of diffracted orders collected by objective lens, the 
more accurately the image will represent the original object.(289) Thus, the objective lens 
is in some ways, the most important part of the microscope.  
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 Important characteristics of a lens include its magnification, its numerical aperture 
(290)(NA), and its immersion medium.  The magnification, which is the enlargement 
factor of an image, is governed by the focal length (fob) of the objective lens (the distance 
from the lens to where the image is in focus), and the distance to the sample (dob) 
[M=dob/fob].  The numerical aperture defines the conical angle over which an objective 
can receive light.  Typically the NA is defined as n1sin(θ), where n1 is the refractive index 
of the immersion medium and θ is the half-angle of the acceptance cone.  Because sin(θ) 
get’s larger as θ approaches 90o, there is a trade-off between the working distance of the 
objective lens, and the NA of the lens.  This equation also shows why the immersion 
medium is important.  Having a larger n1, allows for higher NA irrespective of θ.(291)  
This happens because (as described in detail below in the discussion of Snell’s Law), 
when light passes from one medium into another of a different index of refraction, the 
light path is altered. 
In any type of microscopy, the natural question that arises is: “What is the 
smallest object resolvable with this technique?”  For optical microscopy, two objects can 
be resolved if the principal diffraction maximum of one object coincides with the first 
diffraction minimum of the other.  For a circular objective lens, the angular distance from 
the diffraction maximum (also known as the Airy Disk after physicist Gerorge Airy) to 
the first diffraction minimum is governed by the Raleigh criterion(289):   
d

 22.1)sin(  (B.1) 
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where λ is the wavelength of light (inversely proportional to the frequency ν) and d is the 
diameter of the lens aperture.  This can be converted into a resolution length by 
multiplying to the focal length of the lens.(290) 
xNAd
f
l ob
2
22.122.1

 (B.2) 
Where Δl is the minimum distance over which two objects would appear distinct, and fob 
is the focal length of the objective, and NA is the numerical aperture of the lens system.  
For visible, light and and N.A. of 1.4, this puts the spatial resolution at about 200nm.  So, 
fluorophores closer than 200nm would appear to be the same thing.   
 
Figure B.1 Epifluorescence vs. Transmission Illumination: In Transmission 
illumination, the condenser lens focuses light through the sample, into the objective lens 
which magnifies the image of the sample into the detector. In contrast, in Epifluorescence 
illumination, the objective lens acts to both focus light into the sample, and collect light 
reflected (or emitted) from the sample.  The acts to reduce ambient illumination light 
from reaching your detector. 
 With this background, we now turn to a particular type of light microscopy, 
fluorescence microscopy.  Fluorescence microscopy allows the study of a wide variety of 
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biological processes from cell motility down to the motion individual protein and DNA 
molecules, by labeling parts of the sample with a light emitting fluorophores.(206, 292-
294) There are a wide variety of fluorescence microscopy methods, but they all follow 
the same general principle.  The sample is embedded with (or contains natural i.e. 
autofluorescence) fluorescent molecules (fluorophores).  Illumination of the sample with 
light of a particular wavelength then causes the fluorophore to fluoresce.  The light 
emitted by fluorescence is then detected through the microscope.  For a full review of 
fluorescence techniques the reader is directed to many excellent books and reviews (295-
298), here a brief and incomplete overview will be presented. 
 Fluorescence can occur when light excites the electrons in a chemical compound 
into a higher energy state (for a deeper understanding of singlet and triplet energy states 
and their role in the fluorescence process the reader is directed to the aforementioned 
reviews) via the reaction: 
xexo ShS    
Where So is the ground state energy, h is Planck’s constant and νex is the frequency of the 
excitation light, and Sx is the energy of the excited state.  Nearly all chemical compounds 
can absorb light, however only those whose ΔE= Sx-So =h νex can fluoresce, because 
fluorescence only occurs when the incoming energy matches a specific energy gap 
(known as the Stokes shift) between two electron energy states (a direct result of quantum 
mechanics).  When an electron does jump into the Sx state, it will then relax back down to 
the ground state, by emitting another electron: 
vibrationsheathSS emox    
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where νem is the frequency of the emitted electron.  νem is typically smaller than νex, 
meaning that the emitted photon has a lower energy than the excitation light.   
 Because of the quantized nature of fluorescence, new research is constantly 
looking for better fluorophores.  Fluorophores can be characterized by several properties, 
including their excitation and emissions spectra, their quantum efficiency, their 
fluorescence lifetime, and their photobleaching lifetime.  The quantum efficiency is 
generally the ratio of photons emitted by the fluorophore to photons absorbed(299), while 
the fluorescence life time is the time in which an electron will stay in its excited state 
before fluorescing.  The photobleaching lifetime, on the other hand, is the length of time 
over which a fluorophore can continue absorbing and emitting photons before it losing its 
ability to fluoresce typically due to light induced chemical modification of the 
fluorophore.  “Good” fluorophores can undergo 10,000-40,000 cycles and last ~1s before 
bleaching. (295) 
 Fluorescence microscopy can utilized several different types of illumination.  The 
canonical method of fluorescence illumination is epifluorescence.  In this method of 
illumination, the excitation light passes through an objective lens, directly into the 
sample, the emitted light then passes back through the same objective lens and into a 
viewing area.(295)  Thus, the objective lens acts both as the illumination condenser and 
the fluorescent light collector.  Epifluorescence illumination is typically done using a 
series of filters and a dichroic mirror which reflects light of one wavelength and is 
transparent to light of another wavelength.  The advantage of this type of illumination is 
that only a small percentage of the exciting light that is reflected off the sample back 
towards the detector, as opposed to a transmission microscope where the illumination 
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light is transmitted through a sample and all of the non-absorbed light passes to the other 
side. (See Figure B.1)  Each dichroic mirror must specifically be designed for an 
excitation wavelength and an excitation wavelength. 
 In spite of its advantages over transmission microscopy, epifluorescence 
illumination can often suffer due to large background fluorescence from to the fact that 
the entire sample is illuminated during excitation.  To overcome these deficiencies 
several methods have been developed.  One common technique is the use of a confocal 
microscope.(300, 301)  In a confocal microscope, a pinhole filter is placed in front of the 
detector so that only focused light passes to the detector while all out of focus light 
misses the pinhole.  In so doing, the user is able to focus on one focal plane at a time, 
while light from other focal planes is eliminated, removing much of the background light.  
To get a full image in confocal microscopy, the focus must be scanned across a plane of 
the sample.  The confocal technique can additionally be used to image at various sample 
depths by adjusting the focal plane of the imaging.  
 Another set of low-background illumination techniques are the so-called 
multiphoton techniques.(302, 303)  These techniques involve illuminating the sample 
with a wavelength around double the actual emission wavelength (since energy is 
inversely related to wavelength, E=h/λ where h is Planck’s constant and λ is the 
wavelength, this corresponds to roughly ½ the needed excitation energy).  However, if a 
pulsed laser is used, two photons (or more) could reach the point of focus nearly 
simultaneously, providing enough energy for electron excitation.(302)  In this way, 
fluorophore excitation will only occur at the point of focus, thereby eliminating excitation 
of out-of-focus fluorophores.  Multiphoton techniques allow for deeper sample imaging 
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than confocal techniques, due to the fact that the longer wavelengths suffer less scattering 
in the sample, and the that illumination light is focused on one point in the sample.   
 One final low background illumination technique that should be mentioned is 
Total Internal Reflection Illumination (TIRF).(304, 305)  TIRF takes advantage of the 
fact that an evanescent wave is developed when light is totally internally reflected at an 
interface of two media with different refractive indices.  As a brief refresher, Snell’s Law 
states that when light (polarized in the   direction in this example), is incident on an 
interface, the angle of transmission, the transmitted plane wave vector, and the electric 
field can be given by (See Figure B.2):(306) 
21 )sin()sin( nn TI   (B.3) 
zkxkk TTTTT ˆ)cos(ˆ)sin(  

(B.4) 
  tzkxkiEtzxE TTTToT   )cos()sin(2exp),,(

(B.5) 
Where θI is the angle of incidence, n1 is the index of refraction on the incident side, θT is 
the exit angle on the transmission side of the interface, and n2 is the corresponding index 
of refraction, and ν is the wave frequency.  
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Figure B.2 Snell’s Law when n2 < n1: a) θI < θC, the light passes into the sample; b) θI = 
θC, the wave is reflected along the interface c) θI > θC generates an evanescent into the 
sample. 
 If n2 < n1, there is an angle θC at which and beyond which all of the light will be 
reflected. 
21 )90sin()sin( nn
o
C  (B.6) 
At angles beyond θC: 
1)sin()sin(
2
1 
n
n
CIT   (B.7) 
making the   component of the    T vector imaginary.  It can then be shown that the 
electromagnetic wave propagates as an evanescent wave: 
])[2exp()exp(),( txkizEtxE ToE  

(B.8) 
where the attenuation constant, κ is a function of the angle of incidence, and the 
refractive indices.  The evanescent wave propagates in the   direction, but exponentially 
dies off in the n2 medium.  The intensity of the evanescent field can be written as: 
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Thus, using TIRF illumination, one can generate an evanescent wave that’s intensity 
exponentially dies in the transmission medium.  Experimental δ values range around 
100nm, meaning that only the first 100nm of a sample will be excited fluorescently, 
yielding very low fluorescence background.  The downside is that, in practice, the sample 
must also be < 100nm thick, so TIRF illumination can only be used primarily in single 
molecule studies.  
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Appendix C: Atomic Force Microscopy 
 The primary tool for measuring forces in this work was the Atomic Force 
Microscope (AFM).  The AFM was invented by Binnig, Quate and Gerber in 1986, and 
has quickly risen to prominence as a tool for atomic resolution imaging and force 
sensing, among other things. (307)  Figure C.1 shows a schematic design of a basic AFM.  
It consists of cantilever (a thin beam supported on one end), with a sharp tip hanging off 
(called a probe) at the unsuspended end.  Probes are often conical in shape, and can taper 
down to radii of 1-5nm.  The cantilievers are typically rectangular or triangular in shape 
and composed of silicon or silicon nitride.  A laser is focused on the back of the 
cantilever and deflected into a quadrant photodiode detector (QPD) to sense horizontal or 
torsional deflections in the cantilever.(308)  The cantilever is typically mounted on a 
piezo-electric (piezo) material that allows it to adjust to changes in the laser signal 
through a feedback loop.   
 For details on AFM imaging techniques, the reader is directed to a few of many 
reviews available.(308-312)  Basically, imaging with the AFM is done by raster-scanning 
the tip back and forth over a surface.  Imaging can either be performed in contact mode, 
where a feedback loop adjusts the piezo height to keep the deflection of the cantilever 
constant; or in dynamic mode where the cantilever is driven near its resonant frequency 
and the feedback loop adjusts the piezo to keep the amplitude of oscillations constant.   
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Figure C.1 Basic AFM Setup: One can think of an AFM as a tip mounted on a 
cantilever which can be used to scan a surface.  The cantilever and/or scanner are 
mounted on a piezo electric material allowing constant adjustments through a feed-back 
loop.  A laser reflects off the tip and into a quadrant photo diode to measure the tip-
surface interactions. 
 There are two main types of dynamic mode operation: non-contact and tapping 
mode.  The difference between the two modes is governed by whether the AFM tip 
actually touches the surface.  In non-contact mode, the AFM tip floats 5-15nm above the 
surface, and interacts with the attractive Van der Waals forces of the surface. (311)  The 
tip is driven slightly below its resonance frequency at small oscillations.  The topography 
of the sample can then be re-constructed by measuring changes in the oscillation 
amplitude from Van der Waals forces.  In tapping mode, the cantilever is driven at much 
larger amplitudes, typically between 20-100nm.(311)  The tip is scanned back and forth 
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at a height where it intermittently touches the surface.  Changes in the height of the 
surface cause the vibration amplitude to increase or decrease, and a feedback loop adjusts 
the tip height accordingly.  The difference between the instantaneous tip oscillation 
amplitude, and the reference amplitude (above the surface), read out as an error signal, 
can be used to plot the topography of the sample. 
 In contact mode, the AFM is kept in close contact with the surface as it scans.  
The tip can either be held at a constant height, or at constant force during scanning.  In 
both modes, the topography of the surface can be measured from the deflection of the 
signal off the cantilever.  Constant height mode imaging is not typically used, as the tip 
will quickly be damaged if there are high places on the sample surface.  In constant force 
mode, the deflection of the cantilever is kept constant through a feedback loop, where the 
piezo adjusts the height of the scanner in response to changes in sample height.  Because 
of the deflection can directly be related to a force through calibration (see below), this 
mode is called constant force mode.  The sample topography can be calculated from the 
error between the instantaneous deflection signal and the reference (set point) signal (ΔT-
B in Figure C.2.  The main drawback of contact mode imaging is that soft samples can be 
damaged from tip-surface interactions. 
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Figure C.2 Normal and Lateral Cantilever deflections: The AFM cantilever can either 
deflect normally, shifting the top-bottom (ΔT-B) signal of the QPD, or can twist laterally 
which will show up in the left-right (ΔL-R) QPD signal.  After calibration, the ΔT-B and 
ΔL-R signals can be converted into an length or angular deflection of the cantilever 
which can then be converted into a force through Equations C.1 and C.2. 
. 
 In contact mode, the AFM can also be used to directly measure forces.  This has 
become a powerful technique in protein unfolding studies.(98, 102, 103)  The AFM 
cantilever can bend and twist when interacting with the surface (or a protein) as seen in 
Figure C.2.  Due to its inherent length, width, thickness, and composition material each 
cantilever has a natural spring constant in both the bending (kN) and twisting or lateral 
(kL) modes.  Using Hooke’s law, the force on the cantilever can then be calculated for 
each mode as: 
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xkF LL   (C.2) 
according to Figure C.2.  The changes in bending (Δz) and lateral (Δx) deflections can be 
measured from the change in the top-bottom (ΔT-B), and left-right (ΔL-R) laser signals 
in the QPD according to:   
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where ST-B and SL-R are calibration sensitivities (often called the optical lever sensitivity 
or OLS).  ST-B, the bending sensitivity, can be measured by pushing the cantilever into an 
“infinitely hard” surface.  In principle, this is done by pushing the cantilever onto a 
surface whose stiffness is much higher than that of the cantilever.  The sensitivity is 
measured in units of current or voltage/nanometer and is a measure of how much the T-B 
signal changes per nanometer or indentation into the surface. 
 Calculating the SL-R is not as straightforward, but techniques have recently been 
improving.   Early efforts to calculate SL-R often involved some combination of beam 
bending mechanics, and assumptions about the photodetector.(313-315)  Other 
techniques including the glass rod techniques, and trapezoid techniques involved running 
the tip into a known surface and inducing a twisting of the cantilever.(316-318)  Others 
have used piezoelectric force sensors as part of their calibration techniques.(319)  A 
recent and promising approach has shown that the torsional OLS can be calculated 
directly from the thermal noise spectrum of the cantilever, if the spring constant is know 
a priori. (320)  For our measurements, we typically use the geometrical calibration 
because of its simplicity, and the observation that using other methods (the wedge 
method for example) did not provide drastically more accurate results. 
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 The spring constants kN and kL also can be solved through a variety of methods.  
One of the simplest and most common methods is using the equipartition function to 
calculate the spring constant based on the cantilevers thermal fluctuations.(321, 322)   
2/ zTkk B   (C.5) 
Where k is the spring constant and <z
2
> is the mean squared cantilever fluctuations, 
which can be calculated for the bending or torsional modes.  Updates to the thermal 
calibration procedures have been produced to account for the non-idealness of the 
cantilever as a spring.(323)  There have also been several geometrical calibration 
procedures produced derived from Euler-Bernoulli beam bending equations, the most 
common of which is the Sader method. (314, 315, 324)  For rectangular cantilevers the 
constants are:(319) 
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where G and E are the shear modulus and Young’s modulus respectively of the 
cantilever, and the geometrical parameters are the width of the cantilever, w, the 
thickness of the cantilever, t, the length of the cantilever, L, and the length of the tip, lt.  
In addition, there have been more involved methods proposed such as adding known 
masses to the cantilever and measuring the decrease in resonance frequency.(325) 
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